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Self-assembly allows the rapid formation of complex molecular systems, such as cages, 
through the use of weak interactions between nano-sized building blocks. These multi-
component systems often possess unique properties not observed for conventional molecules 
and have potential applications in areas such as sensing, medicine and catalysis. In particular, 
cage like compounds can act as tiny containers capable of trapping and controlling the 
reactivity of smaller molecules, in a manner similar to the processes used by proteins within 
the human body. Another field of chemistry, called photoredox catalysis, has developed 
compounds capable of absorbing visible light from the sun or household lightbulbs and using 
the resultant energy to perform chemical reactions. This allows reactions to be performed 
without expensive heating that might otherwise destroy the fragile compounds involved. 
This work details attempts to combine these two areas of chemistry to allow the strict control 
of individual reactions that can be performed using green and environmentally friendly 
conditions. Various methods are described in order to increase the stability of the cage 
systems, improve the trapping of smaller molecules within the cage compounds and assess 








Supramolecular chemistry allows the rapid formation of complex systems through self-
assembly. These systems often possess unique properties not observed for conventional 
covalent constructs and have potential applications in areas such as sensing, drug delivery 
and catalysis. Metallosupramolecular container compounds have been shown to catalyse 
reactions with both regio- and stereo-selectivity in methods analogous to enzyme type 
catalysis. Separately, visible-light photoredox catalysis has recently gained considerable 
interest as an efficient, green and mild method for the rapid synthesis of many chemical 
compounds.  
In order to combine the favourable properties of both supramolecular catalysis and visible-
light photoredox catalysis, a number of photoredox active metallosupramolecular assemblies 
were designed, synthesised and analysed. Initial steps were taken to stabilise a known 
iridium-based M6L4 luminescent cage compound to allow guest encapsulation to take place. 
The incorporation of isocyanide donors as strong ligands improved the stability of model 
compounds but synthesis of an analogous three-dimensional assembly was unsuccessful. 
Instead, a “complex-as-ligand” approach was taken that allowed the straight-forward 
formation of Pd2L4 systems from a range of photoactive iridium complexes. Importantly, 
unlike many other photoactive systems, the complexation to palladium did not drastically 
affect the photoredox properties of the constituent iridium complexes. Multiple approaches 
were then taken to improve both the stability and guest binding properties of the photoactive 
assembly in an effort to achieve supramolecular photoredox catalysis. Utilising a model 
system, a general method was thus developed for enhancing the association constants of 
neutral guests in organic solvents by switching to large, non-coordinating counter ions that 
provided reduced competition for the internal binding site. In combination with this 
increased binding affinity, a range of guest properties were adjusted by association with the 
hydrogen bond donor environment of the internal cavity. The encapsulation of quinone based 
oxidants led to unexpected and novel reaction pathways not observed in the bulk phase. As 
such, this work represents a significant advancement in development of 
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Metallosupramolecular systems have shown interesting properties as “molecular flasks” that 
can isolate encapsulated compounds from the bulk phase and catalyse both regio- and stereo-
selective reactions in an enzyme like manner. Separately, photoredox catalysis has shown 
great potential as a mild and environmentally friendly method for the production of complex 
organic compounds. This chapter aims to introduce the reader to these research areas and 
propose the general idea of combining both concepts to produce a single self-assembled 













The idea of catalysis, whereby a substance increases the rate of a chemical reaction and yet 
itself remains unchanged, has transformed the way in which chemistry is performed. From 
the protein-based enzymes that perform thousands of different biochemical transformations 
within our cells to the metal hetero-catalysts that are used to produce millions of tons of 
fertilizers and fuels every day, catalysis plays an essential role in all aspects of human life. 
Without the incorporation of catalysts, these chemical processes would still take place but 
with reaction half-lives measured in years or even millennia. Indeed, some enzymes have 





Enzymes achieve these remarkable rate enhancements by binding substrates in specific 
conformations that favour reactivity. In addition, various functional groups are activated or 
stabilised by the proximity of amino acid side chains with specific properties.
2
 In theory, if 
the transition states of a chemical process are known then an enzyme could be designed from 
scratch to specifically catalyse that chemical process. However, the vast array of 
intermolecular interactions that hold peptide chains together are too complex for rational de 
novo design at present.
3–5
 
Supramolecular chemistry allows the self-assembly of large complex systems from relatively 
simple building blocks. These can be held together by a range of reversible interactions but 
the use of metal-ligand bonds provides the unique advantage of strict geometries and high 
strength. This allows, so called metallosupramolecular systems to be designed and 
synthesised successfully with a high degree of predictability in the resultant structure. 
Discrete metallosupramolecular structures often possess internal cavities that can bind and 
alter the properties of guest compounds and as such, can serve as synthetically achievable 
analogues of biological enzymes. 
Even with efficient catalysis, many industrial processes still require high temperatures and 
harsh conditions to drive chemical processes. Photoredox catalysis offers a mild and 
environmentally friendly alternative whereby visible-light, even in the form of virtually 
limitless sunlight, can be used to drive reactions at room temperature. However, the 
formation of highly reactive species in situ means that stereo- and regio-selective photoredox 
catalysis remains challenging.    
This chapter aims to familiarise the reader with the areas of metallosupramolecular catalysis 





to form photoactive supramolecular assemblies capable of achieving regio- and stereo-





1.3 Metallosupramolecular Catalysis 
1.3.1 Introduction 
One of the first examples of a discrete metallosupramolecular system was discovered 
unexpectedly as a result of investigations with Grignard reagents, malonic esters and oxalyl 
chloride.
6
 The malonic esters and oxalyl chloride combined to form a dianionic bis-bidentate 
ligand (3) that then complexed the free magnesium ions (Scheme 1.1). The isolated Mg4L6 
compound (4) was identified as a symmetrical tetrahedron by X-ray crystallography but the 
internal cavity was far too small for the system to display any of the host:guest chemistry 
that has become fundamental to the potential applications of metallosupramolecular cages.  
Scheme 1.1: Serendipitous discovery of a magnesium based Mg4L6 tetrahedron via formation 
of a dianionic bis-bidentate ligand. 
This result was followed shortly by Fujita and co-workers who developed discrete two-
dimensional palladium squares by capping the palladium centres with ethylene diamine to 
form 90° corner segments (6) (Scheme 1.2).
7
 These Pd4L4 squares (7) were also used to 
demonstrate the first example of guest binding by a self-assembled metallosupramolecular 
system with a reported Ka of 750 M
-1
 for 1,3,5-trimethoxybenzene in water. 





A complementary series of organic soluble metallosupramolecular square compounds were 
also developed by Stang and co-workers using phosphine based capping ligands.
8–10
 
Labilisation of the metal-ligand interactions due to the strong trans-effect of phosphine 
ligands, also aided the formation of the corresponding platinum structures.    
In 1995, Fujita and co-workers expanded upon their initial two-dimensional design and 
reported the synthesis of a Pd6L4 truncated tetrahedron (8) (Figure 1.1).
11
 The structure was 
confirmed by X-ray crystallography of the adamantyl carboxylate salt and 
1
H NMR studies 
showed significant interactions and slow binding between the host and carboxylate guests. 
Fujita and co-workers also highlighted the surprising thermodynamic stability of the 
assembled Pd6L4 cage. Rather than degrading into a complex mixture of partially 
coordinated species upon addition of excess ligand, the cage remained completely intact due 
to a high degree of cooperativity and highlights the thermodynamic stability required for the 
selective formation of discrete metallosupramolecular structures through self-assembly.     
 
Figure 1.1: Structure of the Pd6L4 truncated tetrahedron self-assembled from diamine 
capped palladium. 
Since then, the range of metallosupramolecular assemblies known has increased greatly, as 
has the variety. These systems often possess remarkable properties that make them ideal 




 and catalysis (see later 
for specific examples), many of which rely on the interaction and isolation of guest 
compounds within the resultant internal cavities. For the remainder of this report, the focus 





precedent for catalysis either through alteration of guest properties, stoichiometric rate 
enhancements or even the rare few examples that have achieved true catalysis. It should be 
noted at this point that there are many alternative supramolecular systems that have also 
displayed catalytic activity, such as hydrogen bonded assemblies
18–21
 or covalent 









 but, with the exception of a few specific examples, these organic systems are 
out with the scope of this work.  
1.3.2 Stabilisation of Reactive Species 
The first step in achieving supramolecular catalysis relies on the ability to change the 
physical properties of a substance by encapsulation within a supramolecular framework. In 
many cases, rather than enhancing the rate of reaction, such encapsulation leads to the 
stabilisation of the species in question due to isolation from the bulk phase. Ordinarily, 
compounds in solution will be surrounded by a mixture of solvent molecules, dissolved 
oxygen and other reactants. By isolating a species within a framework, they are prevented 
from interacting with anything other than the framework itself and are often held in much 
more rigid and unusual geometries that can physically prevent reactions that would 
otherwise occur. 
 
Figure 1.2: Structure of calixarene based hemicarcerand used for the encapsulation and 
stabilisation of in situ generated cyclobutadiene. 
This concept was first identified by Cram and co-workers in 1991 with a calixarene based 
hemicarcerand (9) that was capable of binding and stabilising the highly reactive 
cyclobutadiene (Figure 1.2).
41





allowed the in situ preparation of cyclobutadiene (11) within the internal cavity where it 
remained stable in solution at room temperature under an inert atmosphere. 
Perhaps the most prominent example of substrate stabilisation by a metallosupramolecular 
cage was given by Nitschke and co-workers who demonstrated the encapsulation and safe 
storage of white phosphorus within an Fe4L6 tetrahedron (13) (Figure 1.3).
42
 Although the 
portals of the cage are large enough to allow the entry of O2, the intermediate product formed 
from oxidation is too large to fit within the interior of the cage. Whilst encapsulated within 
the cage, P4 can be stored in aqueous solution under air almost indefinitely but can be 
selectively released upon displacement with excess benzene.  
 
Figure 1.3: Chemical structure of water-soluble Fe4L6 metallosupramolecular cage and 
crystal structure of white phosphorus, P4, bound within the internal cavity. For clarity, only 
one ligand is shown. 
In a similar manner, cage 13 can be used to protect furan and prevent it undergoing Diels-
Alder reactions with maleimide (15) (Scheme 1.3).
43
 Again, steric confinement within the 
cage prevents any cyclisation and selective release with excess benzene as a competing guest 








Scheme 1.3: Diels-Alder reaction of furan and maleimide with and without the presence of 
cage 13. 
Using a gallium based tetrahedral cage,
44
 Raymond and co-workers showed that iminium 
cations could be stabilised within the highly anionic cavity (Figure 1.4).
45
 By performing a 
competition experiment with a dynamic library of amines and ketones, the cage was shown 
to recognise slight structural variations in the iminium ions and preferentially bind the most 
ideal conformation. This highlights the enzyme-like ability of supramolecular containers to 
recognise specific molecular targets based on size and shape rather than the generic 
reactivity of common functional groups. 
 
Figure 1.4: Structure of self-assembled anionic Ga4L6 cage (for clarity, only one ligand is 
shown) and stabilisation of encapsulated iminium ions. 
More recently, metal complexes have also been stabilised within metallosupramolecular 
assemblies. Utilising cage 8, Fujita and co-workers incorporated a di-ruthenium complex that 
ordinarily undergoes rapid rearrangement in solution to form an equilibrium mixture of 
conformational isomers (Scheme 1.4).
46





the more unusual cis-bridged isomer was observed along with increased stability towards 
visible-light. The increase in photostability was thought to be due to strict steric confinement 
preventing the release of CO or splitting of the Ru-Ru bond whilst also increasing the rate of 
re-combination. 
 
Scheme 1.4: Conformational isomers of di-ruthenium complex   
Another example of enhanced photostability is given by the encapsulation of radical 
initiators within an anthracene based Pd2L4 system (24) developed by Yoshizawa and co-
workers (Figure 1.5).
47
 Ordinarily, irradiation with UV-light leads to the degradation of 
azobisisobutyronitrile (AIBN, 25a) and the release of  reactive radicals due to the high 
thermodynamic driving force provided by the release of N2. This mechanism is not sterically 
demanding and thus the increased stability within the capsule is thought to arise from the 
high extinction coefficient of the anthracene ligands which prevents any UV absorption by 
the encapsulated guest. Even though encapsulated AIBN remained thermally unstable, the 
thermal stability of the structurally larger derivative (25c) was also improved, owing to the 
increased steric encumbrance which prevented even the slight elongation required for 
homolytic bond cleavage. 
Rather than using extended π-systems for photon absorption, highly coloured ruthenium 
complexes have also been used to protect photosensitive compounds (27-29) from visible 
light by incorporating them into a supramolecular structure (Figure 1.6).
48
 Although simple 
dissolution of the ruthenium complex offers some degree of protection from visible light in 
its own right, encapsulation of the guests within a Pd6(RuL3)8 cage (26) increased the guest 








      
 
Figure 1.5: Structure of Pd2L4 anthracene cage (24) and corresponding encapsulated 
radical initiators guests (25a-c). 
 
Figure 1.6: Structure of ruthenium based Pd6L8 cage (29) and investigated photosensitive 





1.3.3 Regioselectivity & Unusual Reaction Pathways 
Metallosupramolecular assemblies can drastically alter the properties of an encapsulated 
compound due to the restricted environment within the enclosed internal cavities. As such, 
these systems have been termed as “molecular flasks” in reference to their ability to 
encapsulate and contain individual reaction environments.
49
 The restricted spatial confines 
can lead to alterations in the reaction pathways normally observed for solution based 
chemistry and give rise to unusual regio- or stereoselectivity. 
After describing the synthesis of the metallosupramolecular Pd6L4 cage (8), Fujita and co-
workers showed how the internal cavity could be used as a molecular-sized reaction 
container to control the products formed by polymerisation of trialkoxysilanes.
50
 Under 
suitable conditions, trialkoxysilanes are well known to undergo rapid polymerisation to form 
extended siloxane networks.
51
 When the trialkoxysilanes were reacted in the presence of 
Pd6L4 (8), polymerisation was prevented and instead, the trimer was isolated within the 
capsule cavity. The individual trialkoxysilane molecules were able to enter the interior of the 
cage through the open portals where they rapidly condensed to form a trimer that was 
subsequently irreversibly bound. In an extension of this work, a range of different 
metallosupramolecular tubes, bowls and cages were able to selectively produce the siloxane 
monomer, dimer and trimer respectively (Figure 1.7).
52
 
The Pd6L4 truncated tetrahedron (8) described by Fujita has also been utilised as a molecular 
flask for a number of different reactions. The system was found to be a suitable host for a 
range of hydrophobic aromatic guests that bound in a 1:2 host:guest ratio. The dimerization 
of acenaphthylene or naphthoquinone (32) by activation with UV light usually results in a 
mixture of syn or anti products. The exact ratio of these products is often heavily influenced 
by the reaction conditions but a mixture is always obtained. However, when these 
compounds were bound within (8a-b) prior to irradiation, only the sterically less demanding 
syn adduct was formed (Scheme 1.5).
53
 The physical space within the cage interior pre-
arranged the guests into the syn conformation and prevented the formation of the extended 
anti conformer. The size selectivity of the system was shown to be even more specific by the 
dimerization of methyl acenaphthylene (35), where in a similar manner, only the head-to-tail 








Figure 1.7: Structures of the Pd6L4 truncated tetrahedron (8), Pd6L4 bowl (30) and Pd6L4 
tube (31) used to selectively generate the trialkoxysilane trimer, dimer and monomer 
respectively. 
 






Scheme 1.6: Selective dimerization of methyl acenaphthalene within a Pd6L4 cage (8). 
Steric confinement within the cavity of Pd6L4 could also alter the reaction pathways of 
organic radicals (Scheme 1.7).
54
 In situ photoactivation of α-diketones (40) normally results 
in the formation of the cleaved aldehyde (41) but trapped within the cage cavity, the resultant 
radicals are held in proximity long enough to undergo a cyclisation reaction. Although 
different to the normal solution processes, the reaction was not clean and produced 
significant quantities of alternative by products. The authors suggest that the peroxy adduct 
(43) was formed due to the incomplete removal of oxygen and the hydroxy α-diketone (44) 
resulted from reaction with hydroxide radicals formed during the process.  
 
Scheme 1.7: Photoactivation of α-diketones in solution and bound within Pd6L4 (5). 
Encapsulation prevents immediate formation of the aldehyde through hydrogen abstraction. 
In a similar fashion, an o-quinone (45) co-encapsulated with a toluene derivative (46) was 
shown to produce an unusual 1,4-adduct (47) upon UV irradiation of the reaction mixture 
(Scheme 1.8).
55





abstraction from the sterically confined toluene derivative to give a benzylic radical that 
consequently reacts to form the coupled product. This degree of selectivity in radical 
promoted reactions is very difficult to produce in solution due to the high reactivity of 
radical species. This can normally only be achieved by physically holding the substrates in 
fixed geometries as observed for many enzyme catalysed pathways. 
 
Scheme 1.8: Selective redox coupling via a reactive radical intermediate mediated by cage 8. 
By utilising the isolation and stabilisation properties of the cavity, substrates containing 
multiple reaction sites could be selectively protected by partial encapsulation. Nucleophilic 
substitution of allylic chlorides at the terminal position was enhanced by tethering the 
opposite end of the compound within the cage cavity using a large hydrophobic group 
(Scheme 1.10).
56
 Although the reaction selectivity was still not ideal, presumably due to the 
equilibrium formed between the bound and unbound substrate, this demonstrates the 
principal of using cage systems as non-covalent protecting groups. The main advantage 
compared with conventional protecting groups is that the corresponding deprotection step is 
not required as the reaction products are simply isolated by extraction into organic solvents.  
 
Scheme 1.10: Regioselective protection of compounds through partial encapsulation within 
Pd6L4 (8). 
Inspired by the photostability of diruthenium complexes within Pd6L4, Fujita and co-workers 
also demonstrated how this could be used to drive unusual reaction pathways. By irradiating 





bond dissociation was disfavoured and the resultant loss of CO allowed the subsequent 
formation and stabilisation of the alkyne complex (52) (Scheme 1.11).
57
 This complex was 
unstable in the solution phase and immediately rearranged upon extraction (53). Interestingly, 
the importance of steric confinement and substrate specificity was again highlighted since 
the use of the less bulky but-2-yne allowed the immediate formation of the rearranged 
product even when isolated within the cage cavity. 
 
Scheme 1.11: The size-selective stabilisation and formation of a ruthenium alkyne complex 
within cage 5.  
Regioselectivity often occurs within metallosupramolecular systems due to the physical 
restrictions placed on molecular geometry within the steric confines of the internal space; 
however, stereoselectivity can also be induced by incorporation of chiral building blocks 
within the cage structure. By switching the common ethylenediamine palladium corner piece 
for a range of chiral cyclohexyldiamine complexes, chiral assemblies were constructed based 
on the standard Pd6L4 framework (54) (Figure 1.8).
58
 Despite the large distances between the 
internal guests and the external chiral groups, an enantiomeric excess of up to 50% was 
achieved upon the photoinduced [2+2] cycloaddition between 3-methylfluoranthene (55) and 
N-cyclohexylmaleimide (56) (Scheme 1.12). As with many previous examples, the reaction 
was completely regiospecific for the 4-5 position on the 3-methylfluoranthene, due to pre-






Figure 1.8: Structure of the Pd6L4 chiral analogue using an enantiopure palladium 
cyclohexyldiamine complex. 
 
Scheme 1.12: Enantioselective and regioselective [2+2] cycloaddition reaction within the 
cavity of a chiral Pd6L4 analogue.   
1.3.4 Stoichiometric Rate Enhancement 
Since many metallosupramolecular systems are capable of drastically altering the physical 
properties of encapsulated guests, as well as protecting fragile compounds, they can also 
increase the reactivity of relatively inert substances. Increasing the rate of reaction is the first 
step in achieving catalysis and there are now a number of examples of 
metallosupramolecular induced stoichiometric rate enhancement. 
The Fujita lab has been fundamental in the development of metallosupramolecular systems 
capable of reaction rate enhancement. The Pd6L4 system described earlier, along with a range 
of derivatives (8a-d) has been shown to enhance the reaction rates for a number of 
bimolecular reactions (Figure 1.9). A range of stable aromatic systems, not normally 





cyclohexylmaleimide within the cavity of Pd6L4.
59–61
 Due to the extended aromatic rings 
already present in the starting materials, the Diels-Alder reaction does not proceed in 
solution, even at elevated temperature.  
 
Figure 1.9: Structure of Pd6L4 structural analogues utilised for a range of Diels-Alder 
reactions. 
Encapsulation within the cage brings the reagents within such proximity in a pre-organised 
state that the reaction activation barrier is lowered sufficiently enough to allow reaction at 
elevated temperatures. The Diels-Alder product formed from perylene was found to undergo 
rapid oxidation in air after extraction into CDCl3 to rearomatize the π-system but 
interestingly, this did not occur with the encapsulated compound.
59
 This is an unusual 
example of cage induced stability where neither the reagent (O2) nor the potential product 
show any obvious steric reasons for unreactivity; however, the authors do not provide any 
further analysis. 
As well as lowering the reaction activation barrier, the encapsulated transformations 
remained highly regiospecific with the ability to change the desired product using either 
thermal or photochemical activation.
60
 Both aceanthrylene (58) and 1H-
cyclopenta[l]phenanthrene (59) were shown to undergo either a photoinduced [2+2] or a 
thermally induced [2+4] cycloaddition with N-cyclohexylmaleimide (60) (Scheme 1.13). In 







Scheme 1.13: Selective [2+2] and [2+4] cyclisation reactions of “inert” aromatic systems 
by encapsulation within Pd6L4. 
1.3.5 Enhancing Conventional Metal Catalysts 
Many catalysts suffer from various degradation pathways that reduce the catalytic efficiency 
over time and ultimately prevent the catalyst working indefinitely. As supramolecular 
capsules have been shown to significantly alter the properties of guests and protect them 
from reactive species, it could be envisaged that encapsulation of a catalytic species may 
lengthen its active lifetime. Indeed, as long the reaction can still take place within the cage 
cavity, the rate or regioselectivity may even be enhanced due to the steric confinement 
within the cage. 
An early example of this approach was provided by Hupp and co-workers using a porphyrin 
based metallosupramolecular square (Figure1.10).
62
 Encapsulation of a manganese porphyrin, 
66, within the Zn-porphyrin rhenium square, 65, reduced degradation of the catalyst due to 
unwanted side reactions with other porphyrin species and increased the TON by tenfold for a 
styrene epoxidation reaction (Scheme 1.14). Further dilution to prevent intermolecular 
processes and increasing the binding affinity of the manganese porphyrin by switching to the 
tetradentate 67 resulted in a TON increase of up to 100-fold. Due to the steric confines of the 
porphyrin square, the system also displayed moderate substrate selectivity but 






Figure 1.10: Structure of Zn-porphyrin based rhenium square (65), Mn-porphyrin catalytic 
guests (66 and 67) and chiral co-catalyst (68).  
 
Scheme 1.14: Styrene epoxidation with encapsulated manganese porphyrin. 
Raymond and co-workers also attempted catalyst stabilisation by encapsulation of a cationic 
rhodium complex, with well-known allylic alcohol isomerisation properties, within the 
cavity of a Ga4L6 anionic tetrahedron.
63
 However, the activation of the catalyst with H2 was 
found to slowly dissociate the activated complex from the cage. Reactions proceeded at the 
same rate as the solution-based processes for smaller substrates but reaction with sterically 
hindered substrates was completely prevented. Although this shows control of substrate 
selectivity, no evidence was given for improved catalytic rate or lifetime of the catalyst. 
In a similar manner, Raymond and co-workers achieved enhanced catalysis by a fully 
encapsulated metal complex using a gold hydroalkoxylation species bound within the same 
Ga4L6 cage.
64





and increase the yield from 11% to 48%. The use of a “blocking agent” 
(tetraethylphosphonium cation) also provided evidence that encapsulation of the gold 
complex was responsible for the rate enhancement rather than separate catalytic ability of the 
cage. The same encapsulated gold complex has also been shown to catalyse the 
cycloisomerisation of 1,6-enynes with partial protection of the intermediate from water 
resulting in a different product distribution to the uncatalysed solution process.
65
 
Whilst the turn over number (TON) of the gold hydroalkoxylation process was limited to 67, 
a similar method using a ruthenium alcohol isomerisation catalyst provided a TON of 1070.
66
 
This increase from the solution process TON was attributed to protection of the ruthenium 
complex which is normally unstable under aqueous conditions. However, the rate of the 
reaction was slightly hindered by encapsulation. 
Inclusion of dimethyl gold complexes (71) within the Ga4L6 cage gave a dramatic increase in 
the reductive elimination of ethane (Scheme 1.15).
67
 A similar effect was observed for 
trimethyl iodo platinum complexes (74) in the presence of Ga4L6, with extraordinary rate 
enhancements of up to 1.9 x 10
7
 observed. With some adjustments to the cage stability, this 
effect could be combined with a transmetallating agent, SnMe4, to produce a catalytic C-C 
coupling system capable of rapid and efficient release of ethane due solely to the increased 
rate of reductive elimination promoted by encapsulation of the cationic intermediate within 
the cage internal cavity (Figures 1.11 and 1.12). 
 
Scheme 1.15: Conditions for the Ga4L6 (8) catalysed elimination of ethane from 






Figure 1.11: Modified structure of Ga4L6 used for the combined Pt(PEt3)2Me2 and SnMe4 
reductive elimination cycle. The addition of amide capping groups improved the stability of 
the system to the presence of MeI. For clarity, only one ligand is shown.  
 
 
Figure 1.12: Proposed catalytic cycle for the reductive elimination of ethane encapsulated 





1.3.6 Catalytic Internal Cavities 
Many of the previous examples of supramolecular rate enhancement involve the 
preorganisation of two substrates within a sterically confined cavity and thus, increase the 
effective molarity and reduce the entropic penalty towards reaction. However, as the 
resultant product is often a more favourable guest or too large to escape the internal cavity, 
the system cannot turn over and exhibit true catalysis. This product inhibition is a common 
problem for the design of metallosupramolecular catalysts and two main methods have been 
developed to solve this: stabilisation of a reactive intermediate rather than the final product 
or the addition of a secondary solution phase reaction that removes the product from the 
host:guest equilibrium. 
The first reported true catalytic metallosupramolecular system based solely on the properties 
of the internal cavity was demonstrated by Raymond and co-workers with the Ga4L6 
tetrahedron 17 (Scheme 1.16). The 3-aza-cope rearrangement was catalysed for a range of 
ammonium cations (74) with rate enhancements of up to 854 fold.
68
 Since the resultant 
iminium cations (75) hydrolyse rapidly in solution to a non-binding aldehyde (76), the 
product of the rearrangement was removed from the host:guest equilibrium and thus, the 
system was able to turn over catalytically. Changing the solvent or the addition of KCl did 
not alter the rate of the catalyst-free rearrangement and thus, the rate enhancement was found 
to be due to preorganization of the substrate within the cage cavity rather than simply the 
hydrophobic environment or stabilisation of the positive charge. As such, the reaction was 
also found to be highly substrate specific, with only a relatively small subset of substrate 
variants showing reasonable rate enhancements. This enzyme-like catalysis also allowed the 
reaction to proceed enantioselectively with an enantiomeric excess of up to 78% reported 




Scheme 1.16: Ga4L6 (17) catalysed 3-aza-cope rearrangement of ammonium cations 
followed by solution phase hydrolysis to the corresponding aldehyde. 
Further in-depth studies of the reaction mechanism showed that at pH 7, the hydrolysis was 
the rate limiting step.
70





the nucleophile resulted in an increase in the reaction rate. More surprisingly, the reaction 
rate was also increased by the addition of ammonium cations. The iminium intermediate was 
found to have a strong ion pairing interaction with the outside of the cage which shielded the 
compound from hydrolysis due to strong anion-anion repulsion between the cage and 
hydroxide anions. The addition of “innocent” cations allowed competition for the external 
ion-pairing sites and increased the rate of release of the iminium intermediate into solution. 
In a similar manner, orthoformates (77) were also efficiently hydrolysed by Ga4L6 (17) 
(Scheme 1.17). The anionic interior of the cage stabilises the protonated substrate to such a 
degree that the reaction takes place even at pH 11.
71–73
 Importantly, only the very first step in 
the reaction pathway requires specific acid catalysis. Each of the following intermediates (77) 
can be either acid or base hydrolysed and every subsequent hydrolysis decreases the affinity 
of the resultant compound for the cage interior. The final hydrolysis step produces the 
anionic formate product (79) which, due to strong coulombic repulsion, prevents any binding 
and therefore any product inhibition. The deprotection of acetals was also carried out using 
an analogous method (Scheme 1.18). 
 
Scheme 1.17: Ga4L6 (8) catalysed orthoformate hydrolysis under basic conditions. 
 
Scheme 1.18: Ga4L6 (8) catalysed deprotection of acetals under basic conditions. 
Even more remarkable rate enhancements were then achieved utilising Ga4L6 (17) for the 
Nazarov cyclisation of 3,4,5-trimethylhepta-2,5-dien-4-ol (82), with the catalysed process 
proceeding up to 2.1 x 10
6
 times faster than the solution based reaction (Scheme 1.19).
74
 The 
authors attribute this to a combined stabilisation of the cationic intermediate and pre-
organisation of the substrate into a reactive conformation, essentially combining the effects 
of the last two reported processes (3-aza-cope rearrangement and orthoformate hydrolysis). 
The initial product, pentamethylcyclopentadiene (83), strongly inhibited the reaction process 
due to competitive binding within the cage interior. This was overcome by the addition of 





binding product (84). Further studies also elucidated that dihydrofulvene was formed from 
the other stereoisomers of 82 before rearrangement and trapping with maleimide, indicating 




Scheme 1.19: Ga4L6 (17) catalysed Nazarov cyclisation. Product inhibition was prevented by 
a solution phase Diels-Alder reaction to form a bulky, non-binding product (84). 
The latest example of supramolecular catalysis from the Raymond group is the Ga4L6 (17) 
mediated Prins cyclisation of monoterpene derivatives (86) (Scheme 1.20). Protection of the 
reactive intermediates from nucleophilic H2O resulted in the formation of a mixture of 
pulegol stereoisomers (87), rather than the p-menthane-3,8-diols (85) isolated from the 
aqueous solution process.
65,76
 Utilising a chiral analogue of Ga4L6, this reaction also 
proceeded enantioselectively with an enantiomeric excess of up to 69% reported.
77
 As with 
other catalytic reactions within the interior of Ga4L6, the stabilisation of the cationic 
conjugate acid is vital for the reaction rate enhancement. 
 
Scheme 1.20: Standard aqueous phase Prins cyclisation (left) versus the Ga4L6 (8) catalysed 
process (right). 
While the Fujita group was fundamental for the development of supramolecular rate 
enhancement, the Pd6L4 cage (8a) enhanced Diels-Alder reactions discussed previously have 
suffered from severe product inhibition that prevents catalytic turn over. This was first 
overcome by carrying out a bimolecular Diels-Alder reaction within a 
metallosupramolecular “bowl” (30) rather than the complete Pd6L4 cage (8a).
78
 Heating 
encapsulated 9-hydroxy-methylanthrancene (88) and N-cyclohexylmaleimide (60) within 
cage 8a led to the formation of the 1,4-Diels-Alder adduct (Scheme 1.21). However, as 
shown previously with a number of cyclisation reactions, the product remained trapped 





phenylphthalimide (89) using the Pd6L4 bowl (30), the catalyst loading could be reduced 
from stoichiometric quantities to 1 mol% and still maintain 100% conversion to the 9,10-
Diels-Alder product (90). The authors rationalised this catalytic turn over by reasoning that 
both the reagent and intermediate could gain significant stabilisation within the bowl cavity 
through π-π interactions but the resultant bent conformation of the product would prevent 
this and allow release of the weakly bound compound. 
 
Scheme 1.21: A Diels-Alder reaction catalysed within a metallosupramolecular “bowl” (15). 
Rather than increasing the steric bulk of reactants to optimise the fit within the cage cavity, 
altering the capping ligands was shown to decrease the accessible volume of the Pd4L6 cage 
(Figure 1.13).
79
 This reduction in cavity size allowed previously unattainable reaction rate 
enhancements for a number of smaller naphthalene based Diels-Alder reactions (Scheme 
1.22). Despite strong product inhibition, these reactions proceeded slowly with catalytic 
quantities of Pd4L6 at high temperatures, presumably due to the slow release of the 
encapsulated product by metal-ligand dissociation. 
 
Figure 1.13: Modified structure of a Pd6L4 cage incorporating sterically crowded palladium 







Scheme 1.22: Restriction of the cage cavity volume (91) allows the catalysis of Diels-Alder 
reaction between smaller substrates. 
Stabilisation of an anionic intermediate allowed Pd4L6 (8a) to catalyse the Knoevenagel 
condensation of Meldrum’s acid (96) with a range of aromatic aldehydes (95) (Scheme 
1.23).
80
 A similar reaction was also carried out in an analogous cage containing triimidazole 
ligands.
81
 The resultant product (97) is sterically excluded from the cage cavity and the 
reaction proceeds catalytically. As such, this process can be seen as the anionic equivalent of 
Raymond and co-workers stabilisation of cationic intermediates. 
 
Scheme 1.23: Knoevenagel reaction between bulky aromatic aldehydes (95) and Meldrum’s 
acid (96) catalysed by cage 8a.  
Ward and co-workers have recently reported catalysis of a Kemp elimination reaction using 
a Co8L12 cube (Figure 1.14 and Scheme 1.24).
82
 Under alkaline conditions, the Kemp 
elimination relies on nucleophilic attack of hydroxide anions and follows a first order 
relationship with respect to hydroxide concentration. In the presence of 98, the reaction is 
efficiently catalysed and the rate becomes independent of the hydroxide concentration. The 
authors provide evidence that this is due to the binding of hydroxide anions within the 
cationic cage portals and the resultant dramatic increase in the effective molarity of 
hydroxide anions with respect to the bound substrate. When compared with the neutral 
solution process, rate enhancements of up to 6 x 10
6






Figure 1.14: The structure of a self-assembled Co8L12 cube. For clarity, only one ligand is 
shown.  
 
Scheme 1.24: The Kemp elimination catalysed by encapsulation within cage 65. 
Interestingly, the authors attribute the efficient catalytic turn over to the release of the weakly 
bound phenolate anion since, as discussed in additional publications, cage 98 displays a 
stronger affinity for neutral guests rather than charged compounds.
16
 The authors suggest this 
is due to the much more favourable solvation of charged species in water overcoming the 
additional coulombic attraction between the cationic cage and the anionic guest. This is in 
direct contrast to the catalytic mechanism proposed by Raymond and co-workers using cage 
17, whereby cationic species are strongly stabilised within the anionic cage interior relative 
to the bulk aqueous phase. A simple explanation for this difference in activity is not 
available at this time but it does, once again, highlight the subtle balance of forces in play 
that gives rise to supramolecular catalysis and further studies on more systems are required 






1.3.7 Summary & Conclusions 
Over the last two decades, metallosupramolecular containers have shown great promise as 
catalysts. Their ability to modulate the reactivity of encapsulated substrates and act as 
molecular reaction vessels gives them enzyme-like properties that, in theory, can be applied 
to almost any synthetic process. However, there still remains many significant hurdles in the 
realisation of metallosupramolecular catalysts as real world systems capable of working on 
an industrial scale. 
Although examples of reaction rate enhancements have grown substantially, examples of 
true catalytic systems remain rare. While binding and altering the properties of guest 
compounds has proven relatively straight forward, promoting reactions can be challenging. 
Since cages tend to shield encapsulated compounds from the external environment, many of 
the examples described above rely either on the encapsulation of two compounds 
simultaneously or the promotion of a unimolecular reaction.  
Even if a rate enhancement can be achieved, catalytic turnover is often prevented due to 
strong product inhibition, since the very stabilisation of the product that resulted in reaction 
catalysis also infers a greater binding strength for the resultant compound. A number of 
methods have been utilised to prevent this, including stabilisation of reaction intermediates 
and secondary, solution based reactions but these examples remain very few. Indeed, even 
for the many inspirational catalytic examples published by the Raymond group, the 
processes are all based on the same supramolecular structure and a very similar reaction 
pathway. 
The highly selective enzyme-like ability of supramolecular systems can make it difficult to 
rationally screen reactions. The complex array of factors that govern whether a system will 
work cannot be easily predicted. Although the use of ligand-metal complexation has now 
made it relatively straight forward to design and self-assemble complex container 
compounds, the synthesis of a new system can still take months if not years. Once isolated 
and characterised, reaction screening can begin but since the addition of even a single methyl 
group to any individual substrate can have a drastic influence on the size specific reaction 
pathway, it can be very easy to miss potentially successful substrates. Many of these reactive 
substrates are also complex compounds in their own right and not commercially available 





As such, there is still the need for the development of many more metallosupramolecular 






1.4 Photoredox Catalysis 
1.4.1 Introduction 
As famously envisaged by Giacomo Ciamician as early as 1912,
83
 sunlight provides a 
virtually unlimited supply of energy, that if harnessed, could easily provide all of humanities 
current energy needs. As well as direct transformation of light to electricity, the concept of 
using light to initiate otherwise unreactive chemical reactions has gained growing interest 
over the last century. 
Since the discovery of photoinduced chemical reactions by Ciamician and Silber in 1908,
84
 a 
huge range of useful organic transformations have been promoted by irradiation with high 
energy UV-light.
85–87
 However, photoredox catalysis offers many advantages over 
conventional UV photocatalysis. The catalysts absorb visible light which means that 
reactions can be carried out under household fluorescent bulbs or indeed sunlight, rather than 
the expensive, high energy UV lamps required for conventional photocatalysis. In addition, 
irradiation of organic compounds with UV photons often leads to uncontrollable side 
reactions. Since many organic compounds do not absorb in the visible region, direct 
excitation is avoided and consequently, unwanted side reactions are reduced.  
This section hopes to provide the reader with an introduction to the concepts and theory of 
photoredox catalysts and their applications in organic transformations. The area of 
photoredox catalysis is too vast to cover in this work in its entirety and thus, specific 
examples have been chosen to highlight key concepts and recent developments. For 
additional information, the readers are directed to a number of thorough and recent reviews 
published on the subject.
88–97
 
1.4.2 Theory of Photoredox catalysis 
The general principle involves the use of a photoredox catalyst capable of absorbing visible 
light to excite an electron to a higher energy state. This excited state possesses the unique 
property of being both a better reductant and a better oxidant than the ground state 
compound, due to the easier abstraction of the excited electron from a higher energy orbital 
or the easier replacement of an electron in the positive hole.  
The redox potential of a photoredox catalyst can be further enhanced by the use of a 





an electron from a species with a relatively low redox potential; however, the resultant fully 
oxidised or reduced catalyst can then possess a higher redox potential than either the excited 
complex or the sacrificial quencher. The resultant strong oxidant or reductant can then be 
used to promote a range of organic transformations. 
 
 
Figure 1.16: An example of a photoredox catalytic cycle based on an iridium complex. 
Excitation with a visible photon followed by efficient quenching generates either a strong 
oxidant or reductant capable of promoting a wide range of redox reactions. 
1.4.3 Common Photoredox Catalysts 
A photoredox catalyst, just like any other catalyst, must perform multiple turnovers while 
remaining unchanged itself at the end of the reaction process. Additionally, photoredox 
catalysts must be able to absorb photons to form stable, long-lived excited states that can 
then interact with substrates through single electron transfer (SET) pathways. In order for 
successful catalysis to occur, there must be two electron transfer steps: one initial 
reduction/oxidation to form the reactive species followed by back electron transfer to 
regenerate the catalyst. 
A number of different photoredox catalysts have now been employed for use in visible-light 
catalysed chemical transformations (Figure 1.17 and Table 1.1). By far the most common is 
the ruthenium polypyridine complex [Ru(bpy)3]
2+





oxidation potentials, high extinction coefficient, long-lived excited state, and stability under 
most reaction conditions. Iridium cyclometallated complexes have also gained increasing 
popularity due to their increasingly strong reduction potentials. Organic photoredox catalysts 
have seen limited use in comparison, due to their lower redox potentials, but they have 
gained growing interest due to general benefits associated with non-reliance on precious 
metals such as reduced cost and lower toxicity.  
 
Figure 1.17: A range of common photoredox catalysts. 
Table 1.1: Redox potentials for a range of common photoredox catalysts. 
Compound E1/2 M
+































a) converted from original measurement made in DMF vs Fc
+
/Fc b) irreversible process 







1.4.4 Synthetic Applications 
Photoredox catalysis has been in common use since the 1950s but early work was dominated 
by the initiation of polymerisation reactions and the photo-splitting of water. Photoredox 
catalysis as a synthetically useful technique has only really gained momentum in the last few 
decades. 
One of the first synthetically useful visible-light photoredox reactions was developed by 
Cano-Yelo and Deronzier (Scheme 1.25).
104
 Excitation of [Ru(bpy)3]
2+
 led to the reduction 
of stilbene diazonium salts (107) and the subsequent release of nitrogen, cyclisation and back 
electron transfer to regenerate the catalyst gave phenanthrene derivatives (108) in 
quantitative yields. Utilising diazonium salts as effective oxidative quenchers also allowed 





Scheme 1.25: Photoredox synthesis of phenanthrene derivatives from stilbene diazonium 
salts. 
Stephenson and co-workers developed a visible-light photoredox catalysed system for 
reductive dehalogenation of organic compounds (Scheme 1.26).
106
 This environmentally 
friendly and safe alternative to current methods is tolerant of many functional groups 
including organo-iodides. Reductive quenching of the catalyst by 
i
Pr2NEt gave the strong 
reductant [Ru(bpy)3]
+
 which consequently underwent SET to the organohalide (109). 
Subsequent release of the halide gave the alkyl radical which then readily abstracted a 





formic acid or Hantzsch ester (111) dramatically increased the isolated yield. The use of 






Scheme 1.26: Reductive dehalogenation of organohalides using visible-light photoredox 
catalysis. 
The organic radical formed from reductive cleavage of the C-X bond is an incredibly 










 and the total synthesis of gliocladin C.
113
 In addition, the reactive imine 
intermediates formed from reductive quenching of the photoexcited state by tertiary amines 
have also been utilised for a range of organic transformations including, but not limited to, 
phosphonylations, aza-Henry reactions, alkynylations, alkylations, arylations and 
cyanations.
114–123
 The huge range of organic transformations described highlights the 
powerful synthetic utility of visible-light photoredox catalysis to generate highly reactive 
species under very mild conditions. 
Yoon and co-workers developed a photoredox catalysed method for the [2+2] cycloaddition 
of tethered bis(enones) (112) (Scheme 1.27).
124
 Irradiation with visible-light in the presence 
of [Ru(bpy)3]
2+
 and DIPEA produced the reduced catalyst that was then capable of reducing 
the enone to the radical anion. This initiated cyclisation of the tethered alkenes to form the 
cyclobutane product (113) in high yields and diastereomeric selectivity. LiBF4 was required 
as an additive and the authors propose that it plays a dual role in increasing the solubility of 






Scheme 1.27: [2+2] intramolecular cycloadditions initiated by electron transfer from the 
excited state [Ru(bpy)3]
2+
 to form the enone radical anion. 
This work has since been expanded upon to allow the intermolecular cycloaddition of 
unsymmetrical enones
125
 and the [3+2] cycloaddition of aryl cyclopropyl ketones (Scheme 
1.28).
126
 Substituting the Lewis acid for a Brønsted acid led to the formation of the 5-exo-trig 
product (114) through generation of a neutral radical intermediate as opposed to the previous 
radical anion.
127
 This method of activation also had the additional benefit of increased 
reactivity towards previously unreactive alkyl substituted enones.  
 
Scheme 1.28: Under Brønsted acidic conditions, protonation of the enone leads to the 
generation of the neutral radical which subsequently undergoes 5-exo-trig cyclisation. 
Both the [2+2] cycloaddition and 5-exo-trig cyclisation can also be carried out under metal 
free conditions using the organic photoredox catalyst, eosin Y, and utilising a hydrogen bond 
donor catalyst in place of the Lewis acidic lithium cation.
128







 catalysed [2+2] cycloadditions, only the more thermodynamically stable trans-
products could be isolated. 
For all of the above cycloadditions, the photoredox process proceeds via the reductive 
quenching cycle whereby the reactive intermediate is generated by electron transfer from the 
reduced catalyst to the substrate. This reduction process relies on the use of an electron 
deficient alkene to allow the reaction to proceed which severely limits the reaction substrate 
scope. In order to facilitate the [2+2] cycloaddition of electron rich styrenes (115), Yoon and 
co-workers utilised methyl viologen as an oxidative quencher to promote the reaction via the 




Scheme 1.29: [2+2] cycloaddition of electron deficient tethered styrenes (83) catalysed by 
oxidative quenching of [Ru(bpy)3]
2+
. 
This oxidative process was then applied to photoredox promoted Diels-Alder reactions,
130
 
however, the authors report limited substrate scope and high catalyst loadings (Scheme 1.30). 
To prevent rapid back electron transfer from the viologen to the photocatalyst, [Ru(bpz)3]
2+
 
was utilised as a stronger oxidative photocatalyst that possessed a high enough excited state 
potential (+1.4 V vs SCE) that direct oxidation of the substrate could be accomplished 
without the need for a sacrificial quencher.  
 
Scheme 1.30: Photoredox catalysed direct oxidation of electron rich alkenes to promote 
intermolecular Diels-Alder reactions. 
Surprisingly, these highly oxidising conditions were unsuccessful for the corresponding 
intramolecular Diels-Alder due to substrate degradation and thus the reaction proceeded 




 This highlights the 





and thus, the continued generation of a wide variety of photocatalysts with easily tuneable 
properties is fundamental to the future development of the field.  
Many of the processes described above utilise either Lewis or Brønsted base/acid catalysis to 
enhance the reactivity of substrates toward oxidation or reduction. An important 
development in this area was the merger of organocatalysis with photoredox catalysis by 
Macmillan and co-workers (Figure 1.18).
111
 The incorporation of a chiral imidazolidinone 
organocatalyst to generate an enamine intermediate allows efficient chiral induction and 
enantioselectivity for the α-alkylation of aldehydes. Furthermore, like many photoredox 
catalysed processes, the reaction conditions are very mild and tolerant to a large range of 
substrates and functional groups. 
As seen previously, the strongly reducing [Ru(bpy)3]
+ 
species undergoes SET to the alkyl 
bromide followed by C-X bond cleavage to generate the reactive alkyl radical. However, 
rather than the addition of a sacrificial quencher, coupling of the enamine to the alkyl radical 
generates an α-amino radical species that reduces the excited state photocatalyst to form an 
iminium ion that rapidly hydrolyses to the α-alkylated aldehyde product. In this manner, both 
electron transfer steps associated with the photoredox catalyst are synthetically useful and 






Figure 1.18: Combined organocatalytic and photoredox catalytic cycles for the asymmetric 
alkylation of aldehydes.  
 
1.4.5 Summary & Conclusions 
Photoredox catalysts has recently gained great interest as a mild and environmentally 
friendly method for the synthesis of a wide range of organic compounds. The ability to 
perform conventionally difficult organic transformations, such as carbon-carbon bond 
formations, at room temperature with little more than a common household lightbulb or 
sunlight has a certain chemical elegance associated with it. Moreover, the use of organic 
photocatalysts also completely removes the need for potentially toxic and expensive metal 





Despite this obvious synthetic usefulness, there remains a number of issues in the field. 
Examples of enantioselective or regioselective photoredox catalysis remain very rare since 
the generation of highly reactive radical species in situ can make it difficult to control the 
resultant bond formation process. Secondly, many compounds remain unreactive to 
photoredox catalysts due to their high oxidation and reduction potentials.  
As discussed in section 1.3, metallosupramolecular cage compounds are capable of 
activating unreactive substrates and directly controlling both regio- and stereo-selectivity 
through confinement of reactive species within a well-defined internal cavity. As such, a 
combination of photoredox catalysis within the strict confines of a metallosupramolecular 
cavity could allow mild and environmentally friendly alternatives to currently unobtainable 
synthetic routes. The following chapters describe studies made to address this hypothesis and 
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Previous attempts in combining metallosupramolecular catalysis and photoredox catalysis 
led to the synthesis of an Ir6L4 truncated tetrahedron by Lusby and co-workers; however, this 
system was unsuitable for encapsulation of neutral guests due to the required templation by 
bound anions. This work describes attempts to stabilise the Ir6L4 structure by alteration of 
either the cyclometallated or bridging ligands. Switching 2-phenylpyridine for 2-
phenylpyrazine disrupted the structure and reduced the solution stability still further. 
Investigations with isocyanides as bridging ligands showed great promise in the formation of 
two-dimensional homo- and hetero-leptic iridium architectures but the synthesis of the 
corresponding three-dimensional architectures could not be achieved due to ligand instability. 
Therefore, iridium was found to be unsuitable as a structural element in the synthesis of 














As discussed throughout Chapter 1, supramolecular assemblies possess a wide range of 
properties that make them excellent candidates for stereo- or regio-selective catalysis. 
Photoredox catalysis is also an emerging field in chemistry whereby synthetic reactions that 
normally require harsh or complex conditions can be carried out at room temperature using 
nothing more than visible light and an appropriate photocatalyst. In this way, potentially 
delicate functional groups can be protected that would otherwise degrade at high 
temperatures or under UV irradiation.  
In order to try and combine the beneficial properties of both supramolecular and photoredox 
catalysts, Lusby and co-workers previously developed a M6L4 assembly (120·6X) that 
incorporated photoactive 2-phenyl pyridine (ppy) iridium moieties into the structure (Figure 
2.1).
1
 Using 1,3,5-tricyanobenzene as a bridging ligand, the Ir(ppy)2 sub-units were held 
together in a truncated tetrahedron with an internal cavity volume of approx. 500 Å
3
. 
Assembly into a rigid three-dimensional structure also led to an increase in the luminescent 
quantum yield due to loss of non-radiative decay pathways. In comparison, simple 
mononuclear complexes with ancillary nitrile ligands are completely non-emissive in 
solution.   
 
Figure 2.1: Structure of Ir6L4 cage (120·6X) developed by Lusby and co-workers.
1
 
Despite the initial success of producing enantiopure luminescent cage structures, any attempt 
at binding neutral organic guests or carrying out photocatalysis on encapsulated substrates 






effect of four encapsulated counter ions. Although a range of different counter anions could 
be bound within the cavity (OTf, PF6, BF4 or ClO4), any attempt to replace the ions with a 
neutral guest was unsuccessful and the addition of larger counter anions resulted in the 
formation of different molecular species. In order to improve the structural stability of the 
assembly to allow supramolecular catalysis to take place, significant modifications were 
required. The following chapter focuses on further investigations into the mechanism of 







2.3 Counter Anion Dependency 
2.3.1 Introduction 
The Ir6L4 system (120·6X) described by Lusby and co-workers showed a number of 
interesting properties, including enhanced luminescence, but the cage structure depended 
entirely on the presence of encapsulated anions.
1
 Any attempt to replace these encapsulated 
anions with a neutral guest was unsuccessful, presumably due to strong competition for the 
internal binding sites driven by coulombic attraction between the anions and cationic cage. 
In addition, attempts to synthesise an “empty” cage, by self-assembly in the presence of 
large bulky anions (eg. NTf2), were also unsuccessful.  
The stability of the cage system was found to be anion dependent with the cage half-life 
following the trend OTf > PF6 > ClO4 > BF4. Although templation of the cage assembly was 
thought to occur via encapsulation of 4 anions, guest exchange experiments showed that PF6 
had a stronger association constant than OTf for the cage internal cavity. Thus, binding 
strength alone could not explain the trend in cage stability.  
2.3.2 Rate of Ligand Dissociation 
One possible explanation for the reported variation in cage stability was that coordination of 
the counter ions to the iridium centres created a competition pathway for the iridium 
coordination sites. Direct competition between the counter ions and the nitrile ligands would 
increase the dissociation rate of the nitrile ligands and reduce the overall stability of the cage 
structure.  
In order to examine the counter-ion effect on the rate of ligand dissociation, a series of 
iridium bis-nitrile complexes (121·X) were prepared as model compounds (Scheme 2.1). 4-
Fluorobenzonitrile (F-PhCN, 123) was chosen as an appropriate model ligand due to a 
similar benzonitrile binding motif. The fluorine provided an additional spectroscopic handle 
for measuring the system properties through 
19
F NMR spectroscopy. The electron 
withdrawing effect of fluorine substitution could reduce the ligand binding strength but, 
since variation of the counter ion was the key comparison, this should not affect the 






The model compounds were prepared using a similar method to the synthesis of 120·6OTf 
whereby [(Ir(ppy)2Cl)2] was treated with AgX (X = OTf, PF6, BF4 or ClO4) to remove the 
chloride anions followed by addition of the nitrile ligand. Isolation of the compounds was 
carried out by precipitation from CH2Cl2 with Et2O; however, the high solubility of the 
compounds in CH2Cl2, coupled with the small reaction scale, made isolation of the 
complexes in high yields difficult.  
 
Scheme 2.1: Bis-(4-fluorobenzonitrile) complexes used as a model compounds for studying 




H NMR spectroscopy (500 MHz, CD2Cl2, 300 K) of 121·OTf a) with excess 
ligand and b) as an equilibrium mixture of intact and partially dissociated species. Peaks 
corresponding to the bis(nitrile) species [IrL2(F-PhCN)2] (blue), mono(nitrile) [IrL2(F-






Initial NMR experiments of the isolated compounds showed that due to the relatively weak 
binding strength of the monodentate nitrile ligand, dissolution of the isolated complexes in 
CH2Cl2 or C2H2Cl4 leads to an equilibrium mixture of the intact di-substituted complex (121), 
a mono-substituted complex (122) and free ligand (123) (Figure 2.2). The addition of excess 
ligand drives the equilibrium towards the fully intact complex and this method was used to 
determine the spectroscopic assignments for each of the compounds. 
The 
19
F NMR spectra of the equilibrium mixtures showed a similar distribution of species 
that could be driven towards the intact di-substituted complex by the addition of excess 
ligand. Interestingly, the peak associated with the OTf counter ion also showed a distribution 
of species due to complexation with the free binding site on the iridium (Figure 2.3). This 
shows the propensity of the counter ions, rather than solvent, to occupy the free binding site 
on the iridium centre and provides evidence that strong competition by the counter ions for 
the binding sites could therefore lead to increased dissociation of the nitrile ligands.  
 
Figure 2.3: Partial 
19
F NMR spectrum (471 MHz, CD2Cl2, 300 K) of 121·OTf as a) a sample 
with excess ligand showing almost complete dissociation of the OTf anion and b) an 
equilibrium mixture of coordinated (red) and free (blue) OTf.   
Since formation of the equilibrium mixture was rapid (the sample was completely 
equilibrated within 5 minutes) but exchange between the bound and free ligand was slow on 
an NMR timescale, 
19
F EXSY was used to measure the exchange parameters (Figure 2.4). 
19






associated with the 4-fluorobenzonitrile in various states of complexation. As with other 
techniques, 121 was observed along with both 122 and 123.  
 
Figure 2.4: Example 
19
F EXSY (376 MHz, C2D2Cl4, 300 K) spectrum where L = a 
cyclometallated ligand, X = complexed solvent or counter ion and F-PhCN = complexed 4-
fluorobenzonitrile. Peaks corresponding to the di-complexed species [IrL2(F-PhCN)2] (blue), 
mono-complexed [IrL2(F-PhCN)X] (red) and uncomplexed F-PhCN (green). 
For each complex, EXSY spectra were taken over a range of mixing times and plotted versus 
the peak ratios. In order to reduce complications arising from multiple cross peaks, the 
experiments were carried out in the presence of 10 equivalents of 4-fluorobenzonitrile in 
order to minimise the quantity of 122 in solution. The gradient of the straight line plot gives 
the reciprocal of the rate constant (1/𝑘) which can be converted to the observed rate constant 
(𝑘𝑜𝑏𝑠 ) (see experimental for details). The corresponding rates of association/dissociation 
display very little variation with different associated counter ions and for these model 
systems, the rate of ligand dissociation is completely independent of the associated counter 







Table 2.1: Rate of ligand dissociation in relation to the associated counter ion.  
Compound Gradient kobs (s
-1
) 𝑮‡ (kJmol-1) 
2·OTf 0.0512 9.766 67.34 
2·PF6 0.0394 12.690 66.69 
2·BF4 0.0510 9.804 67.33 
2·ClO4 0.0376 13.298 66.57 
 
Since ligand dissociation rate is not responsible for the relative stability of 1.6X, alternative 
explanations were required. Further work by O. Chepelin showed that the counter ion 
dependent cage stability varied in accordance with the relative electrostatic potentials of the 
counter ions.
2
 Increasing the electrostatic potential destabilises the encapsulated arrangement 
of anions due to coulombic repulsion and reduces the effectiveness of anion templation. 






2.4 Phenylpyrazole variants 
2.4.1 Introduction 
Based on earlier experiments by O. Chepelin on iridium macrocycles, 2-phenylpyrazole (ppz) 
was found to enhance the strength of the metal-ligand interaction cis to the nitrogen when 
compared with 2-phenylpyridine (ppy).
2
 This was explained by greater electron withdrawal 
from the phenyl ring leading to a weaker Ir-C bond which consequently increased the 
iridium-nitrile interaction through the trans-effect. Thus, it was surmised that incorporation 
of Ir(ppz)2 moieties rather than Ir(ppy)2 could lead to an analogous Ir6L4 structure (124·6X) 
with enhanced stability (Figure 2.5).  
 
Figure 2.5: Proposed structure of the ppz substituted Ir6L4 truncated tetrahedron. 
2.4.1 Quantification of Ligand Strength 
Before carrying out the difficult resolution of enantiomers required for the synthesis of 
124·6OTf, a series of experiments were designed to quantify the relative ligand binding 
strengths and confirm that ppz did indeed strengthen the iridium-nitrile interaction. 
In a similar manner to the experiments described in section 2.3, the corresponding ppy and 
ppz bis-(4-fluorobenzonitrile) complexes were synthesised. The ppz derivative (125·OTf) 
showed similar solution properties to 121·OTf and rapidly dissociated upon dissolution in 
CH2Cl2 or TCE to form an equilibrium mixture of intact and partially dissociated species 






mixing time was varied, a single EXSY spectrum was recorded for each sample and the 
observed rate constant calculated directly from the cross peak ratios.    
 
Scheme 2.2: Bis-(4-fluorobenzonitrile) complexes used as model compounds for studying the 
effect of ppz versus ppy on the rate of ligand dissociation. 
Comparison of the values showed that 125·OTf displays a slightly slower dissociation of the 
complexed 4-fluorobenzonitrile and consequently a higher activation barrier when compared 
with 121·OTf under identical conditions (Table 2.1).  
Table 2.1: Rate of nitrile dissociation in relation to the cyclometalled ligand.  
Compound r kobs (s
-1
) 𝑮‡ (kJmol-1) 
121·OTf 12.605 0.159 77.54 
125·OTf 37.418 0.053 80.24 
 
Although the stability of 125·OTf was only marginally better than 121·OTf, incorporation of 
ppz into the cage structure could lead to a significant increase in the overall cage stability 






2.4.2 Separation of Ir(ppz)2 Enantiomers 
Previous analysis of 120·6OTf showed that the iridium stereochemistry had a drastic impact 




 The racemic sample constituted a complex mixture of 
cage systems containing a statistical mixture of different enantiomeric centres. In order to 
simplify the system for analysis, the homochiral variant was assembled from enantiopure 
[(Ir(ppy)2Cl)2] prepared using serine as a chiral resolving agent. 
124·6OTf could be expected to form the same complex mixture of diasteromers and thus, 
enatiomerically pure [(Ir(ppz)2Cl)2] (127) was required for the formation of homochiral 
124·6OTf. rac-[Ir(ppz)2D-Serine] (128) was prepared based on the literature procedures 
describing the original synthesis of  enantiopure [(Ir(ppy)2Cl)2] (Scheme 2.3). However, 
unlike the previously investigated [Ir(ppy)2Serine] compounds, separation of the Λ/Δ-
[Ir(ppy)2D-Serine] diasteromers did not require silica chromatography and  instead, the 
diastereomers could be separated based on solubility alone. Partial dissolution in CH2Cl2 
followed by filtration gave a solution containing the single diasteromer Δ-128, confirmed by 
1
H NMR spectroscopy. After separation, enantiopure 127 could be reconstituted by the 
dissolution of 128 in CH3OH and the addition of concentrated HCl(aq). Unfortunately, the 
opposite enantiomer could not be obtained from the solid residue and instead, the process 
was repeated with L-Serine. 
 
Scheme 2.3: Synthesis and separation of serine diasteromers to give enantiopure Λ/Δ-
[(Ir(ppz)2Cl)2]. 
Due to the difference in separation methods, the chirality of 127 could not be assumed based 
on the enantiomers obtained using [(Ir(ppy)2Cl)2]. Instead, the chirality of 128 was 






2.4.3 Synthesis of Phenylpyrazole Ir6L4 Assembly 
Following the successful separation of Λ-127 & Δ-127, 124·6OTf was prepared in an 
analogous manner to the parent compound 120·6OTf. First of all, 127 was treated with 
AgOTf and filtered to remove the competing chloride ligands and provide the OTf counter 
ions required for templation of the cage structure. 1,3,5-tricyanobenzene (tcb, 129) was then 
charged and the mixture stirred at room temperature until a yellow precipitate was formed 
(Scheme 2.4).  
 
Scheme 2.4: Synthesis of [(Ir(ppz)2)6(tcb)4]6OTf (5·6OTf). The compound was prepared 
separately with both Δ & Λ enantiomers of the starting [(Ir(ppz)2Cl)2]. 
NMR analysis in TCE showed the characteristic peak shifts observed upon metal-ligand 
complexation whilst the structure remained completely symmetric (Figure 2.6). DOSY NMR 
confirmed a significant increase in the hydrodynamic radius from 8.8 Å to 14.3 Å which is in 








quality crystals were prepared by slow diffusion of benzene into a saturated solution of 
124·6OTf in TCE. Only partial resolution of the diffraction data was achieved but the 
expected truncated tetrahedral structure was clearly visible and OTf counter anions were 




H NMR (500 MHz, C2D2Cl4, 300 K) comparison of 127 versus 124·6OTf. Strong 
downfield shifts were observed for all proton signals consistent with ligand complexation.   
As observed for 120·6OTf, the 
19
F NMR spectrum showed two partially overlapping peaks 
corresponding to free and encapsulated OTf. However, both peaks were heavily broadened 
due to chemical exchange. VT experiments at reduced temperatures allowed the complete 
resolution of the peaks and showed that coalescence occurred just above room temperature.    
All of characterisation data agreed with the formation of an Ir6L4 truncated tetrahedron in 
solution. Many similarities were observed when comparing 124·6OTf to 120·6OTf, 
including downfield chemical shifts, an identical hydrodynamic radius and encapsulation of 






2.4.4 Stability of Phenylpyrazole System 
In order to assess the stability of 124·6OTf, a scrambling experiment was carried out in 
which the enantiomerically pure samples were combined and the resultant rearrangement to 
a statistical mixture was monitored by 
1
H NMR spectroscopy (Figure 2.7). The results were 
compared with a similar experiment carried out on 120·6OTf by O. Chepelin. Since the 
resultant rearrangement generates a complex mixture, the singlet corresponding to the 
symmetrical ligand was chosen as the best analytical probe due to the ease of integration and 
obvious splitting. However, since a portion of the statistical mixture remains an enantiopure 
cage even after complete rearrangement, the exponential decay functions do not tend to zero. 
In addition, 120·6OTf contains overlapping peaks such that the integral does not diminish as 
far as expected and thus, the exponential decay functions were fitted based on the final 
minimum area. Due to the complex aromatic region, integration was referenced versus the 
grease peak. 
 
Figure 2.7: Partial 
1
H NMR spectra (500 MHz, CD3CN, 300 K) showing slow 
rearrangement of the enantiomerically pure cage systems to the complex statistical mixture. 
The symmetrical 1,3,5-tricyanobenzene peak (green) gradually reduced as the system was 
desymmetrised.  
Despite early experiments lending evidence towards 2-phenylpyrazole strengthening the 
iridium-nitrile interaction compared to 2-phenylpyridine (Section 2.4.1), the stability of the 






124·6OTf. Since mono-nuclear studies indicated a stronger metal-nitrile interaction for the 
ppz derivatives, it seems likely that the reduced stability of 124·6OTf is due to structural 
effects from the self-assembly of a large supramolecular species. The smaller ppz ligands do 
not show any obvious steric clash between adjacent iridium groups; however, the smaller 
size does result in an increase in cage portal size. This may explain the faster rate of 
exchange between bound and free OTf anions as demonstrated by the peak coalescence in 
the 
19
F NMR spectrum for 124·6OTf  compared with the slow binding observed for 
120·6OTf. Interestingly, even at low temperatures, integration of the relevant 
19
F NMR 
signals suggests that a higher proportion of the OTf anions remain unbound at equilibrium 
rather than the distinct 4 encapsulated anions observed for 124·6OTf. Therefore, it seems 
likely that the reduced stability of 124·6OTf is due to weaker templation of the cage 
structure by the encapsulated anions, despite any marginal increases in the iridium-nitrile 
binding strength. 
Whilst the reduced stability of 124·6OTf could potentially be altered by incorporation of 
different anions, the dominating factor in cage formation and stability is still the presence of 
encapsulated anions. Any subtle increase in metal-nitrile bond strength by variation of the 









2.5 Homoleptic Iridium Isocyanide Architectures 
2.5.1 Introduction 
In an effort to further increase the metal-ligand bond strength, isocyanides were proposed as 
a replacement to the nitrile functional groups already employed. Isocyanides show much 
stronger binding affinities for metals, both being better σ-donors and π-acceptors than the 
corresponding nitriles, such that they even rival carbon monoxide in binding strength.
3
 
Assuming the metal-ligand interactions would still be reversible at elevated temperatures to 
allow self-assembly, any supramolecular species formed would then be stabilised at room 
temperature through kinetic trapping. 
Although isocyanide and cyanide based supramolecular structures have been reported 
previously,
4–7
 very few examples exist where the bridging units consist of solely metal-
isocyanide linkages.
8,9
 Since the metal-isocyanide interactions are usually kinetically inert, 
they are often used to incorporate functionality into systems assembled from other more 
labile interactions.
10
 Direct addition of diisocyanides to metals often results in the rapid 
formation of coordination polymers.
11–18
 Successful synthesis of iridium based isocyanide 
supramolecular structures therefore relies on the iridium-isocyanide interaction attaining an 
element of reversibility at high temperatures.  
Since the direct isocyanide analogue of 129, 1,3,5-triisocyanobenzene (130), was unknown 
in the literature, the commercially available 1,4-diisocyanobenzene (131) was initially 
chosen as a model compound to investigate  the feasibility of isocyanides as self-assembly 
components (Figure 2.8). 
 
Figure 2.8: Comparison of 1,3,5-tricyanobenzene (129) versus the envisaged stronger binder, 








Using 131 as a model compound, the synthesis of a two-dimensional structures was 
attempted using conditions based on those used for the original synthesis of 120·6OTf. 
[(Ir(ppy)2Cl)2] and 131 were stirred in TCE and AgOTf was charged to aid the replacement 
of the chloride with loosely coordinated OTf anions. Since the ligands were expected to bind 
irreversibly at room temperature, the mixture was refluxed in order to increase the rate of the 
iridium-isocyanide dissociation and promote the self-assembly and rearrangement to the 
thermodynamic product.  
After cooling and filtering through Celite, analysis of the crude reaction mixture by 
1
H NMR 
spectroscopy showed a complex aromatic region where each of the original 2-phenylpyridine 
signals had been split into a range of different environments. DOSY NMR indicated that the 
peaks all belonged to similar sized species with a radius of approximately 10.4 Å. This 
increase in hydrodynamic radius from the starting material (8.8 Å) suggested that 
complexation had occurred but the formation of well-defined supramolecular species was 
still uncertain. 
Mass spectrometry of the crude mixture confirmed the presence of several different two-
dimensional species. Although additional fragments were observed, the major peaks 
corresponded to predicted [(Ir(ppy)2)n(dib)n]nOTf structures with n = 3,4 or 5. Since the 
majority of the peaks contained equal numbers of Ir(ppy)2 groups and ligand 131, the 
structures for n = 3,4 or 5 were assigned as the cyclised triangle, square and pentagon 
respectively (Figure 2.9). Although alternative non-cyclised structures were also possible, 
the formation of coordination polymers would be expected to give a more random 
distribution of peaks and produce chains of increasing length until irreversible precipitation 
occurred.  
Three-dimensional metallosupramolecular assemblies often form well-defined discrete 
species with the overall configuration dictated by the highly directional transition metal-
ligand bonds. However, in two-dimensional assemblies each metal forms only two structural 
bridges with neighbouring metal centres and thus a greater degree of structural flexibility is 
observed. Since the ideal bond angle of octahedral Ir(III) is close to 90
o
, the expected 
macrocyclic structure with linear ligands is that of a square but the slight structural flexibility 
afforded by the metal centre and ligand backbone accommodates the formation of both the 






slightly less thermodynamically stable due to ring strain, the small energy barriers are easily 
overcome, particularly at elevated temperatures. Similar effects have been observed 




Figure 2.9: Predicted structures for [(Ir(ppy)2)n(dib)n]nOTf where n = 3, 4 or 5. 
2.5.2 Purification 
Since the reaction conditions could not differentiate between the similar cyclised products, 
further purification was required to isolate and confirm their chemical composition. Due to 
the strong metal-isocyanide interactions, the assembled structures were found to be stable on 
silica and individual species could be separated using a solvent gradient method starting with 
100% CH2Cl2 progressing to 10% CH3OH in CH2Cl2. 
The products display green/blue fluorescence under UV light and this was used to monitor 






to compound smearing and staining of the silica, these bands became less visible as the 
column progressed. In addition, the charged nature of the iridium complexes resulted in 
significant product loss on the column. Despite these difficulties, both 132·3OTf and 
133·4OTf were isolated pure and fully characterised by NMR spectroscopy and nESI-MS. 
Since the relative chemical environments and symmetry for each of the structures are so 
similar, the 
1
H NMR spectra are also very difficult to differentiate (Figure 2.10). The only 
noticeable variation is due to slight shifts in the peak positions, particularly apparent for the 
singlet signal associated with the bridging 1,4-diisocyanobenzene ligand. However, DOSY 
confirmed that the isolated 132·3OTf and 133·4OTf had hydrodynamic radii of 8.4 Å and 
9.0 Å respectively. nESI-MS confirmed the structural composition of the isolated species 
and matched with the previous analysis of the crude reaction mixture (Figures 2.27-2.32). 
   
Figure 2.10: 
1
H NMR (500 MHz, CD3CN, 300 K) comparison of isolated rac-
[(Ir(ppy)2)n(dib)n]nOTf where n = 3 (132·3OTf) and n = 4 (133·4OTf). 
Despite purification and confirmation of the molecular structure by NMR and nESI-MS, 
both samples still showed extensive splitting patterns in the 
1
H NMR spectra. This complex 
splitting was thought to be due to the formation of a mixture of diastereomers as observed 
for the Ir6L4 cage systems discussed in section 2.3-2.4.  
To confirm this hypothesis, the synthesis was repeated with enantiopure Λ-[(Ir(ppy)2Cl)2]. 
Importantly, the cyclometallated ligands are completely inert even in refluxing TCE, as 






rearrangement of mer-Ir(ppy)3 to fac-Ir(ppy)3,
21,22
 such that the synthesis could be carried out 
without racemisation of the iridium centres. Due to the smaller scale, only the 
[(Ir(ppy)2)3(dib)3]3OTf triangle could be isolated pure in usable yields. DOSY and nESI-MS 
confirmed that the size and molecular formula were identical to the analogous racemic 
compound, however, the 
1





H coupling patterns confirming that the complex spectrum observed in the 




H NMR (500 MHz, CD3CN, 300 K) Comparison of rac-132·3OTf and Λ-







2.5.3 Stability of Two-dimensional Isocyanide systems 
In order to assess the stability of the isolated isocyanide systems, a scrambling experiment 
was carried out by the addition of a competing ligand. 2,6-Dimethylphenylisocyanide was 
chosen as an appropriate competitor due to a similar mode to 131 and commercial 
availability. 
 
Scheme 2.5: Addition of a 2,6-dimethylphenylisocyanide as a competing ligand for analysis 
of  the structural stability of Λ-132·3OTf. 
Successive heating at high temperatures over the course of several weeks produced only a 
very small quantity of the scrambled products (Figure 2.12). Given that complete scrambling 
of 120·6OTf occurs at room temperature in only a few days, even without the presence of a 
competing ligand and that dissolution in CH3CN results in immediate disassembly of the 









H NMR (500 MHz, CD3CN, 300 K) of successive heating of Λ-13·3OTf (green) 
in the presence of 16 (3 equivalents, orange) resulted in the very slow appearance of the 







2.6 Heteroleptic Iridium Isocyanide Architectures 
2.6.1 Introduction 
Self-assembly presents a powerful method for the synthesis of large complex molecules from 
simple starting materials. However, the combination of multiple ligands to form heteroleptic 
architectures remains challenging as self-assembly often leads to a complex mixture of 
different species. This can be overcome by using a step-wise assembly process where certain 
interactions can be sequentially favoured.
23
 Hupp and co-workers have previously developed 
a range of luminescent square compounds based on the stepwise synthesis of rhenium 
complexes.
24,25
 The initial complexation of a bridging ligand to rhenium produces a dinuclear 
complex that can be isolated and purified by column chromatography. Removal of the 
remaining chloride anions by treatment with AgOTf allows the complexation of a second 
linear bidentate ligand to form a range of molecular square compounds. This selective square 
formation could be applied to the synthesis of iridium-isocyanide structures to produce 
heteroleptic luminescent architectures.   
2.6.2 Synthesis 
While refluxing in TCE (146 ºC) completely labilises all of the iridium-isocyanide 
interactions as demonstrated by the formation of the homoleptic architectures described in 
section 2.5, specific interactions can be favoured at lower temperatures. The most common 
synthetic starting material for iridium complexes is the bridged chloride dimer, 
[(Ir(C^N)2Cl)]2. The bridging chloride complex could be selectively split by the addition of 1 
equivalent of 131 (Scheme 2.6). Since the bridging interactions significantly weaken the Ir-
Cl bond, the initial displacement of the chloride occurs rapidly. Once the chloride is bound to 
only a single iridium centre, the Ir-Cl interaction is strengthened and any additional 
displacement requires high temperatures. The resultant diisocyanide bridged compound (137) 
can be isolated and purified to yield a non-fluorescent yellow/green solid suitable as a 







Scheme 2.6: Synthesis of isocyanide bridged iridium dimer (137) by selective cleavage of the 
bridging chloride bonds. 
Similar diisocyanide bridged complexes have been prepared previously using ruthenium 
bipyridine/terpyridine compounds.
26–30
 Whilst these systems often possess interesting 
photophysical and redox properties, they do not contain easily removable ligands that can be 
utilised for stepwise synthesis of supramolecular structures. 
For the second step in the synthesis, rather than use excessively high temperatures that could 
lead to breakdown products, 137 was treated with AgOTf to replace the tightly bound 
chloride ligands with weakly interacting OTf. Addition of a different linear bidentate ligand, 
such as 4,4’-bipyridine, then led to the formation of a symmetric heteroleptic rectangle in a 
similar manner to that described by Hupp and co-workers (Scheme 2.7).
24
  
Although switching to weaker bipyridine ligands potentially reduces the overall stability of 
the compound, this method represents a unique way of rapidly constructing a wide array of 
heteroleptic architectures from simple starting materials. In theory, any linear bis-bidentate 
ligand could be used for formation of the square allowing easy modulation of the chemical 
and photophysical properties. The step-wise synthetic pathway also selectively generates the 
square rather than alternative molecular structures. As discussed in section 2.5, synthesis of 
the corresponding homoleptic isocyanide architectures results in a complex mixture of 
products but selective formation of 138 results in a much cleaner self-assembly process. 
Interestingly, the formation of the homoleptic 4,4’-bipyridine analogue of 133 could not be 
accomplished even at elevated temperatures. A similar observation was made by Lusby and 
co-workers upon initial attempts to synthesise an iridium analogue of the Pd6L4 truncated 






suggest that the 45º dihedral angle favoured by the pyridine sub-units due to steric 
constraints, heavily disfavours the formation of rigid frameworks. In this sense, this method 
also provides a way of incorporating ligands that would otherwise struggle to form 
homoleptic supramolecular assemblies. 
 
 
Scheme 2.7: Synthesis of heteroleptic iridium rectangle, 138·4OTf, from the isocyanide 








2.7 Three-dimensional Isocyanide Architectures 
2.7.1 Introduction 
The strong metal-isocyanide interaction was found to be labile at elevated temperatures, 
allowing the reversible bond formation required for the self-assembly process. Importantly, 
when cooled to room temperature, the bonds remained stable for long periods of time 
allowing the assembled luminescent structures to remain stable in solution for months at a 
time, even in the presence of competing ligands. However, these model two-dimensional 
systems were too open to expect any strict guest confinement that is fundamental for regio- 
and stereo-selective supramolecular catalysis.  
In order to generate the isocyanide variant of the three-dimensional 120·6OTf, 1,3,5-
isocyanobenzene was required to replace the 1,3,5-tricyanobenzene used in the original 
synthesis. In addition, three-dimensional heteroleptic systems could also be envisaged 
incorporating isocyanide panels joined with 4,4’-bipyridine linkers (Figure 2.13). 
 
Figure 2.13: Proposed structures of potential homoleptic (139) and heteroleptic (140) three-








Synthesis of the 1,3,5-isocyanobenzene was carried out using 1,3,5-triaminobenzene as the 
starting material. This was prepared using literature methods by hydrogenation of the 
commercially available 3,5-dinitroaniline (Scheme 2.8). 
 
Scheme 2.8: Synthesis of 1,3,5-triaminobenzene. 
Conversion of the amino groups to isocyanides was attempted using the Hofmann 
carbylamine reaction (Scheme 2.9). The reactive species, dichlorocarbene, was generated in 
situ by the addition of a strong base to chloroform. Although this reaction was known for 
aniline, there was no literature evidence for the formation of 1,3,5-triisocyanobenzene. 
 
Scheme 2.9: Synthesis of 1,3,5-triisocyanobenzene (145) and the structures of the observed 
mono- (143) and  di-substituted (144) intermediates and product. 
TLC analysis of the reaction mixture showed the slow generation of new species, with 
multiple spots observed indicative of the expected 143, 144 and 145. 
1
H NMR analysis of the 
reaction mixture after 29 h showed a mixture of the starting material, product and 
intermediates. Due to limited number of proton peaks and thus information associated with 
each species, they were identified primarily by chemical shift and relative peak integrations 
for the unsymmetrical intermediates (Figure 2.14). However, extended heating did not lead 
to any further conversion to the final product and instead, all of the peaks slowly diminished. 
Any attempt to optimise the reaction conditions or purify and isolate the compound by 
column chromatography was unsuccessful as the product appeared to rapidly degrade on 










H NMR (500 MHz, CDCl3, 300 K) of crude products from the formation of 145. 
The tri- (red), di- (blue) and mono-isocyanide (green) are all observed along with the 
starting material, 1,3,5-triaminobenzene (orange).  
Storage of the crude reaction samples at room temperature also led to the rapid degradation 
of the isocyanide compounds and the loss of the relevant peaks from the aromatic region. 
The apparent instability of the 1,3,5-triisocyanobenzene made it impossible to isolate or 
purify a usable amount for further studies. As such, alternative systems were explored for 







2.8 Summary & Conclusions 
The photoactive iridium-based supramolecular system, 120·6OTf, developed by Lusby and 
co-workers relies on templation by encapsulated counter anions. Attempts have been made to 
stabilise the structure so that an “empty” cavity could be obtained to allow the encapsulation 
of neutral guest molecules and the development of supramolecular photoredox catalysis. 
The iridium-nitrile bond strength was found to be completely independent of the associated 
counter ions, and thus the counter ion dependent stability of 120·6OTf was thought to arise 
from differences in the templating ability. Separate work by O.Chepelin showed that the 
resultant cage stability followed a direct correlation with the differences in electrostatic 
repulsion between the encapsulated anions.
2
  
Alteration of the cyclometallated ligand from 2-phenylpyridine to 2-phenylpyrazole was 
shown to produce a measurable enhancement in the iridium-nitrile bond strength based on 
mononuclear studies. However, the corresponding cage compound, 124·6OTf, was less 
stable than the parent compound, 120·6OTf, due to more rapid exchange of the encapsulated 
OTf anions. 
In order to further strengthen the iridium-ligand interactions, isocyanides were explored as 
supramolecular building blocks. Self-assembly of two-dimensional homoleptic assemblies 
was accomplished at elevated temperatures and the resultant compounds displayed a 
remarkable increase in stability compared with similar nitrile systems. In addition, a step-
wise synthetic approach to the formation of heteroleptic iridium assemblies was developed 
allowing the selective incorporation of alternative binding groups. 
Despite the room temperature stability of two-dimensional iridium isocyanide assemblies, 
attempts to synthesise the 1,3,5-triisocyanobenzene ligand, required for formation of the 
direct structural analogue of 120·6OTf, were unsuccessful due to the inherent instability of 
1,3,5-triisocyanobenzene. 
Isocyanide iridium compounds show great promise as synthetically useful building blocks 
for generating stable luminescent supramolecular assemblies. However, due to synthetic 
difficulties the remainder of this work will focus on alternative methods of incorporating 
photoredox active building blocks into the structures of well-defined and stable 







2.9.1 General Information 
Unless stated otherwise, all reagents and solvents were purchased from Alfa Aesar, VWR or 
Sigma Aldrich and used without further purification. Column chromatography was carried 
out using Geduran Si60 (40-63 µm) as the stationary phase and TLC was performed on 
precoated Kieselgel 60 plates (0.20 mm thick, 60F254. Merck, Germany) and observed under 








were prepared according to literature procedures. rac-[(Ir(ppz)2Cl)2] was prepared by O. 







F NMR spectra were recorded on either a 500 MHz Bruker AV III 
equipped with a DCH cryo-probe (Ava500), a 500 MHz Bruker AV IIIHD equipped with a 
Prodigy cryo-probe (Pro500), a 600 MHz Bruker AV IIIHD equipped with a TCI cryo-probe 
(Ava600) or a 400 MHz Bruker AV III equipped with BBFO+ probe (Ava400) at a constant 
temperature of 300 K. All DOSY experiments were performed either on the Ava400 or the 
Ava500 using bipolar gradient pulses for diffusion with two spoil gradients 
(ledbpg2s.compensated) pulse sequence. The sequence was carried out under automated 
conditions where the duration of the magnetic field pulse gradient (δ) was 1.5 ms and the 
diffusion time (∆) was 100 ms. Typically in each PFG NMR experiment, a series of 16 
spectra on 32 K data points were collected and the eddy current delay (Te) was set to 5 ms in 
all experiments. The pulse gradients (g) were incremented from 2 to 95% of the maximum 
gradient strength in a linear ramp. The temperature was set and controlled at 300 K with an 
air flow of 400 l h
-1
 in order to avoid any temperature fluctuations due to sample heating 
during the magnetic field pulse gradients. The data was processed using Bruker Topspin 3.2. 
Chemical shifts are reported in parts per million. Coupling constants (J) are reported in hertz 
(Hz). Standard abbreviations indicating multiplicity were used as follows: m = multiplet, q = 
quartet, t = triplet, d = doublet, s = singlet, bs = broad singlet. Where required, peak 
assignments were confirmed through a range of two-dimensional techniques including, 








MS of the cage compounds was performed on a Synapt G2 (Waters., Manchester, UK) mass 
spectrometer or a Q-ToF (Micromass UK Ltd), using a nano-electrospray ionization source 
(ESI), controlled using Masslynx v4.1 software. All of the scans in the experimental are for 
positive ions. The samples were dissolved in acetonitrile or TCE at 50 µM. Prior to analysis, 
instruments were calibrated using a solution of sodium iodide (2 mg/mL) in 50:50 
water:isopropanol. Capillary voltages were adjusted between 1.5 and 2.5 kV to optimize 
spray quality, while the sampling cone and the extraction cone voltage were minimised to 
reduce breakdown of the assemblies. Source temperature was set between 60-120 °C. The 
data was analysed using MassLynx v4.1 and Origin 2015. Predicted isotopic distributions 
were calculated using Molecular Weight Calculator Version 6.49. 
2.9.2 Analysis of Supramolecular Assemblies  
Many fundamental analytical approaches remain exactly the same for studying 
supramolecular systems as they do for standard covalent molecules. However, due to the 
inherent dynamic nature of many supramolecular species, they possess some unique 
challenges when it comes to proving their exact composition and existence. A number of 
these challenges will be discussed here as they are relevant to the entirety of this work and 








X-ray crystallography is now established as a fundamental tool in the elucidation of chemical 
structures. The ability to get the fixed coordinates of the constituent atoms can remove 
almost any doubt as to the correct chemical structure for all but the most challenging 
compounds. This allows the identification of systems that would normally be very difficult 
to distinguish, for example, the reliable assignment of chiral centres.  
The only major drawback to X-ray crystallography is the difficulty in preparing high quality 
crystalline samples. This is particularly difficult for supramolecular systems since many 
contain large cavity spaces filled either with disordered solvent molecules or bound counter 
ions. Coupled with the inherent reversibility of the bonding interactions, this makes high 
quality crystalline samples of supramolecular systems difficult to prepare and particularly 
prone to irreparable damage through solvent loss. 
Despite the practical difficulties, X-ray crystallography has be used extensively in the study 
of supramolecular systems with many being characterised based purely on their solid state 
structures. However, caution should be taken when describing the solution properties of 
discrete, supramolecular systems with reversible interactions based solely on their solid state 
structures. While covalent linkages can be reasonably assumed to remain the same in both 
the solid and the solution states, reversible interactions such as metal-ligand coordination or 
hydrogen bonding can alter significantly.  As such, systems that may show well defined 
cavities in the solid state may dissociate upon dissolution to give either smaller cavities, 
individual components without any defined cavity at all or a mixture of the above. Therefore, 
any discrete supramolecular system analysed by X-ray crystallography must be compared 
with solution based data before jumping to conclusions about any solution based processes 
such as guest inclusion or homogenous catalysis.  
Exchange Spectroscopy (EXSY) 
Nuclear magnetic spectroscopy (NMR) is an invaluable tool for probing the solution state 
properties of molecular compounds. The range of techniques and applications are far too 
numerous to be discussed in totality, however, a number of specialist techniques have been 







The Nuclear Overhauser Effect is commonly used in the form of NOESY spectra for 
determining correlation between nuclei close in space. If the experiment is performed 
quantitatively, this can also be used to measure the exchange of chemical species such as 
metal-ligand complexation or host-guest interactions. For a simple, two species exchange 
system, the intensity of the observed cross peaks can be related to the observed rate 












𝐼𝐴𝐴 & 𝐼𝐵𝐵 = 𝑑𝑖𝑎𝑔𝑜𝑛𝑎𝑙 𝑝𝑒𝑎𝑘 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑖𝑒𝑠 
𝐼𝐴𝐵 & 𝐼𝐵𝐴 = 𝑐𝑟𝑜𝑠𝑠 − 𝑝𝑒𝑎𝑘 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑖𝑒𝑠 
𝜏𝑚 = 𝑚𝑖𝑥𝑖𝑛𝑔 𝑡𝑖𝑚𝑒 𝑖𝑛 𝑠 
Assuming that the system is at equilibrium then the observed rate constant can be assumed to 
be equal to both the forward and reverse processes as given by: 
𝑘1 
    𝐴 + 𝐵  𝐴𝐵         
𝑘−1 
𝑘 = 𝑘1 + 𝑘−1 = 2 × 𝑘𝑜𝑏𝑠      (𝑘1 = 𝑘−1 = 𝑘𝑜𝑏𝑠) 
 
By repeating measurements with a variety of different mixing times, 𝜏𝑚, a more accurate 
value for 𝑘𝑜𝑏𝑠 can be obtained by plotting a graph of ln((𝑟 + 1/(𝑟 − 1)) versus 𝜏𝑚 to give a 
straight line with slope 1/𝑘.35 Direct information about the activation barrier can then be 
obtained using the Eyring equation:
36
  




(𝑅 = 1.9872 𝑐𝑎𝑙 𝐾−1 𝑚𝑜𝑙−1, 𝑘𝐵 = 3.30 × 10
−24 𝑐𝑎𝑙 𝐾−1, ℎ = 1.58 × 10−34 𝑐𝑎𝑙 𝑠) 
Thus, EXSY NMR provides a unique tool for providing quantitative information about 






Diffusion Ordered Spectroscopy (DOSY) 
Diffusion within NMR tubes can often lead to complications in many experiments but it can 
also be utilised to probe the size of molecular species based on their rate of diffusion through 
a particular solvent. Diffusion ordered spectroscopy (DOSY) is carried out by creating a 
gradient within the magnetic field by applying a specific radio frequency pulse. A second 
inverse pulse can then be used to realign the nuclei. Theoretically, if there was zero time 
between the two pulses, the obtained spectra would be identical to the original. However, if a 
time delay is included, diffusion within the sample tube misaligns the molecules with respect 
to the initial pulse. As a result, when the inverse pulse is applied, each signal is reduced in 
strength based on the distance the species has moved in solution. If the experiment is 
repeated with a number of different gradient strengths, an exponential decay function can be 
applied to the decrease in peak intensity to give the diffusion constant, D. 
 
Figure 15: Graphical representation of the effects of diffusion on the dephasing and 







Figure 16: An example stack plot of 
1
H NMR spectra illustrating the relative decrease in 
signal intensity as the applied gradient strength is increased. 
 
The diffusion constant can then be used to calculate the hydrodynamic radius, 𝑟𝑠, for the 





𝜂 = 𝑠𝑜𝑙𝑣𝑒𝑛𝑡 𝑣𝑖𝑠𝑐𝑜𝑠𝑖𝑡𝑦 
It should be noted that hydrodynamic radius includes the solvation shell surrounding the 
compound and assumes a spherical shape. Thus, the calculated radius may not agree exactly 
with predicted space filling models and will vary with different solvents. Nevertheless, by 
direct comparison, DOSY can be used to tell the difference between large supramolecular 
species and their constituent parts. For example, many metallosupramolecular assemblies 
possess high degrees of symmetry which means the 
1
H NMR spectrum of the intact 
assembly can be nearly identical to the 
1
H NMR of the free ligands. The only observable 
changes are usually small peak shifts due to metal complexation. However, the calculated 
hydrodynamic radius obtained from DOSY will show a dramatic increase in size providing 






In addition, many self-assembled systems can also generate a statistical mixture of species 
with non-identical 
1
H NMR spectra, often as a result of chirality. These mixtures generate 
incredibly complex 
1
H NMR spectra due both to the number of species and the lack of 
symmetry, which makes conventional analysis near impossible. DOSY NMR can distinguish 
if the complex 
1
H NMR is due purely to a statistical distribution of identically sized 







2.9.3 Synthetic Procedures 
121 - [Ir(ppy)2(F-PhCN)2]X 
 
General Procedure: 
[(Ir(ppy)2Cl)2] (63.6 mg, 0.059 mmol) and AgX (30.0 mg, 0.117 mmol) were dissolved in 
DCE (30 mL) and stirred in the dark at room temperature for 2 h. The resultant mixture was 
filtered through celite and concentrated under reduced pressure. 4-Fluorobenzonitrile (31.2 
mg, 0.258 mmol) was charged and stirred overnight in a darkened flask. The product was 
precipitated with Et2O, filtered and washed with Et2O to yield a yellow/green solid  
*All NMR peak data abstracted from solutions containing excess free ligand. 
X = OTf (39.6 mg, 50%). 
1
H NMR (500 MHz, CD2Cl2) δ 9.16 (ddd, J = 5.8, 1.2 Hz, 2H, Hh), 
8.05 – 7.99 (m, 4H, He,f), 7.76 – 7.72 (m, 4H, Hj), 7.65 (ddd, J = 7.8, 1.4, 0.5 Hz, 2H, Hd), 
7.53 – 7.48 (m, 4H, Hg), 7.24 – 7.20 (m, 4H, Hi), 6.98 (ddd, J = 7.7, 7.3, 1.2 Hz, 2H, Hc), 
6.83 (ddd, J = 7.5, 1.3 Hz, 2H, Hb), 6.21 (ddd, J = 7.7, 1.2, 0.5 Hz, 2H, Ha). 
13
C NMR (126 
MHz, CD2Cl2) δ 167.68 , 166.77 (d, J = 259.4 Hz), 151.42, 144.68, 143.84, 139.47, 136.95 
(d, J = 10.0 Hz), 131.86, 130.59, 124.86, 124.40, 123.62, 120.36, 119.66, 117.88 (d, J = 23.0 
Hz), 106.46 (d, J = 3.5 Hz). 19F NMR (471 MHz, CD2Cl2) δ -78.75, -99.05 – -99.26 (m). m/z 
(HR-ESI): 501.09700 (predicted [Ir(ppy)2]
+
 = 501.09374), complete ligand dissociation 
observed in CH3OH under MS conditions. 
X = PF6 (29.6 mg, 30%). 
1
H NMR (500 MHz, CD2Cl2) δ 9.13 (ddd, J = 5.7, 1.2 Hz, 2H, Hh), 
8.04 – 8.00 (m, 4H, He,f), 7.73 – 7.67 (m, 4H, Hj), 7.65 (dd, J = 7.9, 1.1 Hz, 2H, Hd), 7.51 – 
7.45 (m, 2H, Hg), 7.24 – 7.17 (m, 4H, Hi), 6.98 (ddd, J = 7.8, 7.3, 1.2 Hz, 2H, Hc), 6.83 (ddd, 
J = 7.5, 1.4 Hz, 2H, Hb), 6.21 (ddd, J = 7.6, 1.2, 0.5 Hz, 2H, Ha). 
13
C NMR (126 MHz, 
CD2Cl2) δ 167.69, 166.77 (d, J = 259.3 Hz), 151.33, 144.68, 143.83, 139.48, 136.85 (d, J = 






23.0 Hz), 106.46 (d, J = 3.5 Hz). 
19
F NMR (471 MHz, CD2Cl2) δ -72.80 (d, J = 711.0 Hz), -
99.05 – -99.18 (m). m/z (HR-ESI): 501.09380 (predicted [Ir(ppy)2]
+
 = 501.09374), complete 
ligand dissociation observed in CH3OH under MS conditions. 
X = BF4 (12.7 mg, 14%). 
1
H NMR (500 MHz, CD2Cl2) δ 9.16 (ddd, J = 5.8, 1.2 Hz, 2H, Hh), 
8.05 – 7.97 (m, 4H. He,f), 7.77 – 7.67 (m, 4H, Hj), 7.65 (dd, J = 7.7, 1.3 Hz, 2H, Hd), 7.53 – 
7.44 (m, 2H, Hg), 7.24 – 7.13 (m, 4H, Hi), 6.98 (ddd, J = 7.5, 1.2 Hz, 2H, Hc), 6.83 (ddd, J = 
7.5, 1.4 Hz, 2H, Hb), 6.21 (dd, J = 7.6, 1.3 Hz, 2H, Ha). 
13
C NMR (126 MHz, CD2Cl2) δ 
167.67, 166.75 (d, J = 259.4 Hz), 151.45, 144.70, 143.89, 139.44, 136.93 (d, J = 10.0 Hz), 
131.86, 130.57, 124.84, 124.35, 123.59, 120.32, 119.62, 117.85 (d, J = 23.0 Hz), 106.51 (d, 
J = 3.6 Hz). 
19





m/z (HR-ESI): 501.09350 (predicted [Ir(ppy)2]
+
 = 501.09374), complete ligand dissociation 
observed in CH3OH under MS conditions. 
X = ClO4 (4.9 mg, 5%). 
1
H NMR (500 MHz, CD2Cl2) δ 9.16 (ddd, J = 5.8, 1.2 Hz, 2H, Hh), 
8.06 – 7.99 (m, 4H, He,f), 7.77 – 7.72 (m, 4H, Hj), 7.65 (dd, J = 7.8, 1.3 Hz, 2H, Hd), 7.52 – 
7.47 (m, 2H, Hg), 7.25 – 7.17 (m, 4H, Hi), 6.98 (ddd, J = 7.5, 1.2 Hz, 2H, Hc), 6.83 (ddd, J = 
7.5, 1.4 Hz, 2H, Hb), 6.21 (dd, J = 7.7, 1.1 Hz, 2H, Ha). 
13
C NMR (126 MHz, CD2Cl2) δ 
167.68, 166.76 (d, J = 259.4 Hz), 151.48, 144.69, 143.90, 139.44, 136.96 (d, J = 9.9 Hz), 
131.87, 130.59, 124.85, 124.36, 123.60, 120.33, 119.63, 117.87 (d, J = 23.0 Hz), 106.53 (d, 
J = 3.6 Hz). 
19
F NMR (471 MHz, CD2Cl2) δ -99.11 – -99.29 (m). m/z (HR-ESI): 501.09540 
(predicted [Ir(ppy)2]
+
 = 501.09374), complete ligand dissociation observed in CH3OH under 
MS conditions. 
 
For reference only: 
1
H NMR (500 MHz, CD2Cl2) δ 7.74 – 7.66 (m, 2H, Hb), 7.23 – 7.16 (m, 2H, Ha). 
13
C NMR 
(126 MHz, CD2Cl2) δ 165.61 (d, J = 255.7 Hz), 135.33 (d, J = 9.5 Hz), 118.55, 117.31 (d, J 
= 22.9 Hz), 109.21 (d, J = 3.5 Hz). 
19









125 - [Ir(ppz)2(F-PhCN)2]OTf 
 
[(Ir(ppz)2Cl)2] (60.8 mg, 0.059 mmol) and AgOTf (30.3 mg, 0.118 mmol) were dissolved in 
DCE (30 mL) and stirred in the dark at room temperature for 2 h. The resultant mixture was 
filtered through celite and concentrated under reduced pressure. 4-Fluorobenzonitrile (62.1 
mg, 0.513 mmol) was charged and stirred overnight in a darkened flask. The product was 
precipitated with Et2O, filtered and washed with Et2O to yield a white solid (51.3 mg, 60%). 
1
H NMR (500 MHz, CD2Cl2) δ 8.26 (dd, J = 3.0, 0.7 Hz, 2H, He), 8.19 (dd, J = 2.3, 0.7 Hz, 
2H, Hg), 7.80 – 7.75 (m, 4H, Hi), 7.29 (dd, J = 7.9, 1.2 Hz, 2H, Hd), 7.27 – 7.22 (m, 4H, Hh), 
7.00 (ddd, J = 7.9, 7.4, 1.3 Hz, 2H, Hc), 6.89 (dd, J = 2.9, 2.3 Hz, 2H, Hf), 6.81 – 6.75 (m, 
2H, Hb), 6.18 (dd, J = 7.6, 1.0 Hz, 2H, Ha). 
13
C NMR (126 MHz, CD2Cl2) δ 166.84 (d, J = 
259.5 Hz), 143.45, 140.58, 136.97 (d, J = 10.0 Hz), 133.58, 127.90, 126.75, 125.91, 124.36, 
119.35, 117.95 (d, J = 23.0 Hz), 112.03, 109.24, 106.31 (d, J = 3.5 Hz). 19F NMR (471 MHz, 
CD2Cl2) δ -78.77, -98.83 – -99.09 (m), -103.46 – -103.70 (m). m/z (HR-ESI): 479.08650 
(predicted [Ir(ppz)2]
+
 = 479.08424), complete ligand dissociation observed in CH3OH. 
Separation of Δ/Λ-[(Ir(ppz)2Cl)2] 
 
rac-[(Ir(ppz)2Cl)2] (245.7 mg, 0.239 mmol), D-Serine (65.2 mg, 0.620 mmol) and NaOMe 
(32.6 mg, 0.603 mmol) were partially dissolved in CH3OH (25 mL). The mixture was stirred 
at 40 ºC for 5 h. The solvent was removed under reduced pressure and crude product 






from the filtrate under reduced pressure to yield a white solid (64.7 mg, 23%). 
1
H NMR (500 
MHz, CD3OD) δ 8.54 (d, J = 2.9 Hz, 1H, He’), 8.50 (d, J = 2.9 Hz, 1H, He), 8.16 (dd, J = 2.3, 
0.6 Hz, 1H, Hg), 7.85 (dd, J = 2.2, 0.7 Hz, 1H, Hg’), 7.38 – 7.34 (m, 2H, Hd,d’), 6.88 – 6.79 (m, 
4H, Hc,c’,f,f’), 6.64 – 6.56 (m, 2H, Hb,b’), 6.24 (dd, J = 7.6, 1.3 Hz, 1H, Ha’), 6.15 (dd, J = 7.5, 
1.3 Hz, 1H, Ha), 5.37 – 5.26 (m, 2H, Hh), 4.04 – 3.95 (m, 1H, Hj), 3.76 – 3.69 (m, 2H, Hi,j). 
*Hj CH2 protons split into two different environments, confirmed by HSQC. 
13
C NMR (126 
MHz, CD3OD) δ 185.26, 145.51, 145.29, 140.61, 139.20, 135.28, 135.22, 134.10, 128.24, 
128.18, 126.63, 126.36, 126.14, 122.76, 122.29, 111.92, 111.85, 108.70, 108.48, 64.83, 
59.46. m/z (HR-ESI): 606.10890 (predicted [M+Na]
+
 = 606.10878), 1189.23080 (predicted 
[2M+Na]
+
 = 1189.22887). 
 
Δ/Λ-[Ir(ppz)2(D-Serine)] (63.7 mg, 0.109 mmol) was dissolved in CH3OH (16 mL). HCl(aq) 
(37 w/v%, 1 mL) was charged dropwise and the solution stirred at room temperature for 1 h. 
The resultant precipitate was filtered and washed with CH3OH. The solid was redissolved in 
CH2Cl2, filtered and the solvent removed under vacuum to yield a white solid (49.8 mg, 
89%). 
1
H NMR (500 MHz, CD2Cl2) δ 8.21 (d, J = 2.9 Hz, 4H, Hg), 7.83 (d, J = 2.2 Hz, 4H, 
He), 7.20 (dd, J = 7.9, 1.2 Hz, 4H, Hd), 6.89 – 6.81 (m, 4H, Hc), 6.73 – 6.66 (m, 4H, Hf), 6.61 
– 6.56 (m, 4H, Hb), 5.96 (dd, J = 7.7, 1.3 Hz, 4H, Ha). 
13
C NMR (126 MHz, CD2Cl2) δ 
143.69, 141.04, 133.02, 127.93, 126.98, 125.76, 122.48, 111.16, 107.26. DOSY NMR (500 
MHz, C2D2Cl4) –logD = 9.77 Hydrodynamic radius = 8.8 Å. m/z (HR-ESI): 479.08450 
(predicted [Ir(ppz)2]
+






Δ/Λ-124·6OTf - [(Ir(ppz)2)6(tcb)4]6OTf 
 
Δ/Λ-[(Ir(ppz)2Cl)2] (25.6 mg, 0.025 mmol) and AgOTf (12.8 mg, 0.050 mmol) were 
dissolved in DCE (10 mL) and stirred in the dark at room temperature for 2 h. The resultant 
mixture was filtered through celite and concentrated under reduced pressure. 1,3,5-
Tricyanobenzene (2.5 mg, 0.016 mmol) was charged and the resultant precipitate was 
filtered and washed with the minimum volume of DCE and Et2O to give a yellow solid (8.7 
mg, 42 %). 
1
H NMR (500 MHz, C2D2Cl4) δ 8.56 (d, J = 2.4 Hz, 12H, Hg), 8.43 (s, 12H, Hh), 
8.24 (d, J = 2.8 Hz, 12H, He), 7.20 (d, J = 8.2 Hz, 12H, Hd), 7.08 (d, J = 2.6 Hz, 12H, Hf), 
6.97 (dd, J = 7.9 Hz, 12H, Hc), 6.74 (dd, J = 7.5 Hz, 12H, Hb), 6.18 (d, J = 7.6 Hz, 12H, Ha). 
13
C NMR not obtained due to low signal strength. 
19
F NMR (376 MHz, C2D2Cl4) δ -77.74, -
78.72. Signals very broad due to chemical exchange. DOSY NMR (500 MHz, C2D2Cl4) –
logD = 9.98 Hydrodynamic radius = 14.3 Å. 
[(Ir(ppy)2)n(dib)n]nOTf 
[(Ir(ppy)2Cl)2] (25.2 mg, 0.024 mmol), 1,4-diisocyanobenzene (6.0 mg, 0.047 mmol) and 
AgOTf (12.1 mg, 0.047 mmol) were partially dissolved in TCE and heated at 100 ºC in a 
darkened flask for 3 days. The solvent was removed under vacuum and the crude products 







rac-132·3OTf - [(Ir(ppy)2)3(dib)3]4OTf 
1
H NMR (500 MHz, CD3CN) δ 9.32 – 9.17 (m, 6H, Hh), 8.25 – 8.09 (m, 12H, He,f), 7.87 – 
7.77 (m, 6H, Hd), 7.58 (s, 12H, Hi), 7.50 – 7.33 (m, 6H, Hg), 7.07 – 7.00 (m, 6H, Hc), 6.97 – 
6.87 (m, 6H, Hb), 6.19 – 6.11 (m, 6H, Ha). *
13
C NMR too complex for analysis. 
19
F NMR 
(376 MHz, CD3CN) δ -79.31. DOSY NMR (500 MHz, CD3CN) –logD = 9.15 
Hydrodynamic radius = 8.4 Å. 
Δ/Λ-132·3OTf - [(Ir(ppy)2)3(dib)3]4OTf 
1
H NMR (601 MHz, CD3CN) δ 9.25 (ddd, J = 5.7, 1.5, 0.8 Hz, 6H, Hh), 8.21 – 8.11 (m, 12H, 
He,f), 7.81 (dd, J = 7.8, 1.2 Hz, 6H, Hd), 7.59 (s, 12H, Hi), 7.44 (ddd, J = 7.3, 5.7, 1.7 Hz, 6H, 
Hg), 7.07 – 7.00 (m, 6H, Hc), 6.97 – 6.89 (m, 6H, Hb), 6.16 (dd, J = 7.7, 1.1 Hz, 6H, Ha). 
13
C 
NMR (126 MHz, CD3CN) δ 168.10, 155.50, 153.18, 145.45, 140.50, 136.19, 131.43, 131.38, 
129.58, 128.72, 125.87, 125.70, 125.04, 121.97. 
19
F NMR (376 MHz, CD3CN) δ -79.25. 
DOSY NMR (500 MHz, CD3CN) –logD = 9.15 Hydrodynamic radius = 8.4 Å. 
rac-133·4OTf  - [(Ir(ppy)2)4(dib)4]4OTf 
 
1
H NMR (500 MHz, CD3CN) δ 9.31 – 9.16 (m, 8H), 8.20 – 8.07 (m, 16H), 7.82 – 7.75 (m, 
8H), 7.53 (s, 16H), 7.49 – 7.36 (m, 8H), 7.07 – 6.98 (m, 8H), 6.95 – 6.86 (m, 8H), 6.21 – 
6.10 (m, 8H). *13C NMR too complex for analysis. 19F NMR (376 MHz, CD3CN) δ -79.32. 






137 - [(Ir(ppy)2)2(dib)Cl2] 
 
[(Ir(ppy)2Cl)2] (59.2 mg, 0.055 mmol) and 1,4-phenyldiisocyanide (7.1 mg, 0.055 mmol) 
were dissolved in TCE (20 mL) and stirred at 60 ºC for 2 h. The solution was concentrated 
under reduced pressure and the product was precipitated with Et2O, filtered and washed with 
Et2O to yield a bright yellow solid (63.2 mg, 95%). 
1
H NMR (601 MHz, CD2Cl2) δ 9.85 (ddd, 
J = 5.9, 1.6, 0.8 Hz, 2H, Hh’), 9.16 (ddd, J = 5.8, 1.6, 0.8 Hz, 2H, Hh), 7.98 – 7.92 (m, 4H, 
He,e’), 7.92 – 7.85 (m, 4H, Hf,f’), 7.67 – 7.59 (m, 4H, Hd,d’), 7.33 (ddd, J = 7.3, 5.9, 1.6 Hz, 2H, 
Hg’), 7.26 (s, 4H, Hi), 7.22 (ddd, J = 7.4, 5.7, 1.6 Hz, 2H, Hg), 6.97 – 6.89 (m, 4H, Hc,c’), 6.88 
– 6.82 (m, 2H, Hb’), 6.82 – 6.75 (m, 2H, Hb), 6.40 (dd, J = 7.7, 0.8 Hz, 2H, Ha’), 6.03 (dd, J = 
7.6, 1.3 Hz, 2H, Ha). Unable to confirm identity of unsymmetrical 2-phenylpyridine protons 
in relation to isocyanide ligand. 
13
C NMR (126 MHz, CD2Cl2) δ 168.53, 167.87, 165.56, 
153.90, 152.10, 145.04, 143.93, 143.87, 138.27, 138.08, 131.55, 130.80*, 130.80*, 130.34, 
128.50, 124.66, 124.62, 124.00, 123.48, 123.17, 122.48, 120.55, 119.68, 74.89. *HSQC 
confirms two carbon atoms at identical ppm. DOSY NMR (500 MHz, CD2Cl2) –logD = 9.11 








rac-138·4OTf - [(Ir(ppy)2)4(dib)2(bipy)2]4OTf 
 
[(Ir(ppy)2)2(dib)Cl2] (12.2 mg, 0.010 mmol) and AgOTf (5.2 mg, 0.020 mmol) were 
dissolved in CH2Cl2 (20 mL). The solution was sonicated for 1 h in a darkened flask and a 
fine white precipitate was formed. 4,4’-Bipyridine (1.6 mg, 0.010 mmol) was charged and 
the mixture was filtered through celite. The yellow filtrate was heated at 60 ºC for 16 h and 
concentrated under reduced pressure. The product was precipitated with Et2O, filtered and 




C NMR too complex for analysis. 
19
F 
NMR (376 MHz, CD2Cl2) δ -78.67. DOSY NMR (500 MHz, CD2Cl2) –logD = 9.29 
Hydrodynamic radius = 10.3 Å. 
145 - 1,3,5-triisocyanobenzene 
 
1,3,5-triaminobenzene (164.9 mg) was dissolved in CH2Cl2 (6.2 mL). 50 w/v% NaOH(aq) 
(3.1 mL) and 
t
Bu4NBr (4.6 mg) were charged. Chloroform (0.5 mL) was charged slowly and 
the mixture was heated at reflux for 29 h. 
1
H-NMR indicated the formation of the mono-, di- 
and triisocyanobenzene analogues. The organic layer was separated and washed with H2O (2 
x 20 mL) and brine (20 mL). The organic layer was dried with MgSO4 and the solvent was 
removed under reduced pressure. Attempted purification was carried out by column 
chromatography with CH2Cl2 as the mobile phase. Product not isolated. 
1
H NMR (500 MHz, 







2.9.4 Counter Ion Induced Ligand Dissociation 
 
Figure 2.17: Mixing time versus peak ratio for 121·X with a range of different counter ions 
analysed by 
19
F EXSY (471 MHz, C2D2Cl4, 300 K). 
For each counter ion, a linear fit was applied and the gradient calculated to give 1/𝑘. Further 
experimental values were calculated as detailed in Section 2.9.2.  
Table 2.3: The rate of ligand dissociation in relation to the associated counter ion.  
Compound Gradient kobs (s
-1
) 𝑮‡ (kJmol-1) 
121·OTf 0.0512 9.766 67.34 
121·PF6 0.0394 12.690 66.69 
121·BF4 0.0510 9.804 67.33 

























H NMR (400 MHz, d6-DMSO, 300 K) showing aromatic region of [Ir(ppz)2(D-
Serine)] and formation of diasteromers upon complexation of D-Serine to racemic mixture 
and isolation of a single diastereomer.  
 
Figure 1.21: Expanded region of 
1
H NMR (400 MHz, d6-DMSO, 300 K) showing isolation of 






2.9.7 Crystal Structure of Δ-124·6OTf 
 
Figure 2.22: Partially resolved crystal structure of Δ-124·6OTf confirming cage structure 
and chirality. 
X-ray quality crystals were grown using slow diffusion of benzene into a TCE solution. All 
structural characterisation was performed by Prof Alexandra M Z Slawin (The University of 
St Andrews). All of the structural data was collected using a Rigaku Saturn diffractometer 
(MM007 high-flux RA/MoKa radiation, confocal optic) at 93 K. All data collection 
employed narrow frames (0.3-1.0) to obtain at least a full hemisphere of data. Intensities 
were corrected for Lorentz polarisation and absorption effects (multiple equivalent 
reflections). The structure was solved by direct methods. Non-hydrogen atoms were refined 
anisotropically with C-H protons being refined in riding geometries (SHELXTL) against F
2
. 
Structural refinement could only be partially resolved but the general cage structure and 








Table 2.4: Crystallographic details and parameters for Δ-124·6OTf. 
Identifier DAPL1N 
Empirical formula C150H96F18Ir6N36O18S6 
Formula weight 4378.29 
Temperature 93(1) K 
Wavelength 0.71075 Å 
Crystal system Primitive Monoclinic 
Space group P21 
Unit cell dimensions a = 17.773(5) Å  α = 90° 
 b = 34.303(9) Å  β = 95.828(4)° 




Density (calculated) 1.256 g cm
-3 




Crystal size 0.100 x 0.100 x 0.020 mm
 
Theta range for data collection 1.60 to 25.42° 
Index ranges -21<=h<=21, -41<=k<=41, -22<=l<=22 
Reflections collected 117344 
Independent reflections 42060 [R(int) = 0.0757] 
Completeness to theta = 25.42° 99.2% 
Absorption correction Multiscan 
Max. and min. transmission 0.931 and 0.690 
Refinement method Full-matrix least-squares on F
2 




Final R indices [I>2sigma(I)] R1 = 0.1684 
R indices (all data) wR2 = 0.4363 
Absolute structure parameter 0.089(18) 












2.9.8 Confirmation of Δ-124·6OTf Stereochemistry 
 
 




2.9.9 Variable Temperature NMR of Anion Encapsulation 
 
Figure 2.24: Variable temperature 
19
F NMR (376 MHz, C2D2Cl4) showing partial 
coalescence at room temperature of the signals corresponding to encapsulated (red) and 







2.9.10 Stability of 124·6OTf versus 120·6OTf 
 
Figure 2.25: Stability of Ir6L4 systems assessed by 
1
H NMR (500 MHz, C2D2Cl4, 300 K) 
scrambling experiments. The percentage scrambling was monitored by integration of the 
1,3,5-tricyanobenzene signal.   
An exponential fit was applied and the corresponding half-lives calculated using the 
following expression:  






ℎ𝑎𝑙𝑓 − 𝑙𝑖𝑓𝑒 = 𝑡1 ln(2) 
The value of 𝑦0 was used to take into account the observation that the peak area did not trend 
to zero due to a statistical quantity of enantiopure material in the scrambled mixture and, in 
the case of 120·6OTf, the presence of overlapping signals.  
Table 2.5: Calculated values for exponential decay functions 
Compound Ligand Mean lifetime, 𝒕𝟏 (h) Half-life (h) 
124·6OTf 2-phenypyrazole (ppz) 56.7 ± 4.6 39 











H NMR (500 MHz, C2D2Cl4, 300 K) of a statistical mixture of two-dimensional 









2.9.12 Mass Spectrometry of Homoleptic Isocyanide Systems 
 
Figure 2.27: Mass spectrum of [(Ir(ppy)2)n(dib)n]nOTf crude mixture. Major peaks are 
identified as the triangle, square or pentagon where n = 3,4 or 5 respectively. 
 
Figure 2.28: Experimental peaks (black) from crude mixture identified as 132·3OTf shown 














Figure 2.29: Experimental peaks (black) from crude mixture identified as 133·4OTf shown 
versus modelled isotopic distribution (red). 
 
Figure 2.30: Experimental peaks (black) from crude mixture identified as 134·5OTf shown 





















Figure 2.31: nESI-MS of the isolated rac-132·3OTf triangle. The molecular ion peak is 











Figure 2.32: nESI-MS of the isolated rac-133·4OTf square. Molecular ion peaks are shown 
















Figure 2.33: nESI-MS of the isocyanide “edge” piece, 137. Molecular ion peaks are shown 
with experimental (black) versus the modelled isotopic distribution (red). The +2 molecular 
ion shows a propensity to dimerise to form the chloro-bridged macrocycle resulting in a +2 















Figure 2.34: nESI-MS of 138·4OTf rectangle. Molecular ion peaks are shown with 
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Due to the difficulties in preparing photoactive assemblies utilising iridium as a structural 
component, a complex-as-ligand method was developed to allow the preparation of a 
photoredox active Pd2L4 type system. The assembled structure could be isolated as a stable 
solid and readily formed a discrete supramolecular system in solution at concentrations 
above 10 µM. Importantly, the beneficial photophysical properties of the iridium complex 
were maintained in the self-assembled cage despite the presence of the heavy Pd
II
 ions. Initial 
guest binding studies in 1:1 CD3CN/D2O showed that a range of neutral organic guests could 
be encapsulated using the hydrophobic effect and the cage could successfully function as a 
photocatalyst. However, regio-selective catalysis was unsuccessful, potentially due to the 














As discussed in Chapter 1, photoactive coordination capsules show great promise in 
combining the beneficial properties of both visible-light photoredox catalysis and that of 
stereo- or regio-selective supramolecular catalysis. The most commonly used photoredox 
catalysts are polypyridyl ruthenium complexes or cyclometallated iridium complexes due to 
their suitable photochemical properties such as high extinction coefficients, long-lived 
excited states, solution stability and high redox potentials.
1–9
 Previous attempts at directly 
incorporating iridium as a structural component into the assembly of a coordination capsule 
were successful in producing a photoactive coordination cage.
10
 Indeed, the cooperative 
binding actually enhanced the luminescent behaviour with respect to structurally similar 
mononuclear complexes. However, the structure was found to be inherently unstable towards 
the encapsulation of neutral organic molecules due to the requirement for the cage to 
encapsulate four templating counter ions. Upon removal of these counter ions, or 
replacement with bulky non-templating anions, the cage rapidly disassembled into the 
constituent monomeric parts. Attempts to stabilise this structure are discussed in chapter 2. 
As an alternative method for developing a stable cage system that incorporated an iridium 
photosensitiser, a complex-as-ligand approach was envisaged by which a cyclometallated 
iridium complex with additional donor sites could be assembled into a coordination capsule 
using an alternative metal linker. 
Many examples of the complex-as-ligand approach already exist whereby kinetically inert 
metal complexes can be used in the stepwise synthesis of heterometallic supramolecular 
assemblies.
11–21
 Indeed, examples are also present where luminescent building blocks have 
been used to create two-dimensional photoactive metallosupramolecular assemblies (see 
chapter 2).
22–26
 However, although many of these systems display an affinity for binding 
ions,
22,24
 host:guest chemistry with neutral organic molecules is limited and the macrocycles 
often lack the three-dimensional confines required for strict regio- or stereo-selective 
supramolecular catalysis. As such, a novel M2L4 iridium functionalised system was designed, 






3.3 Design & Synthesis of “Complex-as-Ligand” 
Systems 
3.3.1 Ligand Synthesis 
Iridium was chosen as the photocatalytic centre due to its ideal photophysical properties and 
the ease in which ancillary ligands could be attached when compared with analagous 
ruthenium polypyridyl chemistry. A complex was designed based on the common 
cyclometallated iridium bis-(2-phenylpyridine) moiety (Ir(ppy)2N^N) where the ancillary 
ligand was altered to incorporate additional metal binding sites (Figure 3.1). Pyridine is 
commonly used as a metal-binding site in coordination chemistry but incorporation of 3- or 
4-substituted pyridines would lead to an incorrect binding angle for the formation of a Pd2L4 
system. Instead, imidazole groups were incorporated to improve the bite angle towards the 
required 180º. The remaining slight offset could then be accommodated by bond rotation 
along the alkyne bridge. 
 
Figure 3.1: Structure of proposed iridium complex containing additional imidazole metal 
binding sites. 
The ancillary ligand (149) was prepared in a single step from the commercially available 
4,4’-dibromo-2,2’-bipyridine and ethynyl-1H-methylimidazole based on a copper-free 









Scheme 3.1: Synthesis of bis-4,4’-(ethynylmethylimidazole)-2,2’-bipyridine (4). 
Complexation of the ancillary ligand (149) was accomplished by heating the ligand and 
[(Ir(ppy)2Cl)2] in ethylene glycol at 150 °C for 24 h (Scheme 3.2). The reaction was found to 
be air sensitive and thorough degassing of the solution under high vacuum was required 
before heating. Unlike other more mild methods for complexation of the ancillary ligand,
28–31
 
high temperatures were required to allow rearrangement of any imidazole bound 
intermediates to the thermodynamically most stable bidentate bipyridine complex. Direct 
substitution of the chloride ions rather than removal via precipitation with silver improved 
the solubility of the resultant complex throughout the reaction and allowed purification of the 
final product by precipitation with KOTf from the aqueous solution.  
 
Scheme 3.2: Complexation of 149 to iridium. Elevated temperatures were required to allow 
rearrangement to the stable bipyridine bidentate complex. 
For many of the reactions, the isolated precipitate was clean and required no further 
purification. When this was not the case, purification of the complex was achieved by silica 
chromatography running a gradient of 0 to 10% CH3OH in CH2Cl2. The complex was fully 






grown by slow evaporation of a 1:1 water:acetonitrile solution of Pd2L4 (151·8OTf) (see 
section 3.7.11 for further details). The obtained structure was consistent with the formation 
of the intended cyclometallated iridium complex, 146·OTf (Figure 3.2). Interestingly, the 
imidazole groups are oriented with the N-donor sites pointing outwards in the solid state. 
However, this was expected to solely due to packing effects and free rotation along the 
alkyne bridge should allow rotation into a favourable binding geometry in solution. 
  
 
Figure 3.2: Crystal structure of 146. Hydrogen atoms, solvent and counter ions are removed 
for clarity. Atoms coloured pink – Ir, light blue – N, green – C (ancillary ligand), dark blue – 
C (cyclometallated ligand). 
3.3.2 Cage Assembly – Zinc 
In order to facilitate guest binding within the cage, a 6-coordinate transition metal was 
chosen for the cage assembly with the aim of forming an M2L4 assembly that contained 
metal centres with free coordination sites. This could potentially provide a driving force for 
the binding of guests containing weak metal-binding sites such as nitriles. The Lewis acidity 
of the metal ions could also favour the formation of radical anions by single electron transfer 
(SET) from the photoexcited iridium complexes. The cationic cage structure would also 
further stabilise the radical anion intermediates allowing the rapid formation of the cyclised 
products (Figure 3.3 and 3.4).  
Zinc was initially chosen as an appropriate 6-coordinate transition metal. The full outer shell 
of the Zn
2+
 was also thought to be advantageous towards preventing quenching of the iridium 










Figure 3.3: A proposed photoredox catalytic cycle for the 2+2 cycloaddition of metal-ligand 
bound substrates within an iridium functionalised Pd2L4 cage. 
Addition of Zn(OTf)2 0.5 eq. resulted in significant 
1
H NMR peak shifts for both the methyl 
imidazole protons and the bipyridine proton held within the inner cavity (Figure 3.5). The 
spectrum remained simple, indicating a symmetrical structure rather than the complex 
spectra associated with mixed species or the dramatically broadened spectra observed for 
polymerisation. Further evidence for cage formation was obtained from DOSY NMR which 








Figure 3.4: Structure of the intended Zn2L4 cage self-assembled from 146·OTf. Axial sites on 
the zinc centres are most likely occupied by solvent molecules or weakly coordinated counter 
ions. 
 
Figure 3.5: Comparison of 
1
H NMR spectra (500 MHz, CD3CN, 300 K) for the mono-
nuclear complex and the Zn2L4 cage. The methyl imidazole protons (red) and the inner 
bipyridine proton (blue) show the most pronounced shifts upon complexation with zinc.  
Although NMR spectroscopy suggested the formation of large symmetrical species, titration 
experiments showed that complexation of zinc and the formation of any higher order species 
was in fast exchange on the NMR timescale (Figure 3.6). As a consequence of this, the peak 
positions were highly dependent on the concentration of zinc present and the addition of 
excess Zn
2+








The weak metal-ligand interactions also made it impossible to detect the intact Zn2L4 species 




H NMR (400 MHz, CD3CN, 300 K) titration of ZnOTf2 into an 8 mM solution of 
1·OTf. The inner ortho-pyridyl (blue) and imidazole (red) protons show the greatest change 





Due to the highly dynamic nature of the resultant zinc assembly, the exact speciation present 
in solution was difficult to interpret since any desymmetrisation of the structure could not be 
observed. In addition, guest binding within the intact assembly was difficult to assess since 
any observed peak shifts could also be attributed to changes in the cage speciation. To avoid 
these complications, alternative metal-linkers were considered for the formation of a more 







3.3.3 Cage Assembly – Palladium 
In order to assemble a more stable structure, square planar palladium was chosen as an 
alternative 2
nd
 row transition metal linker (Figure 3.7). Upon the addition of 
Pd(CH3CN)4·2OTf (0.5 eq.) to 146·OTf in CH3CN at room temperature, the formation of a 
large assembly was observed. In comparison with 150·8OTf, a similar change in proton 
environments was observed, with the methyl imidazole protons and the internal bipyridine 
proton peaks showing the largest change in ppm. However, the 
1
H NMR spectrum showed 
additional splitting patterns visible throughout the spectrum but most easily observed in the 
formation of a triplet-like 1:2:1 signal distribution for the CH3 group (Figure 3.8). 
 
Figure 3.7: Structure of the intended Pd2L4 cage self-assembled from 146·OTf.  
DOSY NMR showed exactly the same increase in size from 6.6 Å to 11.3 Å as observed for 
150·8OTf and confirmed that all of the signals belonged to species of a similar size. 
Although it was unlikely that this “splitting” was due to conventional proton coupling, since 
it was not observed in the parent complex, 
1
H NMR experiments were carried out at different 
field strengths to confirm this hypothesis (Figure 3.9). As no change was observed in the 
position of the additional peaks, the 1:2:1 peak pattern was attributed to different proton 
environments. Pureshift NMR experiments also confirmed this observation since multiple 








Figure 3.8: Comparison of 
1
H NMR spectra (500 MHz, CD3CN, 300 K) for a) 146·OTf b) 
rac-151·8OTf c) pureshift analysis of rac-151·8OTf and d) enantiopure Δ-151·8OTf. Peak 




H NMR (CD3CN, 300 K) of rac-151·8OTf showing the CH3 peaks at different 
magnetic field strengths. As no change in the peak positions was observed, the 1:2:1 






Using separation techniques developed previously by the group,
10
 Δ- or Λ-(Ir(ppy)2Cl)2 was 
used to prepare enantiopure samples of 146·OTf. As expected, the 
1
H NMR remained 
identical for the mononuclear complex, 146·OTf, but upon formation of the cage assembly 
by the addition of Pd(CH3CN)4·2OTf (0.5 eq), no additional signals were observed. 
Confirmation of successful preparation of enantiopure Λ/Δ-146·OTf and Λ/Δ-151·8OTf was 
also provided by circular dichroism (Section 3.7.7).  
One explanation for the observed peak patterns is that the inherent chirality of the iridium 
complex creates a mixture of diastereomers when assembled into a Pd2L4 cage. Since 
146·OTf exists as a racemic mixture of Δ and Λ stereoisomers, this would give rise to a 
series of structures containing a statistical mixture of chiral centres. For a number of sites 
equal to 𝑛, with a 50:50 probability between two states, Λ or Δ, 2𝑛 different combinations 
are possible (Figure 3.10). For 151·8OTf containing 4 different chiral centres, this gives rise 
to 24 = 16 possible arrangements. Due to the cyclic nature of the system, many of these 
possible combinations are chemically identical and instead four different possible 
configurations (A, B, C, and D) are perceived and populated according to their statistical 
likely hood (2, 8, 4 and 2 respectively). An explanation for the 1:2:1 triplet splitting based on 
this model would be to assume that configurations A and D produce identical spectra. 
However, analysis of enantiopure Δ- or Λ-151·8OTf shows that the larger central peak in the 
triplet, rather than the predicted smaller side peak, corresponds to configuration A.  
 






Instead, the peak position can be rationalised based on the configuration of the neighbouring 
groups, i.e. the local chemical environment. For an individual iridium centre (Λ), there are 
four possible configurations based on the chirality of the neighbouring iridium centres 
(Figure 3.11). Depending on the relative orientations of these groups, each 2-phenylpyridine 
ligand on the central iridium complex can either be in an open, enclosed or semi-enclosed 
environment. The semi-enclosed environments occur when the central iridium complex is 
next to two centres with the same symmetry as each other (i.e. ΛΛΛ and ΔΛΔ), while the 
configurations with two centres of opposite symmetry produce an equal mixture of open and 
closed environments. This results in desymmetrisation of the system along the horizontal 
plane for the ΔΛΛ/ΛΛΔ configurations and leads to two different peaks in the 
1
H NMR 
spectrum. Along with the singlet signal from the ΛΛΛ/ΔΛΔ configurations, this gives a 
1:2:1 ratio of chemical environments with the most populated environment corresponding to 
that observed for the homochiral variant. 
Additional evidence for the existence of the cage assembly was obtained by ESI-MS and 
identical spectra were obtained for both the racemic and enantiopure mixtures (Figure 3.26). 
X-ray quality crystals could not be obtained by any conventional methods. Crystals were 
obtained by slow diffusion of diisopropylether into an acetonitrile solution but data of 
sufficient quality could not be obtained even with a synchrotron radiation source. 
Crystallisation by evaporation from a 1:1 mixture of CH3CN and H2O gave the disassembled 







Figure 3.11: Comparison of the four possible configurations for a single iridium centre and 
direct neighbours. Top (red) and bottom (blue) environments are considered independently. 
Assuming the local environment is dominated by the relative orientations of the 










3.4 System Properties 
3.4.1 Stability 
As discussed in Chapter 2, the stability of the previous Ir6L4 luminescent supramolecular 
system was highly dependent on the encapsulated counter anions.
10
 Removal of these anions, 
in order to encapsulate guest compounds, led to the rapid disassembly of the cage structure. 
In comparison, 151·8OTf showed no obvious signs of anion templation or anion dependent 
stability. 
19
F NMR spectroscopy of 151·8OTf in CD3CN shows only a single peak 
corresponding to free OTf (measured versus saturated KOTf in CD3CN) and ESI-MS 




H NMR (500 MHz, CD3CN, 300 K) of 146·OTf, 151·8OTf and comparison with 
a stable mixture of both obtained by the addition of Pd(CH3CN)4·2OTf (0.25 eq.) to a 
solution of 146·OTf. 
151·8OTf was found to be stable for months in CD3CN with no sign of disassembly or 
photobleaching. Unlike 150·8OTf, stable mixtures of 146·OTf and 151·8OTf could also be 
prepared and identified without the formation of partially assembled structures by the 
addition of <0.5 eq. Pd
2+
 (Figure 3.12). Although ligand exchange was slow on the 
1
H NMR 
timescale, the dynamic nature of the system was demonstrated by performing a scrambling 










formation of the complex mixture observed for rac-151·8OTf (Figure 3.13). The half-life 
was calculated as 132 h and shows that the enantiopure assemblies are not significantly more 
thermodynamically stable than any of the alternative mixed chirality systems. 
 
Figure 3.13: Δ/Λ-151·8OTf scrambling experiment in CD3CN at room temperature. The 
proportion of scrambling was measured by the ratio of the central triplet peak to the total 
peak area for the methyl imidazole proton signal. The fitted exponential decay (red) gives a 
mean lifetime of 190 h and a corresponding half-life of 132 h. 
Dilution experiments showed that the system was stable at concentrations above 
approximately 10 µM; however, further dilution resulted in disassembly of the structure to 
produce predominantly free complex (Figure 3.14). Similar observations were made using 
UV/Vis and thus, all experiments, including photophysical investigations, were carried out at 
concentrations greater than or equal to 10 µM.  












Figure 3.14: Stability of 151·8OTf under dilute conditions investigated by 
1
H NMR (600 
MHz, CD3CN, 300 K). Disassembly of the cage (red) to primarily 146·OTf (blue) begins at 
concentrations below approximately 10 µM and complete disassembly is observed below 1 
µM. 
Although still inherently dynamic in nature, the selective formation of 151·8OTf in the 
presence of excess 146·OTf shows that the assembled cage only undergoes slow exchange 
on an NMR timescale and suggests that 151·8OTf is significantly more stable than any of the 
other transient partially assembled structures. As a result, 151·8OTf exists as a well-defined 
discrete metallosupramolecular assembly in solution at concentrations above 10 µM. 
 
  
146·OTf – 1 mM 
151·8OTf – 1 µM 
151·8OTf – 10 µM 
151·8OTf – 100 µM 






3.4.2 Photophysical & Electrochemical Properties 
The photophysical properties of substances can be highly dependent on their surrounding 
environments.
33–39
 Metallosupramolecular systems usually involve the complexation of 
ligand building blocks with transition metal ions to self-assemble large symmetrical 
structures. However, heavy metals ions can effectively quench any beneficial emissive 
properties due to the unpaired electrons present in the outer orbitals and/or the so called 




A large range of transition-metal based luminescent supramolecular assemblies have been 
reported in literature with many using luminescent building blocks self-assembled using 
metal ions.
22,23,32,41,42
 However, other examples exist where highly luminescent compounds 
are efficiently quenched during self-assembly.
43
 These examples can be difficult to assess 
since luminescence is deemed a favourable property, and as such, any systems that show 
strong quenching upon self-assembly are often discussed based on other properties.
16,44
  In 
some cases, severe quenching can only be assumed based on the lack of reported emissive 
data for systems that contain inherently emissive building blocks.
45
 In addition, care should 
be taken when supramolecular systems are initially shown to have identical photophysical 
properties to their individual sub-units. As described in section 3.4.1 and chapter 5, 
supramolecular assemblies often disassemble under the dilute conditions
46
 required for 
fluorescence spectroscopy which could lead to incorrect assignment of the system properties. 




For those that do retain their luminescent properties, a large proportion use the photoactive 
metal components in a structural role.
10,47–54
 In this way, no additional, non-emissive metal 
centres are required and the systems retain their useful photophysical properties, and indeed, 
self-assembly can even lead to an enhancement in quantum yields due to the loss of non-
emissive relaxation pathways afforded by the rigid supramolecular framework.
10
 However, 
the use of photoactive metal centres as the structural components severely limits potential 
variation and can lead to difficulties in balancing the favourable photophysical properties 
with system stability.  
Heteroleptic cyclometallated iridium complexes have gained great research interest over the 






theory describing their photophysical properties is well developed. Unlike common first-row 
transition metal complexes, absorption is dominated by metal to ligand charge transfer 
(MLCT) and ligand centred (LC) transitions (Figure 3.15). The strong ligand field splitting, 
due to the presence of cyclometalled carbon donor atoms, results in a very large energy gap 
between the occupied t2g orbitals and the empty eg orbitals that prevents any transitions due 
to UV/visible light. MLCT is responsible for the broad, low-energy transitions that give 
many iridium complexes their bright colours. Higher energy π-π* transitions are also 
observed as sharper bands in the UV region.  In addition, a weak absorption band is often 
observed stretching far into the visible region that corresponds to low-energy spin forbidden 
3
MLCT transitions that become partially allowed due to strong spin-orbit coupling with 
iridium. 
 
Figure 3.15: A simplified orbital energy diagram showing the observed low-energy metal to 
ligand charge transfer (MLCT) and high-energy ligand centred (LC) transitions observed for 
heteroleptic Ir(III) complexes. The strong ligand field splitting due to the cyclometallated 
ligands means the metal centred (MC) transitions are too high in energy to be observed in 
the UV/Vis spectrum. 
Rapid thermal relaxation of the excited states followed by radiative decay to any of the 
ground vibrational states often gives a series of well-ordered emission bands for fluorescent 
organic compounds (Figure 3.16). However, for most cyclometallated iridium complexes, 









MLCT states, resulting in a broad emission band with a large Stokes-shift. The 
relatively long life-time of these MLCT states, along with the high redox potentials, make 
iridium complexes favourable candidates for photoredox catalysis.    
 
Figure 3.16: Jablonski diagram detailing possible transitions leading to luminescence. 
The absorbance of the mononuclear complex and assembled cage showed similarities but 
with some noticeable differences (Figure 3.17). The weak spin-forbidden transitions remain 
almost identical but the broad band associated with MLCT spin-allowed transitions 
decreases in intensity. In addition, an intensity increase is observed for a sharp absorption 
band at 317 nm. Titration of Pd(CH3CN)4·2OTf into 146·OTf whilst maintaining a constant 







Figure 3.17: Comparison of absorption spectra (100 µM in CH3CN) for 151·OTf (black) and 
146·8OTf (red). 
 













Self-assembly of 151·8OTf resulted in a small red-shift of the emission spectrum (Figure 
3.19). Although emission was more intense for equal concentrations of 146·OTf and 
151·8OTf in acetonitrile, this was as a result of 151·8OTf containing four photoactive 
iridium centres and quantum yield actually decreased upon self-assembly. A similar 
reduction in the luminescent lifetime was also observed. This slight reduction in quantum 
yield and lifetime can be attributed to the heavy atom effect arising from complexation with 
palladium but importantly, complete quenching of the photoexcited state was not observed.  
 
Figure 3.19: Comparison of emission spectra (100 µM in CH3CN) for 146·OTf (black) and 
151·8OTf (red). 
Frozen glass experiments were carried out in a 1:1 mixture of CH2Cl2 and CH3OH and 
compared with room temperature observations made under identical solvent conditions 
(Figure 3.20). As expected, at 77 K the emission of both 146·OTf and 151·8OTf was 
significantly blue-shifted and sharpened due to the removal of thermally occupied vibrational 
states and the lifetimes increased to 5210.57 ns and 3917.94 ns respectively. No significant 
difference was observed between the behaviour of 146·OTf and 151·8OTf suggesting that 
the formation of a rigid cage structure did not significantly reduce the occupancy of 








Figure 3.20: Emission of 146·OTf and 151·8OTf in a mixture of 1:1 CH2Cl2 and CH3OH at 
both room temperature and as a frozen glass at 77 K. 
To ascertain the relative energy levels of 146·OTf and 151·8OTf, electrochemistry was 
performed in CH3CN, using tetraethylammonium hexafluorophosphate as the electrolyte 
(Table 3.1). All measurements were carried out with a glassy carbon working electrode, a 
platinum counter electrode and a Ag/Ag
+
 quasi-reference electrode using ferrocene as an 
internal standard.  
Table 3.1: Comparison of key photophysical and electrochemical properties of compounds 1 

















146 632 84 9.1 -1.52 0.89 
151 675 60 6.1 -1.51 0.94 
Ru(bpy)3 615 153 9.5 -1.71 0.91 
Ir(ppy)2(dtbbpy) 581 557
a
 27.1 -1.80 0.91 
Measurements made in CH3CN in air. Redox potentials measured in CH3CN/TBA versus  
Ag/Ag
+
 and reported versus Fc/Fc
+
 a) degassed in acetonitrile b) literature values were 








Comparison of 146·OTf and 151·8OTf with commonly used ruthenium and iridium 
photoredox catalysts also highlights their similarity and the lack of photoquenching by 
complexation with Pd
II
. However, whilst the oxidation potential remains almost identical, the 
reduction potential is significantly reduced with respect to Ir(ppy)2(dtbbpy) as a result of the 
structural differences between the ancillary ligands. The LUMO of most iridium complexes 
is situated primarily on the ancillary ligand whilst the HOMO resides on the metal centre.
56
 
The addition of the alkyne bridged imidazole groups to the ancillary ligand appears to 
significantly stabilise the LUMO, resulting in a reduced HOMO-LUMO gap and an easier 
ligand centred reduction process.  
Despite this, the redox potentials remain largely unaffected by complexation to palladium 
and the formation of 151·8OTf providing evidence that any electron withdrawal by the 
electropositive metal does not affect the LUMO situated on the ancillary ligand. However, 
the emission wavelength is strongly red shifted suggesting that 
3
MLCT states are stabilised 
by complexation to palladium. 
Whilst the formation of 151·8OTf and complexation with palladium slightly alters the 
photophysical and electrochemical properties of the iridium centre, the supramolecular 






3.4.4 Guest Binding 
Encapsulation of neutral guest compounds within the interior of 151·8OTf was deemed 
essential for any stereo- or regio-selective supramolecular catalysis to be achieved. As four-
coordinate palladium was used as the structural metal in the cage synthesis, rather than six-
coordinate zinc, ligand metal interactions could not be used to provide a driving force for the 
binding of substrates. Instead, it was envisaged that the hydrophobic effect could be used to 
drive the encapsulation of neutral organic guests within the hydrophobic interior of the 
151·8OTf. Consequently, a series of hydrophobic aromatic guests were screened by direct 
addition to a solution of 151·8OTf in 1:1 D2O:CD3CN (1 mM) followed by monitoring any 
change in the 
1
H NMR peak shifts (Figure 3.21 and 3.22). Evidence for binding was given 
by peak shifts for both 151·8OTf and the guest compound with respect to the free 
components under identical conditions. Further evidence was obtained by specific peak 
movements, for instance, the peaks corresponding to the imidazole and the internal 
bipyridine were shielded relative to the empty cage due to the expected π-CH interactions. 
 
Figure 3.21: Expanded view of 
1
H NMR (400 MHz, 1:1 D2O/CD3CN, 300 K) spectra before 
(bottom) and after (top) the addition of phenanthrene (orange) to a solution of 151·8OTf 
(green).  
For those guests that showed measurable peak shifts, 
1
H NMR titrations were carried out to 
quantify the binding strength. In addition to the neutral guests, potassium 
trifluoronapthylborane (G
30
) was also examined to investigate any increased association due 
to coulombic attraction between the negative charge and the positive cage (Figure 3.23). 
Despite the overall charge, G
30
 is water insoluble and can act as a hydrophobic guest with an 






concentration of potassium trifluoronapthylborane could not be taken beyond 8 equivalents 
with respect to 151·8OTf as precipitation of the trifluoronaphthyl borane salt of the cage 
occurred. 
 
Figure 3.22: A list of the neutral compounds screened for guest binding in 151·8OTf. Guests 
either displayed obvious peak shifts (green), very small shifts (yellow) or no change (red) by 
1
H NMR spectroscopy. 
 








Table 3.2: Calculated binding constants for a range of organic guests within 151·8OTf. 





 cis-stilbene 40 ±15 
G
12
 phenanthrene  257 ±33 
G
30
 potassium trifluoro-2-napthalenylborane 429 ±73 
 
In summary, the photophysical properties of the self-assembled cage, 151·8OTf, remain very 
similar to those observed for the mononuclear iridium complex, 146·OTf, despite the 
potential quenching effects of complexation with palladium. The solubility of 151·8OTf in a 
1:1 mixture of H2O/CH3CN was utilised to drive encapsulation of neutral hydrophobic guests 
with binding constants of up to 257 M
-1
 reported. Guest encapsulation could be further 
strengthened by using hydrophobic anions to increase the host:guest interaction through 
coulombic attraction. As such, the complex-as-ligand design allows the rapid formation of 
photoredox active metallosupramolecular compounds that display promising guest binding 
properties and 151·8OTf remains a good candidate for achieving combined supramolecular 







3.5 Photoredox Catalysis 
Having successfully prepared 151·8OTf and confirmed the system stability and favourable 
photoredox properties, a series of photocatalytic processes were tested using 151·8OTf as the 
photocatalyst in 1:1 D2O/CH3CN. 
3.5.1 Isomerisation of Stilbene & Azobenzene 
Heating stilbene to temperatures well in excess of 200 °C results in equilibration to a mixture 
of the cis and trans isomers with the trans-isomer heavily favoured.
57
 As well as direct 
excitation,
58
 cis-stilbene can be prepared from trans-stilbene through photoredox catalysis 
through formation of a radical cation intermediate.
59,60
 Similar treatment of trans-stilbene 
with 151·8OTf followed by irradiation with visible light resulted in isomerisation to 85 % 
cis-stilbene after 16 h (Scheme 3.3). However, further irradiation gave no additional increase 
in the proportion of cis-stilbene present. No isomerisation was observed without the presence 
of 151·8OTf and direct comparison of the equilibrium position under the same solvent 
conditions was not possible due to the high temperatures required to allow thermal 
isomerisation.   
 
Scheme 3.3: Interconversion of trans/cis-stilbene in the presence of 146·OTf or 151·8OTf 
under visible light.  
Interestingly, the oxidation potentials reported for trans-/cis-stilbene (1.09 V/1.20 V versus 
Fc/Fc
+
) suggests that the reaction cannot proceed via a radical cation intermediate since the 
predicted oxidation potentials of the iridium excited states are not sufficient to allow single 
electron transfer (Table 3.3). Instead, the reaction must rely on direct energy transfer from 









Table 3.3: Comparison of one-electron oxidation potentials for cis/trans-stilbene as well as 
the mononuclear and supramolecular photocatalysts. 
Compound E1/2 M
+















Redox potentials recorded in CH3CN/TBA versus Fc/Fc
+








Similarly, azobenzene is well known to undergo trans-cis isomerisation upon irradiation 
with different wavelengths of light.
58
 Irradiation with UV light (approx. 317 nm) leads to π-
π* excitation that results in rearrangement from the cis to trans isomer, while irradiation with 
blue light (approx. 439 nm) gives n-π* excitation to give the opposite trans to cis 
rearrangement. Thus, under visible light in solution, azobenzene exists solely as the trans-
isomer.  
 
Scheme 3.4: Interconversion of trans/cis-azobenzene in the presence of 1·OTf or 7·8OTf 
under visible light. 
The addition of 151·OTf to a solution of trans-azobenzene in a 1:1 mixture of D2O/CD3CN 
led to partial conversion to cis-azobenzene upon irradiation with visible light for 16 h 
(Scheme 3.4 and Figure 3.24). The trans to cis ratio after 16 h irradiation was 3:1 but no 
further change was detected after additional irradiation over 72 h, suggesting that the system 









H NMR (500 MHz, 1:1 D2O/CD3CN, 300 K) of trans-azobenzene (red) and cis-
azobenzene (blue) with 151·8OTf before (bottom) and after (top) irradiation with visible 
light. Peaks corresponding to 151·8OTf are not clearly visible due to the catalytic quantities 
required (1 mol%).  
Despite 
1





difference in either the reaction rate or the equilibrium position was observed upon 
irradiation with 146·OTf suggesting that either the bulk phase process was dominant and/or 
any guest binding was too weak to influence the conformational outcome of the 
isomerisation process. 
3.5.2 Acenaphthylene 
The dimerisation of acenaphthylene by irradiation with UV light can give either the syn or 
anti conformation. The preference for either syn or anti is highly dependent on the 
surrounding environment.
61
 Fujita and co-workers demonstrated that inclusion of 
acenaphthylene within a Pd6L4 cage to form a 2:1 host:guest complex before irradiation with 
UV light resulted in a 100% conversion to the syn conformer (Scheme 3.5).
62,63
 Formation of 
the extended anti conformation was physically impossible within the steric confinement of 
the cage cavity. However, this process still required the use of a high power mercury UV 
lamp in order for the dimerization to proceed. A similar process was also observed by 
Ramamurthy and co-workers using Eosin Y as a photosensitiser with either Fujita’s Pd6L4 













146·OTf was found to efficiently catalyse the dimerization process in the presence of visible 
light (Scheme 3.6). Since a sacrificial quencher was not required, the reaction mechanism 
was thought to proceed via either the radical cation from reductive quenching of the iridium 
excited state or by the excitation of acenaphthylene through direct energy transfer from the 
photocatalyst. As expected, the solution phase process, without the presence of an internal 
cavity, gave a mixture of the syn and anti-conformations. 
 
Scheme 3.6: Visible-light photocatalytic dimerisation of acenaphthylene using 146·OTf and 
151·8OTf and the relative ratios of the syn:anti dimer produced. 
Unfortunately, when the reaction was repeated with 151·8OTf, no significant difference was 
observed in the product distribution or the rate of reaction. Simple modelling and 
examination of the binding constants for similar guests suggests that encapsulation follows a 
1:1 binding model. Furthermore, if 2:1 binding could occur, the relatively low binding 
constants observed suggest that even with a stoichiometric catalyst loading, the percentage of 
guest encapsulated in a 2:1 ratio would be very low. Since no significant rate enhancement 
was observed, the bulk phase background reaction would dominate and significantly reduce 






conformational selectivity, this process does provide evidence that the iridium complex can 
still function as an efficient visible-light photocatalyst while assembled into a 







3.6 Summary & Conclusions 
Only a handful of luminescent metallosupramolecular compounds have been reported 
previously that show a reasonable affinity for neutral organic molecules.
22,32,41,49,52
 Using a 
complex-as-ligand based approach, a novel iridium functionalised Pd2L4 system was 
designed, synthesised and fully characterised by NMR and ESI-MS. Although unstable 
below approximately 10 µM, the 151·8OTf forms a stable system that shows an affinity for a 
range of neutral and anionic hydrophobic compounds in a 1:1 mixture of H2O/CH3CN. More 
importantly, unlike many metallosupramolecular self-assembled structures, the beneficial 
photoredox properties of the constituent iridium complexes remain almost completely 
unaffected by complexation to palladium. As such, this system shows great promise as a 
potential supramolecular photoredox catalyst and represents a jump forward in the current 
state of the field. However, initial attempts at achieving regio- or stereo-selective photoredox 
catalysis were unsuccessful and no significant difference was observed between the 
selectively of 151·8OTf and the corresponding mononuclear complex 146·OTf. This was 
assumed to be due to the relatively low binding constants recorded and thus, further work 
was carried out in an attempt to modify the existing system to improve the overall guest 







3.7.1 General Information 
Unless stated otherwise, all reagents and solvents were purchased from Alfa Aesar, VWR or 
Sigma Aldrich and used without further purification. Column chromatography was carried 
out using Geduran Si60 (40-63 µm) as the stationary phase and TLC was performed on 
precoated Kieselgel 60 plates (0.20 mm thick, 60F254. Merck, Germany) and observed under 







 were prepared 
according to literature procedures. 
For general NMR and MS conditions, refer to Section 2.9.3.   
Many of the compounds synthesised and characterised in this chapter contain OTf counter 
anions. Due to the strong C-F splitting and low concentrations, the OTf signal is often not 
observed in the 
13
C NMR. Where sufficiently intense peaks are observed the signal is 
reported as 122.1 (q, J = 320.6 Hz), otherwise, evidence for the OTf counter anion is given 
solely by 
19




C NMR (500MHz, CD3CN, 300 K) of a saturated solution of KOTf showing 
C-F coupling. 
All UV/Vis spectroscopy was carried out on either an Agilent Technologies, Cary 300 Series 






Spectrometer running Lambda 40. All emission spectroscopy was carried out on a Perkin 
Elmer LS 50 Luminescence Spectrometer running Lambda 40. The Frozen-glass emission 
experiments were carried out on a Perkin Elmer Lambda 55 Luminescence Spectrometer 
running FL Winlab. All emission lifetime measurements were carried out on an Edinburgh 
Analytical Instruments, TM300 Monochromator with a PicoQuant GmbH. 405 nm LASER. 
Circular dichroism was performed on a JASCO J-810 spectropolarimeter controlled using 
JASCO Spectra Manager software and data was collected over a wavelength range of 210-
800 nm, at a scan speed of 100 nm/min, bandwidth of 1 nm and data pitch of 0.1 nm. 
Samples were measured at rt and at given concentrations using a fused silica cuvette with a 
10 mm path length. Where required, cut-off filters (Andover Cooporation) were used. All 
data was analysed and plotted using Origin 2015 software. All measurements were made at 
room temperature (16-21 °C) at 100 µM in CH3CN using a fused silica cuvette with a 10 mm 
path length, unless stated otherwise.  
All electrochemistry was performed using an Autolab GPES 4.9. All of the samples were 
analysed in dry CH3CN (500 µM for mononuclear complexes and 200 µM for cage 
compounds) using 50 mM tetraethylammonium hexafluorophosphate as the electrolyte. 
Measurements were performed using a platinum counter electrode, a glassy carbon working 
electrode and a Ag/Ag
+
 quasi-reference electrode with ferrocene as an internal standard. All 






3.7.1 Synthetic Procedures 
149 - 2,2’-bi(4-ethynyl-1-methyl-imidazolyl)pyridine 
 
To 4,4’-dibromo-2,2’-pyridine (200.0 mg, ), 5-ethynyl-1-methyl-(1H)-imidazole (202.8 mg, 
3 eq., 194 μL), TBAF (602.9 mg, 3 eq.) and PdCl2(PPh3)2 (26.8 mg, 6 mol%) in a dried 
schlenk flask was charged dry THF (15.0 mL). Following repeated cycles of vacuum 
degassing N2 backfills, the solution was heated at reflux for 24 hours. The mixture was 
cooled and the solvent removed under reduced pressure. Water (30 mL) was charged and the 
product was extracted with CH2Cl2 (3 x 30 mL). The crude product was purified by silica 
column chromatography using 1% Et3N, 1% methanol, 98% CH2Cl2. Residual TBA and 
Et3N were removed by recrystallization from MeCN. The product was isolated as an off 
white powder (155.2 mg, yield = 67%). 
1
H NMR (500 MHz, CDCl3) δ 8.69 (dd, J = 5.0, 0.8 
Hz, 2H, Ha), 8.51 (dd, J = 1.5, 0.8 Hz, 2H, Hc), 7.56 (s, 2H, He), 7.44 (d, J = 0.9 Hz, 2H, Hd), 
7.40 (dd, J = 5.0, 1.6 Hz, 2H, Hb), 3.79 (s, 6H, Hf). 
13
C NMR (126 MHz, CDCl3) δ 155.79, 
149.46, 139.18, 136.08, 132.00, 125.17, 122.74, 115.58, 94.52, 82.14, 32.43. m/z (HR-ESI): 
365.15092 (predicted [M+H]
+









146·OTf - [Ir(ppy)2(emibipy)]OTf 
 
[(Ir(ppy)2Cl)2] (99.7 mg, 0.093 mmol) and 4 (67.7 mg, 0.186 mmol) were partially dissolved 
in ethylene glycol (20.0 mL). The solution was degassed under high-vacuum for 20 mins and 
backfilled with N2 before being heated at 150 °C for 18 h. The solution was then cooled and 
diluted with H2O (100 mL) before being washed with Et2O (2 x 50 mL). KOTf (105.0 mg, 
0.558 mmol) was charged and the resultant precipitate was filtered through celite. The 
orange solid was washed with copious amounts of H2O and then washed off the celite with 
CH2Cl2. The solvent was removed under reduced pressure to yield the crude product. If 
necessary, purification could be achieved by silica column chromatography (gradient CH2Cl2 
to 10% CH3OH in CH2Cl2). The product was isolated as a bright orange/red solid (138.1 mg, 
yield = 73%). 
1
H NMR (500 MHz, CD3CN) δ 8.62 (d, J = 1.1 Hz, 2H, Hk), 8.07 (d, J = 8.0 
Hz, 2H, He), 7.94 (d, J = 5.7 Hz, 2H, Hi), 7.90 – 7.84 (m, 2H, Hf), 7.81 (dd, J = 7.8, 1.0 Hz, 
2H, Hd), 7.67 (ddd, J = 5.9, 1.4, 0.7 Hz, 2H, Hh), 7.64 (s, 2H, Hm), 7.53 (dd, J = 5.7, 1.6 Hz, 
2H, Hj), 7.45 (d, J = 0.8 Hz, 2H, Hl), 7.09 – 7.03 (m, 2H, Hc,g), 6.93 (td, J = 7.5, 1.3 Hz, 2H, 
Hb), 6.27 (dd, J = 7.6, 0.9 Hz, 2H, Ha), 3.77 (s, J = 4.8 Hz, 6H, Hn). 
13
C NMR (126 MHz, 
CD3CN) δ 168.30, 156.63, 151.51, 150.87, 150.34, 145.01, 141.72, 139.62, 137.98, 134.61, 
132.46, 131.39, 129.94, 126.76, 125.88, 124.53, 123.67, 120.90, 115.32, 93.92, 87.72, 32.82. 
19
F NMR (471 MHz, CD3CN) δ -79.31 (s). DOSY NMR (500 MHz, CD3CN) –logD = 8.98 
Hydrodynamic radius = 5.6 Å. m/z (HR-ESI): 865.23500 (predicted [M]
+
 = 865.23739) 
1015.19350 (predicted [M+H]
2+







150·8OTf - [Zn2(Ir(ppy)2emibipy)4]8OTf 
 
 
146·OTf (14.2 mg, 0.014 mmol) was dissolved in CH3CN (5 mL). Zn(OTf)2 (2.6 mg, 0.007 
mmol) was charged and washed in with CH3CN (1 mL). The solution was stirred at room 
temperature for 8 h and then concentrated under reduced pressure. The product was 
precipitated with Et2O, filtered and washed with Et2O to yield a bright orange solid (14.9 mg, 
89%). 
1
H NMR (500 MHz, CD3CN) δ 8.75 (s, 24H, Hk), 8.07 (d, J = 8.6 Hz, 24H, He), 7.99 
(s, 24H, Hm), 7.98 (d, J = 5.9 Hz, 24H, Hi), 7.90 – 7.82 (m, 24H, Hf), 7.81 (dd, J = 7.9, 0.9 
Hz, 24H, Hd), 7.65 (d, J = 5.9 Hz, 24H, Hh), 7.59 – 7.53 (m, 48H, Hj,l), 7.10 – 6.99 (m, 48H, 
Hc,g), 6.97 – 6.88 (m, 24H, Hb), 6.26 (dd, J = 7.6, 1.2 Hz, 24H, Ha), 3.87 (s, 36H, Hn). 
13
C 
NMR (126 MHz, CD3CN) δ 168.25, 156.67, 151.69, 150.70, 150.35, 144.96, 142.23, 139.64, 
135.88, 133.92, 132.42, 131.41, 130.09, 127.32, 125.88, 124.52, 123.72, 120.91, 116.83, 
94.37, 85.36, 33.75. 19F NMR (376 MHz, CD3CN) δ -79.12. DOSY (400 MHz, CD3CN) -
log(m
2







151·8OTf - [Pd2(Ir(ppy)2emibipy)4]8OTf 
General Procedure: 
146·OTf (39.2 mg, 0.039 mmol) was dissolved in CH3CN (10 mL) and Pd(CH3CN)4·2OTf 
(11.0 mg, 0.019 mmol) was charged as a solution in CH3CN (0.2 mL). The mixture was 
stirred at room temperature for 16 hours. The solvent was removed under reduced pressure to 




H NMR (500 MHz, CD3CN)) δ 8.77 – 8.73 (m, 8H, Hk), 8.19 – 8.14 (m, 8H, Hm), 8.09 – 
8.03 (m, 8H, He), 7.98 – 7.93 (m, 8H, Hi), 7.88 – 7.82 (m, 8H, Hf), 7.82 – 7.79 (m, 8H, Hd), 
7.79 – 7.75 (m, 8H, Hl), 7.62 – 7.59 (m, 8H, Hh), 7.56 – 7.52 (m, 8H, Hj), 7.09 – 7.03 (m, 8H, 
Hc), 7.03 – 6.97 (m, 8H, Hg), 6.96 – 6.90 (m, 8H, Hb), 6.27 – 6.21 (m, 8H, Ha), 3.78 – 3.71 
(m, 24H, Hn). *all peaks split by mixture of diastereomers so coupling constants not reported, 
see enantiopure. 
13
C NMR (126 MHz, CD3CN) δ 167.33, 155.52, 150.86, 149.54, 149.36, 
143.97, 141.22, 138.70, 134.56, 132.46, 131.45, 130.49, 128.79, 126.76, 123.52, 122.83, 
122.47, 120.00, 116.70, 93.98, 82.67, 33.51. 
19
F NMR (471 MHz, CD3CN) δ -78.96. DOSY 
NMR (500 MHz, CD3CN) –logD = 9.28 Hydrodynamic radius = 11.3 Å. 
Δ/Λ-[Pd2(Ir(ppy)2emibipy)4]8OTf  
1
H NMR (600 MHz, CD3CN) δ 8.74 (d, J = 1.8 Hz, 8H, Hk), 8.17 (d, J = 1.3 Hz, 8H, Hm), 
8.07 (d, J = 8.4 Hz, 8H, He), 7.96 (d, J = 5.9 Hz, 8H, Hi), 7.85 (td, J = 7.9, 1.5 Hz, 8H, Hf), 
7.80 (dd, J = 7.9, 1.4 Hz, 8H, Hd), 7.76 (d, J = 1.3 Hz, 8H, Hl), 7.61 (d, J = 5.7 Hz, 8H, Hh), 
7.54 (dd, J = 5.8, 1.6 Hz, 8H, Hj), 7.05 (td, J = 7.6, 1.2 Hz, 8H, Hc), 7.00 (ddd, J = 7.2, 5.8, 








C NMR (126 MHz, CD3CN) δ 168.26, 156.48, 151.77, 150.47, 150.28, 144.90, 
142.12, 139.63, 135.52, 133.42, 132.38, 131.42, 129.71, 127.62, 125.89, 124.44, 123.76, 
122.09 (q, J = 320.6 Hz), 120.93, 117.61, 94.91, 83.61, 34.42. 
19
F NMR (471 MHz, CD3CN) 







3.7.3 Mass Spectrometry of Cage Compounds 
151·8OTf - [Pd2(Ir(ppy)2emibipy)4]8OTf 
 
 
Figure 3.26: Mass spectrum of 151·8OTf. The peaks found by experiment (black) are shown 
















3.7.4 Stability of 151·8OTf 
 
Figure 3.27: Normalised absorption spectra for 151·8OTf in CH3CN at increasing dilutions. 
At concentrations < 1 µM, the cage has almost completely dissociated to give a spectrum 











3.7.5 Absorption and Emission of 146·OTf and 151·8OTf 
 
Figure 3.28: Normalised plot of absorbance and emission (ex@377 nm) for 146·OTf and 
151·8OTf in CH3CN. Slight changes are observed in the absorption bands upon binding to 
palladium and the emission wavelength is red shifted. 
3.7.6 Quantum Yield Determination 
Quantum yields were determined in CH3CN using Ru(bpy)3Cl2 as a commercial standard. 
Absorption and emission data were obtained for each sample at the isobestic point with the 
standard and the relative emission intensities calculated. The quantum yield was recorded 
both in air and after degassing via argon purging. 
Table 3.4: Quantum yield values in CH3CN for 146·OTf and 151·8OTf. 















3.7.7 Circular Dichroism of Δ/Λ 146·OTf and 151·8OTf 
 
Figure 3.29: Circular dichroism plot for isolated enantiopure 146·OTf and 151·8OTf in 
CH3CN. Measurements taken at equal molarities and thus 151·8OTf contains four times the 






3.7.8 Luminescent Lifetimes of 146·OTf and 151·8OTf 
 
Figure 3.30: Lifetime of 146·OTf in acetonitrile showing experimental data (black) and fitted 
exponential decay function (red). Calculated lifetime = 84.44 ns. 
 
Figure 3.31: Lifetime of 151·8OTf in acetonitrile showing experimental data (black) and 






3.7.9 Electrochemistry of 146·OTf 
 
Figure 3.32: Oxidation of 146·OTf in CH3CN versus Ag/Ag
+
 with ferrocene as an internal 
standard. 
 
Figure 3.33: Reduction of 146·OTf in CH3CN versus Ag/Ag
+







3.7.10 Electrochemistry of 151·8OTf 
 
Figure 3.34: Oxidation of 151·8OTf in CH3CN versus Ag/Ag
+
 with ferrocene as an internal 
standard. 
 
Figure 3.35: Reduction of 151·8OTf in CH3CN versus Ag/Ag
+







3.7.11 Crystal Structure of 146·OTf 
All crystal data collection and analysis was carried out by Dr. Gary S. Nicol, The University 
of Edinburgh. 
 
Figure 3.36: The crystal structure of 146·OTf.  
Single dark red block-shaped crystals of 146·OTf were recrystallised from a 1:1 mixture of 
CH3CN and H2O by slow evaporation. A dark red block-shaped crystal with dimensions 
0.14×0.12×0.05 was mounted on a MITIGEN holder in Paratone oil. Data were collected 
using a Bruker SMART APEXII diffractometer diffractometer equipped with an Oxford 
Cryosystems Cryostream 700+ low-temperature apparatus operating at T = 150.0 K. 
Data were measured using  and  scans of n/a (d, scan_width)° per frame for n/a (d, 
scan_rate) s using MoK radiation (sealed tube, 50 kV, 30 mA). The total number of runs 
and images was based on the strategy calculation from the program Bruker APEX2. The 
actually achieved resolution was  = 26.404. 
Cell parameters were retrieved using the SAINT (Bruker, V8.34A, 2013) software and 
refined using SAINT (Bruker, V8.34A, 2013) on 9220 reflections, 10 of the observed 
reflections. Data reduction was performed using the SAINT (Bruker, V8.34A, 2013) 
software which corrects for Lorentz polarisation. The final completeness is 100.00 out to 
26.404 in . The absorption coefficient () of this material is 3.043 and the minimum and 








The structure was solved in the space group C2/c (# 15) by Direct Methods using the 
ShelXT
69
 structure solution program and refined by Least Squares using version of 
ShelXL.
70
 All non-hydrogen atoms were refined anisotropically. Hydrogen atom positions 
were calculated geometrically and refined using the riding model. Water H atoms were 
identified from a difference Fourier map but then refined with fixed, or restrained, co-
ordinates. In particular, H atoms bonded to O6 required a constraint on the co-ordinates. One 
H atom comes into close proximity with its symmetry-equivalent, though there is no other 
obvious residual peak corresponding to a missing H atom. Displacement ellipsoid restraints 
were used on the acetonitrile molecule. The largest residual peak is 3.3 electrons high 
located 0.81 A from Ir1. A semi-empirical absorption correction was applied. 
C47H41F3IrN9O6S, Mr = 1109.15, monoclinic, C2/c (No. 15), a = 33.9184(6) Å, b = 
10.3853(2) Å, c = 28.2591(5) Å,  = 113.5090(10)°,  =  = 90°, V = 9128.1(3) Å3, T = 
150.0 K, Z = 8, Z' = 1, (MoK) = 3.043, 95017 reflections measured, 9354 unique (Rint = 
0.0598) which were used in all calculations. The final wR2 was 0.1027 (all data) and R1 was 
0.0381 (I > 2(I)). 
 
Figure 3.37: The structure of 146·OTf. Displacement ellipsoids are at the 50pc probability 








3.7.12 Guest Binding Experiments 
For each titration, a solution of host with a guest compound was titrated into a solution of 
host, maintaining a constant concentration of host compound throughout. For each 
observable peak shift of 151·8OTf in the 
1
H NMR spectra, the peak position was plotted 
against the concentration of guest. A global non-linear curve fitting function was then 
applied to the combined plots using the 1:1 binding model given by:
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𝑦 = 𝑦0 + ∆𝑦
(
 







Figure 3.38: Example data from titration of phenanthrene (G
12
) with 151·8OTf in a 1:1 
mixture of D2O/CD3CN. 
For further discussion of 
1
H NMR titration methods and approximation of associated 







3.7.13 Isomerisation of Stilbene and Azobenzene 
Stilbene or azobenzene (0.5 mmol) were charged to a solution of 146·OTf or 151·8OTf (1 
mL, 0.5 mM) in 1:1 D2O/CD3CN. The solution was irradiated with visible-light using a 
standard household 40 W fluorescent bulb at room temperature overnight. The reaction 





Scheme 3.7: Visible-light photocatalytic isomerisation of stilbene and azobenzene using 







3.7.14 Dimerisation of Acenaphthylene 
Acenaphthylene (7.5 mg, 0.5 mmol) was charged to a solution of 146·OTf or 151·8OTf (1 
mL, 0.5 mM) in 1:1 D2O/CD3CN. The solution was irradiated with visible-light using a 
standard household 40 W fluorescent bulb at room temperature overnight. The CD3CN was 
removed under vacuum and the product extracted with CH2Cl2 and passed through a silica 
plug to remove the catalyst. The solvent was removed under vacuum and re-dissolved in 
CDCl3 for NMR analysis. 
 
Scheme 3.8: Visible-light photocatalytic dimerisation of acenaphthylene using 146·OTf and 




H NMR (500 MHz, CDCl3, 300 K) of extracted product from the 
photodimerisation of acenaphthylene under visible light using no catalyst (bottom) or 
151·8OTf (top). The reaction produces both the syn (blue) and anti (red) confirmations 
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Although a complex-as-ligand approach has been shown to allow the synthesis of a 
photoactive metallosupramolecular assembly, the relatively low affinity for hydrophobic 
guest compounds prevented efficient regio-selective catalysis. Since the cage was 
coordinatively saturated, guest encapsulation was driven by the hydrophobic effect. The 
modular synthetic approach was utilised to synthesise a range of derivatives designed to 
improve the overall guest affinity. In order to improve the cage hydrophobicity, additional 
phenyl rings were added to close off the open portals. However, this had an adverse effect on 
the cage stability and lowered the binding strength of previously known guests. Merthods to 
improve the water solubility of the system were attempted and included nitrate ion 
metathesis, the introduction of PEG side chains and the addition of charged functional 
groups but without success. However, a “click” based methodology was developed for 
simple modification of the parent system and improves the previous modular construction 














One of the potential barriers to stereo- and regio-selective catalysis within the internal cavity 
of 151·8OTf was the relatively weak association of neutral guest molecules. As palladium 
was required to form a stable supramolecular structure (Figure 4.1), the resultant Pd2L4 
system is coordinatively saturated and there are no specific metal-ligand interactions 
providing a driving force for guest encapsulation (See previously, Figure 3.3).
1–4
 Since the 
host:guest interactions achieved through the hydrophobic effect are weak, bulk phase 
background reactions are likely to dominate when carrying out catalytic reactions. In 
addition, the instability of the system at high dilutions hinders detailed photophysical 
investigations of any photoredox reaction pathways. However, the modular synthesis of the 
cage structure allows for the relatively straight forward alteration of the cage properties 
through modification of the constituent parts. As such, a number of different methods were 
investigated to increase the system stability of 151·8OTf and increase the affinity for neutral 
organic guests.  
 
Figure 4.1: The structure of the iridium functionalised Pd2L4 cage, 151·8OTf, self-assembled 








4.3 Restricted Portal Size 
4.3.1 Introduction 
While 151·8OTf contains an internal cavity, the portals in and out are very large and allow 
rapid exchange of small molecules with the surrounding bulk media. As a result, the internal 
cavity is only partially hydrophobic since many areas are open to the surrounding solvent. In 
order to increase the association of neutral organic molecules with the interior of the cage, a 
variety of extended structural analogues were prepared (Figure 4.2). Molecular modelling 
suggested that substitution of the phenylpyridine ligand with an additional bulky group could 
reduce the size of the cage portals and thus increase the hydrophobicity of the cage cavity 
(Figures 4.3). The restricted openings would also increase the energy barrier for guest 
association and dissociation potentially resulting in slow binding conditions.  
 
Figure 4.2: Proposed structures of extended 2-phenylpyridine analogues. 
Synthesis of 154·OTf and 155·OTf was carried out in an analogous manner to the parent 
146·OTf complex. Upon formation of the Pd2L4 assembly 156·8OTf, a very complex 
1
H 
NMR spectrum was observed rather than the slight “splitting” previously described for 
151·8OTf (Figure 4.4). 
1
H DOSY confirmed that every signal belonged to a species of 
similar size and the synthesis of the homochiral variant confirmed that the “splitting” was 
still due to a complex distribution of the iridium chiral centres. Identical absorbance and 
emission data were also recorded for both the racemic and enantiopure 156·8OTf. The 
additional complexity observed in the 
1






the increased configurational communication between the iridium centres as a result of the 
overlapping phenyl rings. 
 
 
Figure 4.3: Spartan models of 151 and 156 illustrating the reduction in portal size upon 
addition of extended phenyl groups. 
As seen for the formation of 151·8OTf, significant peak shifts were observed for the 
imidazole and the internal hydrogen signals. A large down-field shift was also observed for 
the additional phenyl rings upon cage formation, consistent with strong π-π interactions. 
Similar observations were made for the diisopropyl variant, 157·8OTf. However, due to the 
difficulties associated with preparing 157·8OTf or the corresponding enantiopure analogues 










H NMR (500 MHz, CD3CN, 300 K) of 154·OTf, rac-156·8OTf and Δ-156·8OTf. 
Significant shifts are observed for the methyl imidazole (red), the internal proton (blue) and 
the extended phenyl group (green) upon cage formation. Overlap between the additional 
phenyl groups, in combination with a distribution of iridium chiral centres, creates a 











As described in Chapter 3, the stability of 156·8OTf was investigated both under dilute 
conditions and through scrambling experiments. Diluting the system below approximately 10 
µM resulted in disassembly of the cage structure and set a lower concentration limit on both 
luminescence investigations and catalytic screening. As well as closing off the cage portals, 
the additional phenyl groups present in 156·8OTf were shown to overlap in molecular 
modelling (Spartan) and interact by 
1
H NMR spectroscopy. If the π-π interactions provided 
an additional force for holding the iridium complexes together, then an increase in the 
stability of the system would be expected.  
In order to assess the kinetic stability of 156·8OTf, a scrambling experiment was carried out 
whereby equal quantities of Δ- and Λ-156·8OTf were combined in CD3CN at room 
temperature and the resultant rearrangement of the system to a statistical equilibrium was 
monitored by 
1
H NMR in a method analogous to that outlined in Chapter 3 (Figure 4.5). 
 
Figure 4.5: Δ/Λ-156·8OTf scrambling experiment in CD3CN at room temperature. The 
proportion of scrambling was measured by the ratio of the central triplet peak to the total 
peak area for the methyl imidazole proton signal. The fitted exponential decay (red) gives a 
half-life of 13.7 h.  











Fitting an exponential decay function to the relative ratio of enantiopure to mixed 156·8OTf 
in solution showed a much more rapid rearrangement of the system compared with 
151·8OTf (Table 4.1). The half-life of 156·8OTf (13.7 h) was an order of magnitude lower 
than 151·8OTf (132 h). As such, the additional phenyl groups appear to significantly disrupt 
rather than stabilise the supramolecular structure.  
Table 4.1: Stability of cage systems assessed by scrambling experiments. 
Host Ligand Mean lifetime (h) Half-life (h) 
151·8OTf 2-phenylpyridine 189.8 131.6 
156·8OTf 2,5-diphenylpyridine 19.8 13.7 
All measurements made in CD3CN at room temperature. 
As described in Chapter 2, it was postulated that rac-151·8OTf exists as a statistical mixture 
of diastereomers. The same is also true of rac-156·8OTf but the increased steric bulk 
provided by the additional phenyl groups results in a much more complex spectrum due to 
increased interactions between the neighbouring iridium complexes. However, this steric 
clash is also likely to destabilise the formation of heterochiral variants since a mismatch 
would result in a direct steric clash between adjacent groups rather than a favourable overlap. 
In this sense, the homochiral variants would be expected to be far more stable than the 
heterochiral structures and thus, it was surprising that scrambling between Δ and Λ-
156·8OTf even occurs. Although entropy could provide some of the driving force for 
rearrangement to an extended range of structures, it seems likely that any interaction 
between the adjacent iridium complexes is unfavourable and the palladium-imidazole 






4.3.3 Photophysical & Electrochemical Properties 
Comparison of the photophysical and electrochemical properties of 154·OTf and 156·8OTf 
with the original 2-phenylpyridine system, 146·OTf and 151·8OTf, shows remarkable 
similarities (Table 4.2). Neither the emission wavelength nor the redox potentials show any 
major variation and thus both systems should behave in a similar manner with respect to 
photoredox catalysis.    
Table 4.2: Comparison of luminescent properties and redox potentials for original 2-
phenylpyridine systems and the corresponding 5-phenyl substituted variants. 
Compound Ligand
 
λem (nm) E1/2 M/M
-
 (V) E1/2 M
+
/M (V) 
146·OTf 2-phenylpyridine 632 -1.52 0.89 
151·8OTf 2-phenylpyridine 675 -1.51 0.94 
154·OTf 2, 5-diphenylpyridine 634 -1.48 0.91 
156·8OTf 2, 5-diphenylpyridine 682 -1.49 0.94 
Measurements made in CH3CN in air. Redox potentials measured in CH3CN/TBA versus 
Ag/Ag
+
 and reported versus Fc/Fc
+
  
The similarity between each of the systems can be explained by the location of the relevant 
HOMO and LUMO orbitals. For most cyclometallated iridium complexes, the HOMO is 
located on the metal centre and the LUMO is located on the charge-neutral ancillary ligand. 
Thus, any substitution of the 2-phenylpyridine only influences the redox potentials through 
alterations in the metal centred HOMO due to remote electron withdrawal or donation. Since 
the additional phenyl groups are only slightly electron donating, very little change is 
observed in both the redox potentials and the emission wavelength. In contrast, substitution 
or alteration of the ancillary ligand can result in large changes in the reduction potential or 






4.3.4 Guest Binding 
Restriction of the portal size was hypothesised to increase the barrier to guest exchange and 
create a more enclosed hydrophobic pocket that could bind neutral organic guests more 
strongly. The best guests previously found for 151·8OTf were examined for 156·8OTf to 
explore whether an increase in binding constant could be observed (Figure 4.6). Due to the 
need to use enantiopure 156·8OTf to allow monitoring of the peak shifts in the required 
1
H 
NMR titrations, only a restricted selection of guests were investigated.  
 
Figure 4.6: 151·8OTf guests investigated for enhanced binding in 156·8OTf.  
Comparison of the measured binding constants reveals that the reduction in portal size 




 for the internal cavity of 156·8OTf (Table 4.3). 
Although the barrier to guest exchange was expected to increase, both guests still showed 
fast exchange on an NMR timescale. The reduction in binding affinity may be explained by 
steric restraint of the cavity altering the guest orientation and reducing any preferential 
interactions such as π-π stacking.  
Table 4.3: Comparison of binding constants for guest compounds within 2·8OTf and 5·8OTf. 






151·8OTf 257 ±33 
156·8OTf 62.8 ±14 
G
30
 potassium trifluoronapthylborane 
151·8OTf 429.2 ±73 
156·8OTf 139.5 ±24 
 
Although further exploration of guest structures could result in species that show a stronger 
affinity for the cavity of 156·8OTf than 151·8OTf, restriction of the portal size did not show 
any potential for significantly increasing guest binding and thus, alternative strategies were 







4.4 Designing Water Soluble Derivatives 
4.4.1 Introduction 
The hydrophobic effect has been used extensively as a general method for driving the 
encapsulation of neutral organic molecules within the cavities of metallosupramolecular 
architectures.
5–13
 The driving force occurs since water forms an unstable network around 
hydrophobic compounds. The resultant reduction in the number of strong hydrogen bond 
interactions, normally present in the bulk phase, results in  “high-energy water”. Interactions 
between the host and guest reduces the amount of “high energy water” required to solvate 




The incorporation of palladium as a building block for the assembly of Pd2L4 assemblies 
gave greater structural stability. However, the use of a square planar metal centre removed 
the ability to bind organic guest molecules through metal-ligand interactions. As an 
alternative, the hydrophobic effect was used to drive the encapsulation of a range of neutral 
organic guests in a 50:50 mixture of water and acetonitrile (See Chapter 3). However, the 
need to incorporate acetonitrile for cage solubility dramatically reduced the strength of the 
hydrophobic effect and was thought to result in the relatively weak binding constants.
13
 In 
order to increase the affinity of neutral compounds for the cage interior, a range of 
alternative cage systems were designed and synthesised in an effort to increase the cage 
solubility in exclusively water. 
4.4.2 Nitrate Counter Anions 
Many of the currently known water soluble metallosupramolecular systems make use of 
nitrate counter anions.
10,15
 In particular, the Fujita group has made extensive use of nitrate 
anions for the formation of water soluble systems.
11,16,17
 Previous work within the group has 
also shown how exchanging the associated counter anions for nitrate drastically increased 
the water solubility of cobalt based cages.
18
 
Ion metathesis during the synthesis of the iridium complex, 146·X, was attempted by the 
addition of saturated KNO3(aq) to precipitate the crude product from the ethylene glycol/H2O 
mixture but the additional aqueous solubility prevented efficient precipitation from the polar 






added polarity afforded by the nitrate anion made conventional purification by column 
chromatography difficult. 
Rather than isolate the nitrate salt directly, 146·BF4 (isolated by direct addition of KBF4 to 
the ethylene glycol/H2O mixture) was treated with an anion exchange resin to exchange the 
associated counter anion for Cl‾ (Scheme 4.1). Subsequent treatment with AgNO3 then 




F NMR spectroscopy 
with 1,2-difluorobenzene as an internal standard showed that removal of the BF4 anions had 
been mostly successful, <1% still remained. However, given the small proportion remaining 
and low yields achieved, the complex was taken forward for further investigations.  
 
Scheme 4.1: Anion exchange process of the synthesis of 146·NO3. 
Since 146·NO3 was not fully soluble in H2O, the cage formation was carried out using 
Pd(NO3)2 in a 2:1 mixture of CD3CN and H2O. After stirring at room temperature for 3 days, 
a complex 
1
H NMR spectrum with broad peaks was observed and 
1
H DOSY confirmed an 
increase in the hydrodynamic radius from 6.8 Å to 11.1 Å. Additional heating at 70 ºC did 
not produce any visible change in the 
1
H NMR spectrum but the 
1
H DOSY showed a 
decrease in radius to 8.4 Å. No evidence for the formation of a Pd2L4 system could be 
obtained by mass spectrometry. 
The lack of evidence of a distinct structure by 
1
H NMR spectroscopy suggested difficulties 
in the self-assembly process and this was attributed to the increased coordinating ability of 
nitrate versus OTf. This was expected to be minimised in more polar solvents as 
demonstrated by the assembly of similar palladium based systems in H2O or DMSO
4
 but the 
insolubility of 146·NO3 prevented the process from being carried out in those alternative 






in solution could actually favour the formation of large Pd12L24 supramolecular systems. 
They postulate that this was due to stabilisation of cationic intermediates in close proximity 
with each other. A similar process could be taking place during the formation of 151·8NO3 
but the increased cationic charge due to the iridium complex, along with the coordinating 
ability of NO3‾, stabilises the constituents parts to such a degree that the Pd2L4 system is no 
longer the thermodynamic minimum.    
4.4.3 Polyethyleneglycol Solubilising Groups 
Water solubility is often achieved by incorporating polar or charged functional groups into a 
compound structure. In order to allow the straightforward modification of the cage structure, 
a “click” based methodology was developed using the well-known copper-catalysed alkyne-




Figure 4.7: General reaction methodology for the click functionalisation of iridium 
complexes. 
The initial synthetic target was the polyethyleneglycol (PEG) functionalised phenyltriazole 
system. PEG groups have been used extensively to aid water solubility in a range of 
systems
20–23
 and have also been previously reported for aiding the solubility of 
metallosupramolecular cage compounds in water.
18
 After preparation of the PEG-
phenyltriazole ligand, the corresponding iridium complex was prepared in an analogous 
method to the 2-phenylpyridine parent system except that synthesis of the bridged chloride 
intermediate, 7, did not proceed as expected. Precipitation of the product from 2-
methoxyethanol did not occur even after cooling. 
1
H NMR analysis of the isolated crude 
product showed a mixture of multiple species that could not be separated by silica column 
chromatography. However, ESI-MS of the isolated compound gave a single peak for the 
correct mono-nuclear [Ir(C^N)2]
+






purification to afford the PEG functionalised complex, 159·OTf (Figure 4.8). The difficulties 
observed in isolating the phenyltriazole based iridium bridged chloride dimer have 
previously been reported for similar iridium compounds and can attributed to the low 
stability of the bridged chloride structure and the formation of a range of different transient 
species in solution.
24
   
 
Figure 4.8: The structures of the PEG functionalised iridium complex, 8·OTf, and the 
required bridged chloride intermediate 7. 
The solubility of 159·OTf was found to be similar to 146·OTf with a maximum 
water:acetonitrile ratio of 2:1 at 
1
H NMR detectable concentrations. However, the 
corresponding cage compound was synthesised in order to confirm that the assembly did not 
gain additional water solubility from the combination of eight PEG groups surrounding the 
exterior of the cage structure (Figure 4.9). As expected, the cage formation with 
[Pd(CH3CN)4·2OTf] led to additional signals in the 
1
H NMR spectrum and the distinctive 
1:2:1 peak distribution for the methyl imidazole signals (Figure 4.10). 
1
H DOSY confirmed 
that every signal belonged to a large species with a similar hydrodynamic radius to the parent 











H NMR (500 MHz, CD3CN, 300 K) of 159·OTf and 160·8OTf indicating the 
characteristic 1:2:1peak distribution observed upon cage formation. Overlapping peaks are 
coloured purple.  
Despite the successful formation of a PEG functionalised cage system, the resultant aqueous 
solubility 160·8OTf was not significantly different from the maximum 2:1 D2O/CD3CN ratio 
observed for the parent system, 151·8OTf. 
Although PEG molecules are water soluble, the terminal methyl group significantly reduces 
the overall polarity of the molecule. Since the parent compound, 151·OTf, is soluble in polar 








that the mild polarity of the short ethylene glycol chain was not enough to increase the water 
solubility of 160·OTf. Rather than prepare the alcohol variant of the PEG azide to give the 
hydroxyPEG-phenyltriazole (161), the click reaction was repeated with the commercially 
available 4-ethynyl-benzenemethanol to give the hydroxybenzyltriazole PEG (162) 
containing both the original water solubilising PEG group and an additional free hydroxyl 
group (Figure 4.11).   
 
Figure 4.11: The structures of OHPEG-phenyltriazole (161, not prepared) and 
hydroxybenzyltriazolePEG (162). 
 
Scheme 2: Synthesis of the proposed hydroxybenzyl-PEG functionalised iridium complex 
(163·OTf) and isolation of mono- (164·OTf) and di- (165·OTf) methoxyethoxy adducts. 
Complexation of 162 with iridium to prepare the bridged chloride dimer gave the previously 
discussed complicated 
1
H NMR spectrum and the isolated solid was used without further 






gave a mixture of products in the crude reaction mixture. Purification by silica column 
chromatography yielded the unexpected mono- and di-methoxyethoxy ether compounds 
(Scheme 4.2).  
Given the difficulties in purifying or analysing the bridged chloride intermediate, it was 
initially uncertain whether the ether linkage was formed during the initial cyclometallation 
reaction or from residual 2-methoxyethanol during the complexation of 149. However, ESI-
MS of the crude bridged chloride in CH3CN showed almost complete conversion to the 
mono- or di-ether coupled analogues after the cyclometallation step (Figure 4.12). 
 
 
Figure 4.12: ESI-MS of [(Ir(OHbenzylptPEG)2Cl)2]. Peaks a labelled as 163 (red), 164 
(blue) and 165 (green). Each ion exists as the free, mono- and di-CH3CN adduct where M = 
Ir(C^N)2. 
Although the unexpected ether formation reduced the polarity of the intended hydroxyl 
group, the resultant compounds still contained additional PEG chains and could be 






(Figure 4.13). However, the solubility of the isolated complexes and the resultant cage were 
not found to vary significantly from the maximum 2:1 H2O/CH3CN ratio observed for 
previous systems. 
 
Figure 4.13: The structure of the PEG functionalised cage (166·8OTf) prepared from the di-
methoxyethoxy adduct (165·OTf). 
4.4.4 Charged Solubilising Groups 
Due to the lack of water solubility provided by PEG groups and the incompatibility of polar 
hydroxyl groups to the synthesis of iridium complexes, charged functional groups were 
explored as potential water solubilising groups. Since these groups could potentially interfere 
with the synthesis and isolation of the iridium complexes, protecting group chemistry was 
utilised such that the deprotection step could be carried out just before or after the self-
assembly of the Pd2L4 cage systems (Figure 4.14).  
Synthesis of the required ligands was carried out in an analogous manner to the previous 
“click” procedure from known literature azides. The corresponding iridium bridged chloride 
intermediates displayed similar properties to the previously isolated phenyltriazole 
complexes and were used without further purification. Both 167·OTf and 169·OTf were 
isolated in reasonable yields after purification by conventional silica column 
chromatography. As with the previous structural modifications, assembly of the 







Figure 4.14: The proposed structures of iridium complexes and corresponding Pd2L4 cages 
functionalised with anionic (168, 172) and cationic (170, 174) water solubilising groups 
along with the corresponding protecting groups. 





H NMR analysis showed a mixture of very similar 
species in solution. 
1
H DOSY also confirmed the similarity of the mixed species but they 
could not be separated by any means, potentially due to the complicated zwitterionic nature 
of the cationic iridium centre with anionic solubilising groups. A similar deprotection 
process could not be carried out with 171·8OTf since hydroxide rapidly reacted with the 
coordinated palladium to form insoluble Pd(OH)2 and the free complex 167·OTf or 168·OTf.  
Similarly, deprotection of 169·OTf using N2H4 produced an impure mixture that could not be 
purified by column chromatography,
26,27
 recrystallisation or acid/base extraction, however, 
the resultant compounds were soluble in H2O. 
Although the introduction of charged solubilising groups did result in water soluble iridium 







4.5 Summary & Conclusions 
As described in Chapter 3, although 151·8OTf showed an affinity for a range of neutral 
guests, the measured binding constants were relatively low. In an attempt to increase the 
binding constants, to reduce competition between bulk phase background reactions during 
catalysis, a range of sterically crowded and water soluble variants were explored. 
The addition of phenyl groups to the peripheral cyclometallated ligands was expected to 
stabilise the cage system and increase guest binding.  Despite the overlapping aromatic rings 
predicted by molecular modelling and the strong up-field shifts consistent with π-π 
interactions upon formation of 156·8OTf, the stability of the system decreased by 
approximately 10 fold. The additional phenyl groups were also intended to reduce the portal 
size and increase the hydrophobicity of the internal cavity, however, for those guests studied 
the binding constants decreased. Alternative guests that show a preference for the more 
enclosed cavity may exist but no dramatic increase in the overall binding strength of guests 
was observed. 
An alternative approach was then employed to increase the guest binding affinity by 
increasing the solubility of 151·8OTf in H2O and thus strengthen the hydrophobic effect. 
Incorporation of NO3‾ anions through anion metathesis led to an increase in water solubility 
but the cage formation could not be accomplished in the presence of NO3‾, potentially due to 
increased stabilisation of the cationic species and competitive binding to Pd
2+
. 
Due to the modular synthesis developed for 151·8OTf, derivatisation of the structure was 
relatively straight forward using “click” chemistry to functionalise phenyl-triazole ligands 
with water solubilising groups. The addition of PEG groups did not significantly alter the 
solubility of the iridium complexes or corresponding cage compounds and the more polar 
hydroxyl groups were incompatible with the synthetic conditions. The introduction of 
charged solubilising groups was successful in producing water soluble species but 
purification of the resultant mixtures could not be achieved. 
Alteration of 151·8OTf to increase guest binding by increasing the hydrophobicity of the 
internal cavity and enhancing the hydrophobic effect in H2O was unsuccessful. However, a 
number of alternative systems were successfully prepared and characterised by the straight 






approach to synthesis. This demonstrates the success and flexibility of the complex-as-ligand 







4.6.1 General Information 
Unless stated otherwise, all reagents and solvents were purchased from Alfa Aesar, VWR or 
Sigma Aldrich and used without further purification. Column chromatography was carried 
out using Geduran Si60 (40-63 µm) as the stationary phase and TLC was performed on 
precoated Kieselgel 60 plates (0.20 mm thick, 60F254. Merck, Germany) and observed under 









butanoic acid ethyl ester,
30







 were prepared according to literature procedures. 
The synthesis of compounds 146·OTf and 151·8OTf are described in full in Chapter 3. 
For detailed information on the analytical methods, please refer to Sections 2.9.1 and 3.7.1. 
4.6.2 Synthetic Procedures 
2-phenyl-5-(2,6-diisopropylphenyl)pyridine 
 
5-bromo-2-phenylpyridine (300.8 mg, 1.285 mmol), 2,6-diisopropylphenylboronic acid 
(397.2 mg, 1.927 mmol) and Pd(PPh3)4 (14.8 mg, 1 mol%) were dissolved in toluene (20 
mL). K2CO3 (2M in H2O, 10 mL) was charged and the mixture was degassed under N2 and 
heated at reflux for 3 days. The crude mixture was cooled and HCl (2M in H2O, 30 mL) 
charged. The product extracted with Et2O, dried over MgSO4 and the solvent was removed 
under vacuum. The crude product was purified by silica chromatography running 80% 
hexane, 20% CH2Cl2 to give a colourless solid (175.9 mg, 43 %). 
1
H NMR (500 MHz, 
CDCl3) δ 8.54 (dd, J = 2.2, 0.8 Hz, 1H, Hf), 8.11 – 8.08 (m, 2H, Hc), 7.83 (dd, J = 8.0, 0.8 
Hz, 1H, Hd), 7.59 (dd, J = 8.0, 2.2 Hz, 1H, He), 7.54 – 7.49 (m, 2H, Hb), 7.46 – 7.42 (m, 1H, 






1.14 – 1.09 (m, 12H, Hg, Hi). 
13
C NMR (126 MHz, CDCl3) δ 155.81, 150.15, 147.51, 139.14, 
137.98, 135.56, 134.82, 129.18, 128.97, 128.76, 126.93, 122.94, 119.82, 30.56, 24.23. m/z 
(HR-ESI): 292.13321 (predicted [M+H]
+
 = 292.13410) mp = 128-130 ºC. 
Δ/Λ-[(Ir(Phppy)2Cl)2] 
 
Δ/Λ-[(Ir(Phppy)2Cl)2] was prepared using an analogous procedure to that previously reported 
for Δ/Λ-[(Ir(ppy)2Cl)2].
28
 rac-[(Ir(Phppy)2Cl)2] (125.9 mg, 0.091 mmol), L-Serine (28.8 mg, 
0.274 mmol) and NaOMe (14.8 mg, 0.274 mmol) were dissolved in CH3OH (50 mL) and 
stirred at 40 ºC for 16 h. The solvent was removed under vacuum and the crude products 
separated by silica column chromatography running 0.5% Et3N, 1.0% CH3OH in CH2Cl2. 
The faster running diastereomer Δ-[(Ir(Phppy)2(L-Serine)] was isolated pure, dissolved in 
CH3OH (25 mL) and HCl(aq) (35%, 0.5 mL) was charged. The mixture was stirred at room 
temperature for 1 h and the resultant precipitate filtered, washed with CH3OH and dried 
under vacuum to yield Δ-[(Ir(Phppy)2Cl)2] as a bright yellow solid (31.6 mg, 25%). The 
remaining impure fractions were retained, converted to [(Ir(Phppy)2Cl)2] and the procedure 
repeated with D-Serine to afford  Λ-[(Ir(Phppy)2Cl)2] as a bright yellow solid (22.9 mg, 
18%). Δ/Λ-[(Ir(Phppy)2Cl)2] 
1
H NMR (500 MHz, CDCl3) δ 9.81 (d, J = 2.1 Hz, 4H, Hg), 
7.53 (d, J = 8.5 Hz, 4H, He), 7.47 – 7.36 (m, 16H, Hd, Hi, Hj), 7.32 (dd, J = 8.5, 2.2 Hz, 4H, 
Hf), 7.15 – 7.11 (m, 8H, Hh), 6.79 – 6.73 (m, 4H, Hc), 6.58 – 6.53 (m, 4H, Hb), 5.91 (dd, J = 
7.8, 0.8 Hz, 4H, Ha). 
13
C NMR (126 MHz, CDCl3) δ 167.00, 149.37, 145.81, 143.67, 135.75, 
133.97, 133.06, 130.62, 129.36, 129.01, 128.50, 126.24, 123.64, 121.42, 117.70. m/z (HR-
ESI): 1376.25094 (predicted [M]
+








2-phenyl-5-(2,6-diisopropylphenyl)pyridine (175.9 mg, 0.558 mmol) and Na3IrCl6 (132.1 mg, 
0.279 mmol) were partially dissolved in 2-methoxyethanol (30 mL). The mixture was stirred 
at room temperature until complete dissolution (5 h) and then heated at reflux under N2 for 
16 h. The solvent was removed under vacuum and the crude residue purified by silica 
chromatography running 50% CH2Cl2 and 50% hexane to give a bright yellow solid (111.8 
mg, 47%). 
1
H NMR (500 MHz, CDCl3) δ 9.25 (s, 4H, Hg), 7.92 (d, J = 8.2 Hz, 4H, He), 7.64 
(d, J = 8.2, 4H, Hf), 7.56 (dd, J = 7.8, 1.4 Hz, 4H, Hd), 7.41 (t, J = 7.8 Hz, 4H, Hi), 7.31 – 
7.22 (m, 8H, Hh), 6.90 – 6.81 (m, 4H, Hc), 6.76 – 6.67 (m, 4H, Hb), 6.28 (d, J = 7.6 Hz, 4H, 
Ha), 2.89 – 2.71 (m, 8H, Hj), 1.28 – 1.09 (m, 48H, Hk). 
13
C NMR (126 MHz, CDCl3) δ 
166.24, 150.73, 147.47, 144.35, 138.71, 135.11, 134.44, 132.29, 129.44, 129.18, 124.09, 
123.13, 123.08, 121.92, 118.08, 30.98 (Cj), 30.87 (Cj), 24.73 (Ck), 24.57 (Ck), 24.17 (Ck), 
24.05 (Ck). *isopropyl groups split into multiple environments due to restricted rotation. m/z 




















154·OTf - [Ir(Phppy)2(emibipy)]OTf 
 
[(Ir(Phppy)2Cl)2] (27.4 mg, 0.020 mmol) and 149 (14.5 mg, 0.040 mmol) were partially 
dissolved in ethylene glycol (2.0 mL). The solution was degassed under high-vacuum for 20 
mins and backfilled with N2 before heating at 150 °C for 18 h. The solution was then cooled 
and diluted with H2O (10 mL) before being washed with Et2O (2 x 5 mL). KOTf (22.5 mg, 
0.120 mmol) was charged and the resultant precipitate was filtered through celite. The 
orange solid was washed with copious amounts of H2O and then washed off the celite with 
CH2Cl2. The solvent was removed under reduced pressure to yield the crude product. If 
necessary, purification could be achieved by silica column chromatography (gradient CH2Cl2 
to 10% CH3OH in CH2Cl2). The product was isolated as a bright orange/red solid (19.0 mg, 
yield = 64%). 
1
H NMR (500 MHz, CD3CN) δ 8.62 (d, J = 1.7 Hz, 2H, Hm), 8.19 – 8.12 (m, 
2H, He, Hf), 8.05 (dd, J = 5.7, 0.5 Hz, 2H, Hk), 7.86 (dd, J = 7.9, 1.0 Hz, 2H, Hd), 7.77 (dd, J 
= 1.8, 1.0 Hz, 2H, Hg), 7.63 (s, 2H, Ho), 7.56 (dd, J = 5.7, 1.7 Hz, 2H, Hl), 7.44 (d, J = 0.9 Hz, 
2H, Hn), 7.43 – 7.34 (m, 10H, Hh, Hi, Hj), 7.13 – 7.05 (m, 2H, Hc), 6.99 – 6.92 (m, 2H, Hb), 
6.41 (dd, J = 7.6, 0.8 Hz, 2H, Ha), 3.79 – 3.72 (m, 6H, Hp). 
13
C NMR (126 MHz, CD3CN) δ 
167.15, 156.81, 151.64, 150.78, 147.57, 144.67, 141.75, 138.05, 137.97, 137.33, 136.44, 
134.63, 132.67, 131.49, 130.21, 130.00, 129.79, 127.70, 127.06, 126.05, 123.82, 120.98, 
115.31, 93.93, 87.88, 32.81. 
19
F NMR (471 MHz, CD3CN) δ -79.30 (s). 
1
H DOSY NMR 
(500 MHz, CD3CN) –logD = 9.01, hydrodynamic radius = 6.0 Å. m/z (HR-ESI): 1017.30190 
(predicted [M]
+











Pr2Phppy)2Cl)2] (16.0 mg, 0.009 mmol) and 149 (6.8 mg, 0.019 mmol) were partially 
dissolved in ethylene glycol (2.0 mL). The solution was degassed under high-vacuum for 20 
mins and backfilled with N2 before heating at 150 °C for 18 h. The solution was then cooled 
and diluted with H2O (10 mL) before being washed with Et2O (2 x 5 mL). KOTf (10.5 mg, 
0.056 mmol) was charged and the resultant precipitate was filtered through celite. The 
orange solid was washed with copious amounts of H2O and then washed off the celite with 
CD2Cl2. The solvent was removed under reduced pressure to yield the crude product. If 
necessary, purification could be achieved by silica column chromatography (gradient CD2Cl2 
to 10% CH3OH in CD2Cl2). The product was isolated as a bright orange/red solid (15.4 mg, 
yield = 62%). 
1
H NMR (601 MHz, CD3CN) δ 8.47 (d, J = 1.5 Hz, 2H, Hn), 8.17 (d, J = 8.4 
Hz, 2H, He), 7.90 (d, J = 7.1 Hz, 2H, Hd), 7.86 (d, J = 5.7 Hz, 2H, Hl), 7.74 (dd, J = 8.3, 1.9 
Hz, 2H, Hf), 7.63 (s, 2H, Hp), 7.51 (d, J = 1.8 Hz, 2H, Hg), 7.43 (dd, J = 5.7, 1.6 Hz, 2H, Hm), 
7.41 (s, 2H, Ho), 7.31 (t, J = 7.8 Hz, 2H, Hi), 7.21 (dd, J = 7.8, 0.9 Hz, 2H, Hh2), 7.12 (m, 4H, 
Hc, Hh1), 7.04 – 7.00 (m, 2H, Hb), 6.48 (d, J = 7.6 Hz, 2H, Ha), 3.72 (s, 6H, Hq), 2.68 (hept, J 
= 6.8 Hz, 2H, Hj2), 2.04 (hept, J = 7.1 Hz, 2H, Hj1), 1.18 (d, J = 6.8 Hz, 6H, Hk2a), 1.00 (d, J 
= 6.8 Hz, 6H, Hk2b), 0.90 (d, J = 6.9 Hz, 6H, Hk1a), 0.60 (d, J = 6.8 Hz, 6H, Hk1b). 
13
C NMR 
(126 MHz, CD3CN) δ 166.87, 156.35, 151.27, 150.54, 149.74, 148.01, 147.61, 144.86, 
141.77, 140.95, 138.06, 137.04, 134.75, 134.33, 132.67, 131.46, 130.22, 130.00, 126.45, 
126.17, 123.90, 123.89, 123.76, 120.60, 115.22, 93.67, 88.04, 32.77, 31.55, 31.28, 24.76, 
24.08, 23.61, 23.52.
 19
F NMR (471 MHz, CD3CN) δ -79.31 (s). 
1
H DOSY NMR (500 MHz, 
CD3CN) –logD = 9.04, hydrodynamic radius = 6.5 Å. m/z (HR-ESI): 1185.48590 (predicted 
[M]
+









156·8OTf - [Pd2(Ir(Phppy)2emibipy)4]8OTf 
 
General Method 
[Ir(Phppy)2emibipy]OTf (15.2 mg, 0.013 mmol) was dissolved in CH3CN (5 mL). 
[Pd(CH3CN)4·2OTf] (3.71 mg, 0.007 mmol) was charged as a solution in CH3CN (267 µL). 
The solution was stirred at room temperature for 16 h. The solution was concentrated under 
vacuum. The product was precipitated with Et2O, filtered, washed with Et2O and dried under 





C NMR too complicated for detailed analysis due to complex mixture of 
diastereomers. 
19
F NMR (471 MHz, CD3CN) δ -79.30. 
1
H DOSY NMR (500 MHz, CD3CN) 
–logD = 9.31, hydrodynamic radius = 12.1 Å. 
Δ/Λ-[Pd2(Ir(Phppy)2emibipy)4]8OTf  
1
H NMR (601 MHz, CD3CN) δ 8.83 (d, J = 1.4 Hz, 8H, Hm), 8.22 (d, J = 0.6 Hz, 8H, Ho), 
8.11 (d, J = 8.4 Hz, 8H, Hf), 8.07 (d, J = 5.8 Hz, 8H, Hk), 7.97 (dd, J = 8.6, 2.1 Hz, 8H, He), 
7.85 (dd, J = 8.0, 0.8 Hz, 8H, Hd), 7.80 (d, J = 1.2 Hz, 8H, Hn), 7.60 (dd, J = 5.7, 1.6 Hz, 8H, 
Hl), 7.55 (d, J = 2.1 Hz, 8H, Hg), 7.15 – 7.06 (m, 40H, Hc, Hh, Hi), 6.99 – 6.95 (m, 8H, Hj), 
6.95 – 6.92 (m, 8H, Hb), 6.32 (dd, J = 7.6, 0.7 Hz, 12H, Ha), 3.75 (s, 6H). 
13
C NMR (126 
MHz, CD3CN) δ 167.14, 156.56, 152.07, 150.48, 147.22, 144.65, 142.27, 138.21, 137.32, 
136.38, 135.74, 133.51, 132.57, 131.57, 129.93, 129.93, 129.37, 128.07, 127.69, 126.11, 
123.97, 122.27 (q, J = 320.9 Hz), 121.04, 117.69, 94.99, 84.00, 34.52.
 19
F NMR (471 MHz, 
CD3CN) δ -78.94. 
1













PrPhppy)2emibipy]OTf (5.8 mg, 4.35 µmol) was dissolved in CD3CN (0.5 mL). 
[Pd(CH3CN)4·2OTf] (1.24 mg, 2.18 µmol) was charged as a solution in CD3CN (20 µL). 





C NMR too complicated for detailed analysis due to complex mixture of 
diastereomers. 
19
F NMR (471 MHz, CD3CN) δ -79.07. DOSY NMR (500 MHz, CD3CN) –









146·BF4 - [Ir(ppy)2(emibipy)]BF4 
 
[(Ir(ppy)2Cl)2] (226.7 mg, 0.211 mmol) and 149 (154.0 mg, 0.423 mmol) were partially 
dissolved in ethylene glycol (40.0 mL). The solution was degassed under high-vacuum for 
20 mins and backfilled with N2 before heating at 150 °C for 18 h. The solution was then 
cooled and diluted with H2O (150 mL) before being washed with Et2O (2 x 100 mL). KBF4 
(133.1 mg, 1.055 mmol) was charged and the resultant precipitate was filtered through celite. 
The orange solid was washed with copious amounts of H2O and then washed off the celite 
with CH2Cl2. The solvent was removed under reduced pressure to yield the crude product. 
The product was isolated as a bright orange/red solid (138.1 mg, yield = 73%). 
1
H NMR 
(500 MHz, CD3CN) δ 8.62 (d, J = 1.5 Hz, 2H, Hk), 8.07 (d, J = 8.1 Hz, 2H, He), 7.94 (d, J = 
5.6 Hz, 2H, Hi), 7.90 – 7.83 (m, 2H, Hf), 7.81 (dd, J = 7.9, 1.3 Hz, 2H, Hd), 7.67 (d, J = 5.9 
Hz, 2H, Hh), 7.64 (s, 2H, Hm), 7.52 (dd, J = 5.7, 1.6 Hz, 2H, Hj), 7.45 (d, J = 0.9 Hz, 2H, Hl), 
7.08 – 7.03 (m, 4H, Hc, Hg), 6.97 – 6.90 (m, 2H, Hb), 6.27 (dd, J = 7.8, 1.0 Hz, 2H, Ha), 3.77 
(s, 6H, Hn). 
13
C NMR (126 MHz, CD3CN) δ 285.28, 273.62, 268.48, 267.87, 267.33, 262.00, 
258.70, 256.61, 254.96, 251.59, 249.45, 248.37, 246.92, 243.76, 242.87, 241.52, 240.65, 
237.88, 232.32, 210.92, 204.71, 149.81. 
19





B). m/z (HR-ESI): 865.23800 (predicted [M]
+






146·NO3 - [Ir(ppy)2(emibipy)]NO3 
 
[Ir(ppy)2(emibipy)]BF4 (47.1 mg, 0.049 mmol) was dissolved in CH3CN (3 mL). Amberlite 
CG-400 resin (100 mg) was charged and the mixture was gently agitated at room 
temperature for 1 h. The mixture was filtered, AgNO3 (8.4 mg, 0.049 mmol) charged and the 
solution stirred at room temperature for 18 h in a darkened flask. The resultant mixture was 
filtered through celite and the solvent removed under vacuum to yield an orange/red solid 
(8.1 mg, 18%). 
1
H NMR (500 MHz, 2:1 CD3CN/D2O) δ 8.63 (d, J = 1.7 Hz, 2H, Hk), 8.04 (d, 
J = 8.2 Hz, 2H, He), 7.91 (d, J = 5.7 Hz, 2H, Hi), 7.87 – 7.80 (m, 2H, Hf), 7.77 (dd, J = 8.0, 
1.3 Hz, 2H, Hd), 7.73 (s, 2H, Hm), 7.61 (dd, J = 5.8, 1.5 Hz, 2H, Hh), 7.49 (dd, J = 5.7, 1.6 
Hz, 2H, Hj), 7.42 (s, 2H, Hl), 7.06 – 6.97 (m, 4H, Hc, Hg), 6.91 – 6.85 (m, 2H, Hb), 6.22 (dd, 
J = 7.6, 1.2 Hz, 2H, Ha), 3.74 (s, 6H, Hn). 
13
C NMR (126 MHz, 2:1 CD3CN/D2O) δ 168.14, 
156.56, 151.49, 150.79, 150.19, 145.00, 141.86, 139.75, 136.97, 134.35, 132.42, 131.38, 
129.98, 126.89, 125.90, 124.60, 123.74, 120.95, 115.67, 93.95, 86.91, 33.10. 
1
H DOSY 
NMR (500 MHz, 2:1 CD3CN/D2O) –logD = 9.32, hydrodynamic radius = 6.8 Å. m/z (HR-
ESI): 865.23520 (predicted [M]
+
 = 865.23739). 
 
 








Phenylacetylene (306.42 mg, 3.000 mmol) and azido-2-PEG (435.45 mg, 3.000 mmol) were 
dissolved in a mixture of water (6 mL) and 
t
BuOH (6 mL). Sodium ascorbate (10 mol%, 1M 
in H2O) and Cu(II)SO4.5H2O (1 mol%, 300 mM in H2O) were charged and immediate 
precipitation was observed. The mixture was stirred thoroughly at room temperature for 16 h. 
The mixture was diluted with H2O (50 mL) and the product was extracted with CH2Cl2. The 
organic layer was dried over MgSO4 and the solvent removed under vacuum to yield a 
yellow oil that slowly crystallised to form an off-white solid (512.1 mg, 69%). 
1
H NMR (500 
MHz, CDCl3) δ 8.01 (s, 1H, Hd), 7.88 – 7.79 (m, 2H, Hc), 7.46 – 7.38 (m, 2H, Hb), 7.36 – 
7.30 (m, 1H, Ha), 4.59 (t, J = 5.0 Hz, 2H, He), 3.89 (t, J = 5.0 Hz, 2H, Hf), 3.67 – 3.57 (m, 
2H, Hg), 3.55 – 3.46 (m, 2H, Hh), 3.37 (s, 3H, Hi). 
13
C NMR (126 MHz, CDCl3) δ 130.88, 
128.81, 128.02, 125.69, 121.10, 71.76, 70.56, 69.57, 59.04, 50.35. m/z (HR-ESI): 248.14028 
(predicted [M]
+
 = 248.13935), 270.12176 (predicted [M+Na]
+
 = 270.12130), 517.25381 
(predicted [2M+Na]
+








158 – [(Ir(ptPEG)2)Cl)2] 
 
Phenyl triazole-2-PEG (423.4 mg, 1.712 mmol) and Na3IrCl6.xH2O (405.7 mg, 0.0856 mmol) 
were partially dissolved in 2-methoxyethanol (125 mL). The mixture was stirred at room 
temperature for 2 h until complete dissolution and then heated at reflux for 16 h. The solvent 
was removed under vacuum to yield a yellow oil. Purification by silica chromatography 
running 100% CH2Cl2 to 10% CH3OH in CH2Cl2 still showed multiple species by 
1
H NMR. 
DOSY confirms all signals belong to similar sized species. Used without further purification. 
m/z (HR-ESI): 685.25560 (predicted [Ir(ptPEG)2]
+












Crude (Ir(ptPEG)2Cl)2 (31.2 mg) and 149 (15.8 mg, 0.043 mmol) were partially dissolved in 
ethylene glycol (2.0 mL). The solution was degassed under high-vacuum for 20 mins and 
backfilled with N2 before heating at 150 °C for 18 h. The solution was then cooled and 
diluted with H2O (10 mL) before being washed with Et2O (2 x 5 mL). KOTf (24.5 mg, 0.130 
mmol) was charged and the resultant precipitate was filtered through celite. The orange solid 
was washed with copious amounts of H2O and then washed off the celite with CH2Cl2. The 
solvent was removed under reduced pressure to yield the crude product. If necessary, 
purification could be achieved by silica column chromatography (gradient CH2Cl2 to 10% 
CH3OH in CH2Cl2). The product was isolated as a bright orange/red solid (29.4 mg, yield = 
57%). 
1
H NMR (500 MHz, CD3CN) δ 8.56 (d, J = 1.7 Hz, 2H, Hm), 8.20 (s, 2H, He), 8.12 (d, 
J = 5.7 Hz, 2H, Hk), 7.64 (s, 2H, Ho), 7.54 (dd, J = 7.6, 1.0 Hz, 2H, Hd), 7.51 (dd, J = 5.7, 1.6 
Hz, 2H, Hl), 7.44 (s, 2H, Hn), 7.04 – 6.98 (m, 2H, Hc), 6.91 – 6.84 (m, 2H, Hb), 6.26 (dd, J = 
7.5, 0.5 Hz, 2H, Ha), 4.50 – 4.35 (m, 4H, Hf), 3.85 – 3.73 (m, 4H, Hg), 3.78 (s, 6H, Hp), 3.55 
– 3.43 (m, 4H, Hh), 3.41 – 3.30 (m, 4H, Hi), 3.22 (s, 6H, Hj). 
13
C NMR (126 MHz, CD3CN) δ 
157.62, 157.42, 152.23, 146.68, 141.72, 137.86, 136.92, 134.34, 133.44, 129.31, 129.04, 
125.86, 123.87, 123.32, 121.28, 93.95, 87.46, 72.44, 70.99, 69.31, 58.99, 52.93, 32.86. 
19
F 
NMR (471 MHz, CD3CN) δ -79.32 (s). 
1
H DOSY NMR (500 MHz, CD3CN) –logD = 9.02, 
hydrodynamic radius = 6.2 Å. m/z (HR-ESI): 1049.44710 (predicted [M]
+






160·8OTf - [Pd2(Ir(ptPEG)2emibipy)4]8OTf 
 
[Ir(ptPEG)2emibipy]OTf (4.7 mg, 3.92 µmol) was dissolved in CD3CN (0.5 mL). 
[Pd(CH3CN)4·2OTf] (1.12 mg, 1.97 µmol) was charged as a solution in CD3CN (63 µL). 
The solution was left at room temperature for 5 h to give a bright red solution (100% by 
NMR). Product not isolated. 
1
H NMR (500 MHz, CD3CN) δ 8.71 – 8.65 (m, 8H, Hm), 8.23 – 
8.17 (m, 16H, He, Ho), 8.17 – 8.08 (m, 8H, Hk), 7.79 – 7.72 (m, 8H, Hn), 7.59 – 7.47 (m, 16H, 
Hd, Hl), 7.03 – 6.97 (m, 8H, Hc), 6.90 – 6.83 (m, 8H, Hb), 6.25 – 6.20 (m, 8H, Ha), 4.46 – 
4.31 (m, 16H, Hf), 3.86 – 3.68 (m, 40H, Hg, Hp), 3.49 – 3.37 (m, 16H, Hh), 3.37 – 3.26 (m, 
16H, Hi), 3.17 – 3.12 (m, 24H, Hj). 
13
C NMR (126 MHz, CD3CN) δ 157.56, 157.20, 152.48, 
146.20, 142.22, 136.77, 135.32, 133.31, 133.10, 129.31, 128.83, 126.70, 123.93, 123.30, 
122.16 (q, J = 321.0 Hz), 121.26, 117.70, 94.95, 83.41, 72.34, 70.93, 69.24, 58.89, 52.83, 
34.46. 
19
F NMR (471 MHz, CD3CN) δ -79.03. 
1
H DOSY NMR (500 MHz, CD3CN) –logD = 







162 - OH benzyl ptPEG 
 
Ethynyl benzyl alcohol (461.8 mg, 3.494 mmol) and azido-2-PEG (507.2 mg, 3.494 mmol) 
were dissolved in a mixture of water (6 mL) and 
t
BuOH (6 mL). Sodium ascorbate (10 mol%, 
1M in H2O) and Cu(II)SO4.5H2O (1 mol%, 300 mM in H2O) were charged and immediate 
precipitation was observed. The mixture was stirred thoroughly at room temperature for 16 h. 
The mixture was diluted with H2O (50 mL) and the product was extracted with CH2Cl2. The 
crude product was purified by silica chromatography running 100% CH2Cl2 to 10% CH3OH 
in CH2Cl2 to give a colourless solid (592.3 mg, 61%). 
1
H NMR (500 MHz, CDCl3) δ 8.02 (s, 
1H, He), 7.89 – 7.76 (m, 2H, Hd), 7.49 – 7.37 (m, 2H, Hc), 4.74 (d, J = 5.3 Hz, 2H, Hb), 4.61 
(t, J = 5.0 Hz, 2H, Hf), 3.92 (t, J = 5.0 Hz, 2H, Hg), 3.66 – 3.62 (m, 2H, Hh), 3.56 – 3.53 (m, 
2H, Hi), 3.38 (s, 3H, Hj), 2.17 (bt, J = 5.8 Hz, 1H, Ha). 
13
C NMR (126 MHz, CDCl3) δ 
147.47, 140.83, 130.12, 127.43, 125.84, 121.03, 71.75, 70.53, 69.54, 65.02, 59.03, 50.32. 
m/z (HR-ESI): 278.15103 (predicted [M+H]
+
 = 278.14922), 300.13270 (predicted [M+Na]
+
 
= 300.13240), 577.27589 (predicted [2M+Na]
+









OHbenzylptPEG (204.3 mg, 0.737 mmol) and Na3IrCl6 (174.6 mg,0.368 mmol) were 
partially dissolved in 2-methoxyethanol (100 mL). The mixture was stirred at room 
temperature until complete dissolution was observed (1 h) and then heated at reflux under N2 
for 16 h. The solvent was removed under vacuum and H2O (100 mL) charged. The crude 
product was extracted into CH2Cl2 and the solvent was removed under vacuum. Product used 







Crude (Ir(OHbenzylptPEG)2Cl)2 (92.0 mg) and 149 (42.9 mg, 0.118 mmol) were partially 
dissolved in ethylene glycol (10.0 mL). The mixture was degassed under high-vacuum for 20 
mins and backfilled with N2 before heating at 150 °C for 18 h. The solution was then cooled 
and diluted with H2O (50 mL) before being washed with Et2O (2 x 25 mL). KOTf (66.6 mg, 
0.354 mmol) was charged but no precipitate was observed. The solvent was removed under 
reduced pressure and the crude product purified by silica chromatography running 100% 
CH2Cl2 to 10% CH3OH in CH2Cl2. Two different products were isolated:  
164·OTf - [Ir(monoPEG-ptPEG)2(emibipy)]OTf 
 
 
164·OTf. Yield = 17.1 mg, 11%. 
1
H NMR (500 MHz, CD3CN) δ 8.54 – 8.45 (m, 2H, Hp, 
Hp’), 8.24 – 8.17 (m, 2H, Hh, Hh’), 8.13 – 8.05 (m, 2H, Hn, Hn’), 7.79 – 7.65 (m, 2H, Hr, Hr’), 
7.55 – 7.39 (m, 6H, Hf, Hf’, Ho, Ho’, Hq, Hq’), 7.03 – 6.94 (m, 2H, Hg, Hg’), 6.23 – 6.17 (m, 
2H, He, He’), 4.51 – 4.40 (m, 4H, Hi, Hi’), 4.38 (s, 2H, Hd or Hd’), 4.30 (s, 2H, Hd or Hd’), 3.84 – 
3.73 (m, 10H, Hj, Hj’, Hs, Hs’), 3.52 – 3.42 (m, 8H, Hb, Hc, Hk, Hk’), 3.38 – 3.32 (m, 4H, Hl, 
Hl’), 3.27 (s, 3H, Ha), 3.21 – 3.19 (m, 6H, Hm, Hm’). 
13
C NMR (126 MHz, CD3CN) δ 157.37, 
157.33, 152.11, 146.60, 141.68, 139.58, 137.83, 136.12, 134.30, 132.60, 128.98, 125.80, 
123.53, 123.16, 122.10 (q, J = 320.8 Hz), 121.23, 115.33, 93.90, 87.46, 73.76, 72.53, 72.37, 
70.91, 70.30, 69.32, 58.92, 58.90, 52.88, 32.80. Unable to distinguish all 13C peaks due to 
partial desymmetrisation. 19F NMR (471 MHz, CD3CN) δ -79.31. m/z (HR-ESI): 1167.41400 
(predicted [M]
+






165·OTf - [Ir(diPEG-ptPEG)2(emibipy)]OTf 
 
 
165·OTf. Yield = 11.5mg, 7%. 
1
H NMR (500 MHz, CD3CN) δ 8.55 (d, J = 1.5 Hz, 2H, Hp), 
8.21 (s, 2H, Hh), 8.11 – 8.04 (m, 2H, Hn), 7.63 (s, 2H, Hr), 7.52 (d, J = 7.7 Hz, 2H, Ho), 7.50 
– 7.46 (m, 2H, Hf), 7.43 (d, J = 0.9 Hz, 2H, Hq), 6.99 (dd, J = 7.8, 1.6 Hz, 2H, Hg), 6.20 (d, J 
= 1.5 Hz, 2H, He), 4.51 – 4.37 (m, 4H, Hi), 4.30 (s, 4H, Hd), 3.83 – 3.73 (m, 4H, Hj), 3.77 (s, 
6H, Hs), 3.53 – 3.41 (m, 12H, Hb, Hc, Hk), 3.39 – 3.31 (m, 4H, Hl), 3.27 (s, 6H, Ha), 3.21 (s, 
6H, Hm). 
13
C NMR (126 MHz, CD3CN) δ 157.37 , 157.33 , 152.11 , 146.60 , 141.68 , 
139.58 , 137.83 , 136.12 , 134.30 , 132.60 , 128.98 , 125.80 , 123.53 , 123.16 , 121.23 , 
115.33 , 93.90 , 87.46 , 73.76 , 72.53 , 72.37 , 70.91 , 70.30 , 69.32 , 58.92 , 58.90 , 52.88 , 
32.80 . 
19
F NMR (471 MHz, CD3CN) δ -79.31. 
1
H DOSY NMR (500 MHz, CD3CN) –logD 










166·8OTf - [Pd2(Ir(PEGptPEG)2emibipy)4]OTf 
 
[Ir(PEGptPEG)2emibipy]OTf (5.7 mg, 3.78 µmol) was dissolved in CD3CN (0.5 mL). 
[Pd(CH3CN)4·2OTf] (1.08 mg, 1.90 µmol) was charged as a solution in CD3CN. The 
solution was left at room temperature for 16 h to give a bright red solution (100% by NMR). 
Product not isolated.
1
H NMR (500 MHz, CD3CN) δ 8.69 (m, 8H, Hp), 8.25 – 8.13 (m, 16H, 
Hh, Hr), 8.15 – 8.04 (m, 8H, Hn), 7.77 (m, 8H, Hq), 7.58 – 7.46 (m, 16H, Hf, Ho), 7.03 – 6.95 
(m, 8H, Hg), 6.15 (m, 8H, He), 4.48 – 4.32 (m, 16H, Hi), 4.28 (s, 16H, Hd), 3.75 (m, 24H, Hs), 
3.83 – 3.66 (m, 16H, Hj), 3.54 – 3.36 (m, 48H, Hb, Hc, Hk), 3.34 – 3.26 (m, 16H, Hl), 3.25 (m, 
24H, Hm), 3.14 (m, Ha). 
13
C NMR (126 MHz, CD3CN) δ 157.37, 157.33, 152.11, 146.60, 
141.68, 139.58, 137.83, 136.12, 134.30, 132.60, 128.98, 125.80, 123.53, 123.16, 122.10 (q, J 
= 320.7 Hz), 121.23, 115.33, 93.90, 87.46, 73.76, 72.53, 72.37, 70.91, 70.30, 69.32, 58.92, 
58.90, 52.88, 32.80. *HSQC confirmed peak at 58.94 represents two overlapping carbon 
environments. 
19
F NMR (471 MHz, CD3CN) δ -79.08. 
1
H DOSY NMR (500 MHz, CD3CN) 








Ethylbutylate phenyl triazole (228.5 mg, 0.881 mmol) and Na3IrCl6 (208.8 mg, 0.441 mmol) 
were partially dissolved in 2-methoxyethanol (100 mL). The mixture was stirred at room 
temperature until complete dissolution was observed (1 h) and then heated at reflux under N2 
for 16 h. The solvent was removed under vacuum and H2O (100 mL) charged. The crude 
product was extracted into CHCl3, dried over MgSO4 and the solvent was removed under 
vacuum. A solid was isolated re-dissolving the crude product in CH3CN followed by 
precipitation with Et2O. The solid was filtered, washed with Et2O and dried under vacuum to 
give a beige solid (260.0 mg, 79%). Used without further purification. m/z (HR-ESI): 
709.20640 (predicted [ML2]
+
 = 709.21090), 750.23390 (predicted [ML2(CH3CN)]
+
 = 
750.23745), 791.26020 (predicted [ML2(CH2CN)2]
+







167·OTf - [Ir(pt-ester)2(emibipy)]OTf 
 
Crude (Ir(pt-ester)2Cl)2 (30.9 mg) and 149 (15.1 mg, 0.041 mmol) were partially dissolved in 
ethylene glycol (5.0 mL). The solution was degassed under high-vacuum for 20 mins and 
backfilled with N2 before heating at 150 °C for 16 h. The solution was then cooled and 
diluted with H2O (50 mL) before being washed with Et2O (2 x 25 mL). KOTf (23.4 mg, 
0.124 mmol) was charged and the resultant precipitate filtered onto celite, washed with water 
and dried under vacuum. The product was washed off the celite with CH2Cl2 and the solvent 
removed under vacuum. The crude product was purified by silica chromatography running 
100% CH2Cl2 to 10% CH3OH in CH2Cl2 to give the product as a bright orange solid (15.3 
mg, 30%). 
1
H NMR (500 MHz, CD3CN) δ 8.55 (d, J = 1.6 Hz, 2H, Hm), 8.13 (s, 2H, He), 
8.10 (d, J = 5.8 Hz, 2H, Hk), 7.64 (s, 2H, Ho), 7.53 (dd, J = 7.6, 0.9 Hz, 2H, Hd), 7.50 (dd, J = 
5.7, 1.6 Hz, 2H, Hl), 7.44 (s, 2H, Hn), 7.06 – 6.97 (m, 2H, Hc), 6.92 – 6.83 (m, 2H, Hb), 6.27 
(d, J = 7.3 Hz, 2H, Ha), 4.34 (t, J = 6.9 Hz, 4H, Hf), 4.00 (q, J = 7.1 Hz, 4H, Hi), 3.78 (s, 6H, 
Hp), 2.21 (t, J = 6.9 Hz, 4H, Hh), 2.08 (m, 4H, Hg), 1.16 (t, J = 7.1 Hz, 6H, Hj). 
13
C NMR 
(126 MHz, CD3CN) δ 172.93, 157.67, 157.39, 152.16, 146.66, 141.68, 137.80, 136.82, 
134.24, 133.45, 129.28, 128.92, 125.75, 123.79, 123.35, 120.83, 93.91, 87.34, 61.24, 51.95, 
32.81, 31.12, 25.73, 14.51. 
19
F NMR (376 MHz, CD3CN) δ -79.33. 
1
H DOSY NMR (500 
MHz, CD3CN) –logD = 9.06, hydrodynamic radius = 6.8 Å. m/z (HR-ESI): 1073.35140 
(predicted [M]
+








168·OTf - [Ir(pt-acid)2(emibipy)]OTf 
 
[Ir(pt-ester)2(emibipy)]OTf (3.7 mg, 3.03 µmol) was dissolved in a mixture of CH3OH (0.2 
mL) and CH2Cl2 (1.8 mL). NaOH (2M in CH3OH, 9.08 µmol) was charged and stirred at 
room temperature for 72 h. The solvent removed under vacuum and the residue re-dissolved 
in D2O for analysis. Compound not isolated pure. 
171·8OTf - [Pd2(Ir(pt-ester)2(emibipy))4]8OTf 
 
[Ir(pt-ester)2emibipy]OTf (2.6 mg, 2.13 µmol) was dissolved in CD3CN (0.5 mL). 
[Pd(CH3CN)4·2OTf] (0.61 mg, 1.07 µmol) was charged as a solution in CD3CN. The 
mixture was left at room temperature for 16 h to give a bright red solution (100% by NMR). 
Product not isolated. 
1






8H, Ho), 8.14 – 8.05 (m, 16H, He, Hk), 7.78 – 7.70 (m, 8H, Hn), 7.57 – 7.49 (m, 16H, Hd, Hl), 
7.03 – 6.96 (m, 8H, Hc), 6.90 – 6.81 (m, 8H, Hb), 6.26 – 6.16 (m, 8H, Ha), 4.33 – 4.23 (m, 
16H, Hf), 3.96 – 3.87 (m, 16H, Hi), 3.79 – 3.70 (m, 24H, Hp), 2.20 – 2.14 (m, 16H, Hh), 2.05 
– 1.98 (m, 16H, Hg), 1.10 – 1.02 (m, 24H, Hj). 
13
C NMR (126 MHz, CD3CN) δ 172.88, 
157.69, 157.23, 152.50, 146.20, 142.23, 136.71, 135.33, 133.37, 133.04, 129.35, 128.77, 
126.65, 123.92, 123.39, 120.92, 117.71, 94.98, 83.35, 61.18, 51.90, 34.47, 31.09, 25.69, 
14.50. 
19
F NMR (471 MHz, CD3CN) δ -79.04. 
1
H DOSY NMR (500 MHz, CD3CN) –logD = 







Butyl phthalimide phenyl triazole 
 
Phenylacetylene (218.8 mg, 2.142 mmol) and azido butylphthalimide (523.3 mg, 2.142 
mmol) were dissolved in a mixture of water (6 mL) and 
t
BuOH (6 mL). Sodium ascorbate 
(10 mol%, 1M in H2O) and Cu(II)SO4.5H2O (1 mol%, 300 mM in H2O) were charged and 
immediate precipitation was observed. The mixture was stirred thoroughly at 60 ºC for 6 h. 
The mixture was diluted with H2O (50 mL) and the product was extracted with CH2Cl2. The 
organic layer was dried over MgSO4 and the solvent removed under vacuum to yield a 
yellow oil. The product was purified by silica chromatography in CH2Cl2 to give a colourless 
solid (242.6 mg, 33%). 
1
H NMR (500 MHz, CDCl3) δ 7.87 – 7.79 (m, 4H, Hc, Hi), 7.78 (s, 
1H, Hd), 7.74 – 7.68 (m, 2H, Hj), 7.45 – 7.38 (m, 2H, Hb), 7.35 – 7.28 (m, 1H, Ha), 4.46 (t, J 
= 7.2 Hz, 2H, He), 3.75 (t, J = 6.9 Hz, 2H, Hh), 2.10 – 1.93 (m, 2H, Hf), 1.84 – 1.71 (m, 2H, 
Hg). 
13
C NMR (126 MHz, CDCl3) δ 168.51, 147.96, 134.20, 132.12, 130.77, 128.94, 128.22, 
125.85, 123.45, 119.73, 49.69, 37.00, 27.68, 25.70. mp (116-130 ºC). m/z (HR-ESI): 
347.15200 (predicted [M+H]
+
 = 347.15025), 369.13350 (predicted [M+Na]
+









Butylphthalimide phenyl triazole (153.2 mg, 0.442 mmol) and Na3IrCl6 (104.5 mg, 0.221 
mmol) were partially dissolved in 2-methoxyethanol (10 mL). The mixture was stirred at 
room temperature until complete dissolution was observed (1 h) and then heated at reflux 
under N2 for 16 h. EtOH (20 mL) was charged and the resultant solid filtered. The crude 
product was suspended in H2O, extracted into CHCl3, dried over MgSO4 and the solvent was 
removed under vacuum to give a beige/green semi-solid (107.7 mg, 53%). Used without 
further purification. m/z (HR-ESI): 883.23460 (predicted [Ir(C^N)2]
+
 = 883.23270), 
924.26110 (predicted [Ir(C^N)2(CH3CN)]
+
 = 924.25924), 965.28730 (predicted 
[Ir(C^N)2(CH3CN)2]
+
 = 965.28579).   







169·OTf - [Ir(pt-phthN)2(emibipy)]OTf 
 
Crude (Ir(pt-phthN)2Cl)2 (50.2 mg) and 149 (19.9 mg, 0.055 mmol) were partially dissolved 
in ethylene glycol (8.0 mL). The solution was degassed under high-vacuum for 20 mins and 
backfilled with N2 before heating at 150 °C for 16 h. The solution was then cooled and 
diluted with H2O (50 mL) before being washed with Et2O (2 x 25 mL). KOTf (30.9 mg, 
0.164 mmol) was charged and the resultant precipitate filtered onto celite, washed with water 
and dried under vacuum. The product was washed off the celite with CH2Cl2 and the solvent 
removed under vacuum. The crude product was purified by silica chromatography running 
100% CH2Cl2 to 10% CH3OH in CH2Cl2 to give the product as a bright orange solid (58.1 
mg, 76%). 
1
H NMR (500 MHz, CD3CN) δ 8.50 (dd, J = 1.7, 0.7 Hz, 2H, Hn), 8.11 (s, 2H, 
He), 8.07 (dd, J = 5.7, 0.7 Hz, 2H, Hl), 7.81 – 7.74 (m, 4H, Hj), 7.74 – 7.68 (m, 4H, Hk), 7.64 
(s, 2H, Hp), 7.52 – 7.49 (m, 2H, Hd), 7.43 (dd, J = 5.7, 1.6 Hz, 2H, Hm), 7.41 (s, 2H, Ho), 
7.01 – 6.94 (m, 2H, Hc), 6.89 – 6.83 (m, 2H, Hb), 6.24 (d, J = 7.2 Hz, 2H, Ha), 4.33 (t, J = 6.7 
Hz, 4H, Hf), 3.73 (s, 6H, Hq), 3.57 – 3.34 (m, 4H, Hi), 1.91 – 1.77 (m, 4H, Hg), 1.63 – 1.46 
(m, 4H, Hh). 
13
C NMR (126 MHz, CD3CN) δ 169.21, 157.64, 157.35, 152.13, 146.66, 
141.63, 137.81, 136.81, 135.07, 134.15, 133.43, 133.10, 129.31, 128.89, 125.77, 123.77, 
123.75, 123.32, 120.82, 115.35, 93.95, 87.32, 52.34, 37.59, 32.79, 27.60, 26.01. 
19
F NMR 
(471 MHz, CD3CN) δ -79.31. 
1
H DOSY NMR (500 MHz, CD3CN) –logD = 9.07, 
hydrodynamic radius = 7.0 Å. m/z (HR-ESI): 1247.37480 (predicted [M]
+







170·OTf - [Ir(pt-NH2)2(emibipy)] 
 
[Ir(pt-phthN)2(emibipy)]OTf (12.1 mg, 8.66 µmol) was dissolved in ethanol (25 mL). 
Hydrazine hydrate 80% (50 µL) was charged and refluxed under N2 for 72 h. The solution 
was cooled, acidified with 1M HCl(aq) and refluxed for 1 h. The solution was cooled and 
salicylaldehyde (300 µL) was charged and the resultant mixture stirred under N2 at room 
temperature for 1 h. The precipitate was extracted with Et2O and the aqueous layer basified 
to pH 9-10 with a combination of NaCO3 (aq) (sat) and NaOH(aq) (2.5 M). The resultant 
precipitate was filtered, washed with ethanol and re-dissolved in CD3OH for analysis. 







173·8OTf - [Pd2(Ir(pt-phthN)2(emibipy))4]8OTf 
 
[Ir(pt-phthN)2emibipy]OTf (3.1 mg, 2.22 µmol) was dissolved in CD3CN (0.5 mL). 
[Pd(CH3CN)4·2OTf] (0.63 mg, 1.11 µmol) was charged as a solution in CD3CN. The 
mixture was left at room temperature for 16 h to give a bright red solution (100% by NMR). 
Product not isolated. 
1
H NMR (500 MHz, CD3CN) δ 8.60 – 8.57 (m, 8H, Hn), 8.25 – 8.19 (m, 
8H, Hp), 8.13 – 8.08 (m, 8H, Hl), 8.07 (s, 8H, He), 7.82 – 7.76 (m, 8H, Ho), 7.67 – 7.61 (m, 
16H, Hj), 7.61 – 7.56 (m, 16H, Hk), 7.51 – 7.43 (m, 16H, Hd, Hm), 7.01 – 6.94 (m, 8H, Hc), 
6.87 – 6.81 (m, 8H, Hb), 6.21 – 6.16 (m, 8H, Ha), 4.28 – 4.20 (m, 16H, Hf), 3.76 – 3.68 (m, 
24H, Hq), 3.37 – 3.31 (m, 16H, Hi), 1.78 – 1.69 (m, 16H, Hg), 1.45 – 1.37 (m, 16H, Hh). 
13
C 
NMR too complex/weak for full analysis. 
19
F NMR (471 MHz, CD3CN) δ -79.05. 
1
H DOSY 








4.6.3 Mass Spectrometry of Cage Compounds 




Figure 4.15: ESI-MS of 156·8OTf. The peaks found by experiment (black) are shown in 



























Figure 4.16: ESI-MS of 157·8OTf. The peaks found by experiment (black) are shown in 























160·8OTf - [Pd2(Ir(ptPEG)2emi)4]OTf 
 
 
Figure 4.17: ESI-MS of 160·8OTf. The peaks found by experiment (black) are shown in 






















166·8OTf - [Pd2(Ir(PEGptPEG)2emi)4]OTf 
 
 
Figure 4.18: ESI-MS of 166·8OTf. The peaks found by experiment (black) are shown in 























171·8OTf - [Pd2(Ir(pt-ester)2emi)4]OTf 
 
Figure 4.19: ESI-MS of 171·8OTf. The peaks found by experiment (black) are shown in 






















173·8OTf - [Pd2(Ir(pt-phthN)2emibipy)4]OTf 
 
 
Figure 4.20: ESI-MS of 173·8OTf. The peaks found by experiment (black) are shown in 






















4.6.4 Stability of 156·8OTf 
The stability of 156·8OTf was assessed using an analogous method to that outlined for 
151·8OTf in Chapter 3.     
4.6.5 Guest Binding 
All guest binding experiments were carried out following the procedures outlined in Chapter 
3.  
4.6.5 Photophysics of 156·8OTf 
 







Figure 4.22: The addition of Pd
2+
 to 154·OTf monitored by absorbance (CH3CN, 300 K). A 
similar decrease in the 
1
MLCT bands and increase in the LC bands was observed compared 
with the original 151·8OTf system. 
 







4.6.6 Electrochemistry of 154·OTf and 156·8OTf 
 
Figure 4.24: Oxidation of 154·OTf in CH3CN versus Ag/Ag
+
 with ferrocene as an internal 
standard. 
 
Figure 4.25: Reduction of 154·OTf in CH3CN versus Ag/Ag
+








Figure 4.26: Oxidation of 156·OTf in CH3CN versus Ag/Ag
+
 with ferrocene as an internal 
standard. 
 
Figure 4.27: Reduction of 156·OTf in CH3CN versus Ag/Ag
+
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Previous attempts at increasing the affinity of a Pd2L4 cage for organic guests in polar 
solvents were unsuccessful. As an alternative, the potential of guest binding in organic 
solvents was investigated. A control compound, a simple Pd2L4 system developed previously 
by Hooley and co-workers, was studied as a receptor for hydrogen bond acceptor guests. The 
self-assembly process allows the generation of hydrogen bond donor pockets, not normally 
observed in solution, due to complexation of Pd
II
 to the pyridines. Quinones were identified 
as ideal guests and naphthoquinone was used as a standard for exploring the effects of 
switching counter anions and solvent on the host:guest affinity. Reducing the polarity of the 
solvent from CH3OH to CH2Cl2 and switching the counter anion from OTf to the non-
coordinating BArF resulted in over a 10
4
 fold increase in the binding constant. Additionally, 





, one of the highest reported for metallosupramolecular systems. Alternative 
compounds, including ketones, aldehydes, amides and nitro groups, were also shown to 
interact with the cage cavity. The ability to significantly alter the affinity of organic guests 
within metallosupramolecular cages by simply altering the associated counter ion or solvent 















Almost all of the fundamental applications of supramolecular container compounds rely on 
binding guest compounds within the interior cavity and as such, the strength of the 
interactions between the container and guest are very important to the field.
1
 Previous work 
in the field has focused on purely determining whether there is an interaction between the 
host and guest, either by direct detection using x-ray crystallography and mass spectrometry 
or by monitoring changes upon guest encapsulation using techniques such as ultraviolet-
visible spectroscopy and NMR.
2–10
 However, more recently, a more concerted effort has 
been made to quantify these interactions through the use of titration techniques
11–19
 with the 




Many supramolecular species have been found to encapsulate guest compounds in a range of 
different conditions. The most widely utilized technique for the encapsulation of neutral 
guest compounds in metallosupramolecular containers is the hydrophobic effect whereby 
apolar compounds are driven inside the hydrophobic cage cavity in H2O or other highly polar 
solvents. This provides a widely applicable and general method for binding organic 
substrates without specific host:guest interactions but there are limitations. Due to the 
specific hydrogen bond lattice required to generate the hydrophobic effect, the strength of 
binding drops off dramatically in solvents other than water which can severely limit the 
breadth of container design.
12,16
 Synthesis of water soluble metallosupramolecular containers 
can be challenging, as although they often carry a high charge, many designs incorporate 
large hydrophobic ligands as structural elements (see chapter 3 and 4). In addition, any 
increase in the overall charge by altering the number or type of coordinated metals can also 
reduce the hydrophobicity of the internal cavity.   
In order to allow binding in apolar solvents, specific interactions such as hydrogen bonding 
and metal-ligand complexation are required. However, the associated counter ions usually 
accompanying metallosupramolecular species have been found to act as guests in their own 






 Competition between the 
counter ion guests can therefore result in significantly weaker binding to neutral guest 
compounds, particularly for highly charged systems. In addition, due to ion pairing between 






higher than the bulk medium, further increasing the binding strength of ions relative to 
neutral guests.  
To avoid these issues and maximize host guest interactions we hypothesized that subtle 
changes to the associated counter ions and the solvent could alter the guest binding constants 
for a range of suitable guests. By incorporating large, non-coordinating counter anions, ion-
pairing with the cage is reduced and enhanced binding of neutral guest compounds is 










5.3 The Model System 
5.3.1 Introduction 
Hooley and co-workers previously reported a Pd2L4 capsule based on bis-pyridine ligands 
prepared as its NO3‾ salt.
26
 The system is relatively simple; requiring only a two-step 
synthesis from commercial compounds and can be prepared on a multi-gram scale. The 
system’s simplicity also aids analysis of host:guest interactions and the high degree of 
symmetry reduces the total number of NMR signals. The well-defined hydrogen bond donor 
sights within the cavity also provide a simplified binding model for prediction of appropriate 
guest compounds. 
The authors originally reported weak binding constants for a number of linear organic 
compounds in DMSO that were chosen based on their ability to interact with the Pd
II
 ions. 
However, based on our hypothesis, the conditions chosen (NO3‾ counter anions in DMSO) 
would heavily compete with any favourable binding interactions and prevent any measurable 
guest association with hydrogen bond acceptor guests. In order to confirm this, 1·OTf was 
prepared (Figure 5.1) and a range of suitable guests were screened by comparing the 
1
H 
NMR spectrum in CH3CN before and after the addition of the guest. 
 
Figure 5.1: The structure of the Pd2L4 metallosupramolecular cage chosen as a model 






Naphthoquinone was found to produce significant shifts in the 
1
H NMR spectrum of 
175·4OTf (Figure 5.2). As expected, the cage peaks most affected by the presence of a guest 
are the internal protons, both on the pyridine ring and the central benzene ring. Further 
evidence towards the binding mode was provided by the deshielding of the pyridyl protons 
due to hydrogen bonding with the carbonyl groups and shielding of the central benzene rings 
due to CH-π interactions  
 
 
Figure 5.2: An example 
1
H NMR (500 MHz, CD3CN, 300 K) spectrum of 1·4OTf (green), 






5.3.2 System Stability 
Before selecting the system for further studies, the stability of the cage under dilute 
conditions was assessed due to the need to perform dilution experiments with slow binding 
guests (Figure 5.3). The system was found to be stable in solution at room temperature for 
the duration of the project (> 6 months) at concentrations above 50 µM. At concentrations 
less than 50 µM the cage equilibrium shifts towards free ligand until at concentrations below 
5 µM, the intact cage is no longer observed. Only the cage or free ligand are observed 
throughout this concentration range and no partial structures were identified suggesting 
significant cooperativity towards cage assembly. Care was therefore taken to maintain 




H NMR (600 MHz, CD3CN, 300 K) stability experiment showing degradation of 
175·4OTf (green) under dilute conditions to form predominantly free ligand (blue). 
5.3.3 Binding Experiments 
In order to quantify the binding constants and investigate the host:guest system, titration 
experiments were carried out by 
1







NMR titrations were carried out with increasing concentrations of guest while keeping the 
host concentration constant. The host peak positions were then plotted against guest 










 approximately, slow binding on the 
1
H 
NMR timescale was observed at room temperature that prevented the use of standard NMR 
titrations. The low stability of the cage compounds also prevented measurements based on 
dilution experiments. As such, binding constants were measured through a series of 
competition experiments using anthraquinone as a universal standard. Anthraquinone itself 
was measured versus benzoquinone for which the binding constant was known through 
conventional 
1








5.4 Enhanced Guest Binding 
5.4.1 Solvent Properties 
Solvents have always played a major part in all aspects of chemistry and their properties can 
heavily influence the outcome of a reaction.
27
 Even in very concentrated samples, the solvent 
molecules often outnumber the compound of interest by a thousand to one and indeed, so 
called neat reactions performed without an added solvent still utilise one of the reactants to 
solvate each individual molecule. It is therefore no surprise that the chosen solvent often 
plays an essential role in the reaction pathway and that the wrong choice of solvent can lead 
to unwanted side reactions or prevent a reaction from proceeding at all. 
For metallosupramolecular compounds, the central cavity is often occupied by solvent 
molecules and/or associated counter ions, demonstrated by the rapid degradation of crystals 
upon solvent loss. For host:guest interactions governed by hydrogen bonding, it would be 
expected that polar, hydrogen bond acceptor solvents would be more likely to compete for 
the hydrogen bond donor sites. Thus, apolar solvents that show no preference for the 
hydrogen bonding environments could lead to stronger association constants for neutral 
guests in 175·4OTf.  
In order to investigate this hypothesis, the binding strength of naphthoquinone within 
175·4OTf was measured using 
1
H NMR titrations in a number of different solvents ranging 
from the most polar, CD3OD, to the least polar, CD2Cl2 (Table 5.1). For each experiment, the 
peak shifts for 175·4OTf were plotted relative to the guest concentration and fitted globally 
against a 1:1 binding model. The associated experimental errors were found to be ±25 % (see 
section 5.7.8). 
Table 5.1: Association constants (Ka) for naphthoquinone and 175·4OTf in a range of 
different organic solvents. 













CD3OD 175·4OTf 2.58 x 10
1 
-8.1 33.0 5.8 
CD3CN 175·4OTf 2.07 x 10
2
 -13.3 36.6 4.7 
d8-THF 175·4OTf 2.91 x 10
2 
-14.2 7.5 5.3 
CD2Cl2 175·4OTf 1.84 x 10
3 
-18.8 8.9 1.1 
CD3NO2 175·4OTf 1.99 x 10
3 






As expected, the Ka was found to increase by almost a factor of 10
2
 simply by altering the 
polarity and hydrogen bond acceptor ability of the solvent. However, CD3NO2 was found to 
be very similar to CD2Cl2 despite having vastly different hydrogen bond acceptor (HBA) 
properties. CD2Cl2 is a very weak HBA and as such, a difference in the binding constant 
would be expected if association was based solely on the solvent properties. However, the 
binding strength of the associated counter anions will also increase in apolar solvents and 
thus the similar binding constants measured for naphthoquinone in CD3NO2 and CD2Cl2 
suggest that the low HBA ability means that the solvent molecules no longer compete 
effectively for the binding site and so the guest binding strength is limited solely by the 
associated counter anion.     
5.4.2 Counter Ion Properties 
In order to assess the counter anion dependence of guest binding, a range of different 
analogues of the cage were prepared containing alternative anions using either a different 
starting palladium salt or ion metathesis. Samples were prepared with the original OTf⁻ as 
well as BF4⁻, PF6⁻, SbF6⁻, Ph4B⁻ and BArF⁻. Each of the compounds was fully characterised 
by NMR and mass spectrometry.  
All of the systems were stable in solution above 50 µM with the exception of 175·4Ph4B, 
which completely degraded within hours. The 
1
H NMR spectrum of the solution in CD3CN 
showed the rapid formation of biphenyl along with the corresponding disassembly of the 
cage to give free ligand. This coupling process has been previously reported using both an 
electrochemical method and the addition of an oxidant such as cerium ammonium nitrate. 
Oxidation of the Ph4B could lead to the formation of Pd
0
 and explain the resultant 
degradation of the cage structure.  
1
H NMR studies of the different counter ion species revealed similar proton shifts to that 
associated with the binding of guests within the cage cavity (Figure 5.4). In particular, the 
internal ortho-pyridyl proton, shows a distinctive downfield shift, analogous to that observed 
upon the introduction of a hydrogen bonding guest. Only for very large, bulky ions, such as 
BArF⁻, can an “empty” cavity be observed where the resultant peak shift is determined 









Figure 5.4: Stack of 
1
H NMR spectra for 175·4X with different counter ions in CD3CN. The 
shift in the internal ortho-pyridyl hydrogen (9.2-9.5 ppm) follows a similar trend to that 
observed for guest binding. 
 
Figure 5.5: A space-filling model of 175
4+
 along with individual models of the counter ions. 
OTf⁻, BF4⁻, PF6⁻, SbF6⁻ and BArF⁻ are shown to highlight the relative sizes of the species 
involved. The large size of BArF⁻ procludes encapsulation within the cavity. 
For those counter ions that are able to fit within the cavity, the expected trend is observed 
where the internal ortho-pyridyl peaks become more deshielded with an increase in the 
coordinating ability of the counter anion. OTf⁻ results in the largest shift due to specific 






anions follow a trend in binding strength given by BF4⁻ > PF6⁻ > SbF6⁻ which matches the 
calculated trend in polarity (Figure 5.6).  
 
Figure 5.6: Calculated ionisation potential surfaces for OTf⁻, BF4⁻, PF6⁻ and SbF6⁻. Scale 




Figure 5.7: ESI-MS of 175·4X comparing the charge state distribution with different counter 
ions. 175·4OTf shows a more wide-spread distribution of charge states indicating that the 
OTf⁻ counter ions are more tightly bound in the gas phase than the other, less coordinating 
anions. 
Mass spectrometry for each of 175·4X also showed a trend towards more loosely bound ions 
(Figure 5.7). For 175·4OTf, a wide spread of charge states was observed but for 175·4BArF 
under identical spray conditions, the [175]
4+







































relative to the lower charge states, indicating easier removal of the associated counter ions in 
the gas phase. 
For each of the different counter ions, the binding constant of naphthoquinone in CD3NO2 
was measured using 
1
H NMR titrations (Table 5.2). CD3NO2 was chosen as the test solvent 
since many of the 175·4X salts had very low solubility in CD2Cl2, and the resultant strong 
guest binding conditions aided the experiment. The observed trend showed an increase of 
over ten fold in the binding strength from the most, OTf⁻, to the least interacting, BArF⁻. 
Since the BArF counter anions are too sterically crowded to enter the cage cavity, the 
binding constant of naphthoquinone reported in 175·4BArF can represent the affinity of the 
guest versus bound solvent molecules.   
Table 5.2: Association constants (Ka) for naphthoquinone and 175·X in CD3NO2. 
Solvent Counter anion Ka (M
-1
) ΔG (kJmol-1)  
CD3NO2 OTf⁻ 1.99 x 10
3
 -18.9  
CD3NO2 BF4⁻ 6.52 x 10
3
 -21.9  
CD3NO2 PF6⁻ 1.30 x 10
4
 -23.6  
CD3NO2 SbF6⁻ 2.22 x 10
4
 -24.9  
CD3NO2 BArF⁻ 4.99 x 10
4
 -27.0  
 
5.4.3 Combined Binding Effects 
In order to assess the ability to combine both the solvent and counter ion effects, the 
association constant of naphthoquinone in 175·4BarF was measured in a range of solvents 
and compared with the previous data for 175·4OTf (Table 5.3). Combining both a non-polar, 
non-coordinating solvent and a large, non-coordinating counter ion lead to a maximum 




 for 175·4BArF in CD2Cl2. This represents a total increase 
of over 10
4
 in the binding strength of naphthoquinone by simply altering the solvent and 
associated counter ions. Note that the binding constant for 175·4BArF in CD2Cl2 was 
measured using the competition experiments described in section 5.6.7 due to resultant slow 
binding on an 
1







Table 5.3: Comparison of observed binding constants for naphthoquinone within 175·4OTf 
and 175·4BArF. 










































In general, altering the solvent was more effective in increasing the affinity for 
naphthoquinone then altering the associated counter anion. This was unexpected, since 
moving to a less polar solvent would not only increase the affinity of the neutral guest for the 
cage cavity but also increase the ion-pairing effect of the counter anion, thereby cancelling 
out any benefit. However, the ion-pairing effect can be observed by comparing the 
differences in the binding properties of 175·4OTf with 175·4BArF in different solvents. 
Since 175·4BArF can be considered a vacant cavity only occupied by solvent molecules, the 
difference in binding between 175·4OTf and 175·4BArF represents the binding strength of 
OTf⁻ within the cavity. As the solvent decreases in polarity to the non-polar CD2Cl2, a large 
increase in the binding affinity of OTf⁻ was observed due to the increased ion-pairing. 
Interestingly, the smallest change in ΔG is observed for CH3CN rather than the most polar 
solvent, CD3OD. Since the association constant of naphthoquinone was lowest in CD3OD, 
this suggests that the low affinity for OTf⁻ in CD3CN is due to preferential solvation of the 
anion. This matches the observation that 175·4OTf is far more soluble in CD3CN than any 
other solvent. This highlights the complex and subtle interplay of forces that govern the 
strength of guest binding in metallosupramolecular container compounds. However, 
particularly for systems in non-polar solvents, the use of large, non-coordinating anions can 







5.5 Structural Dependency 
Although naphthoquinone was used as a model guest compound, 175·4X also showed the 
propensity to bind a number of different quinone based compounds and alternative 
functional groups. For the stronger binding species, with a Ka above approximately 10
5
, slow 
binding behaviour was observed relative to the 
1
H NMR timescale. The instability of the 
cage systems at low concentrations prevented the use of dilution experiments. As such, the 
association constants for these guests were measured using a combination of competition 
experiments. The Ka of anthraquinone was first measured using benzoquinone as a standard. 
Anthraquinone was then used as a standard for all other strong binding species. 
5.5.1 Quinone-based compounds 
For quinone-based compounds, an increase in binding constant was observed upon 
increasing the π-π interactions around the quinone group by the addition of aromatic rings 
(Figure 5.8). The association constant increased by approximately 10
2
 fold for each of the 
first two ring additions (Table 5.4). The addition of extra aromatic rings increased the 
binding strength still further but by smaller increments since protrusion from the cavity 
through the cage portals limits the effect of additional substitution away from the binding 
motif.   
 
Figure 5.8: The structures of increasing sterically crowded quinones investigated for 
host:guest properties within 175·4BArF. 
Table 5.4: Calculated binding constants for a range of quinone guests. 
Guest Name Host Ka (M
-1
) ΔG (kJmol-1) 
G
29
























Pentacenedione was found to bind with a Ka = 7.98 x 10
8
 under the previously deduced ideal 
conditions of 175·4BArF in CD2Cl2. This is one of the highest binding constants reported for 
any metallosupramolecular species to date. The high binding strength allowed the growth of 
X-ray quality crystals of G
32⊂175·4BArF from a solution of 175·4OTf with 2 equivalents of 
pentacenedione in CH3CN by vapour diffusion with 
i
Pr2O (Figure 5.9).  
 
Figure 5.9: Crystal structure of 175·BArF containing bound G
32
. Atoms are coloured 
hydrogen (white), carbon (green), nitrogen (blue), oxygen (red) and iridium (pink). External 
hydrogens, solvent molecules and counter anions are omitted for clarity. 
Each of the carbonyl groups is located in one of the tetradentate hydrogen bonding pockets 
created by the ortho-pyridyl hydrogens. The average H···O hydrogen bond distance is 2.55 
Å and the average bond angles are 155.6° and 122.9° for C-H···O and H···O=C respectively. 
The crystal structure also shows a bend in the pyridyl ligands towards the pentacenedione 
which suggests a series of π-π or CH-π interactions that may contribute to the higher binding 
constants observed in solution (Figure 5.10). Although the observed ligand curvature was not 
present in the crystal structure originally reported by Hooley et al.,
26
 the differences could 







          
Figure 5.10: Comparison of ligand geometry between 175·4OTf with and without bound G
32
. 





 also gave rise to peaks associated with each of the host:guest complex. This 
evidence for association in the gas phase, a phenomenon not observed for any of the weaker 
binding guests, also highlights the strength of the host:guest interactions. Dissociation of the 
host:guest complex was achieved though collision induced dissociation to form increasing 
levels of the empty cage followed by complete disassembly of the cage structure at higher 
energies. 
Whilst the addition of slow binding symmetrical quinones reduces the cage symmetry from 
D4h to D2h, the inclusion of asymmetric quinones leads to almost complete desymmetrisation 
of the cage proton peaks. Addition of 1 equivalent of 2-aminoanthroquinone (G
33
) alters the 
system from a D4h to a Cs point group and gives rise to a more complex 
1
H NMR spectrum. 
1
H DOSY NMR confirmed that all of the peaks belong to a single species. The splitting 
patterns are most easily observed for the hydrogen atoms within the internal cavity as these 
peaks are most affected by the inclusion of guest compounds. Figure 5.11 shows a 
comparison between the 
1




, both bound within 175·4BArF. 
The ortho-pyridyl peak at ~9.6 ppm shows a distinct four-fold splitting due to the Cs 
symmetry i.e. separate environments are observed for top, bottom, front and back. However, 
the peak corresponding to the internal benzene peak at ~6.1 ppm is only split into two 
separate signals since they lie along the central plane and thus have no top/bottom. 
Interestingly, encapsulation within 175·BArF also highlighted the presence of G
31
 as an 
impurity present in the commercial sample of G
33
. A binding constant could not be obtained 
G












 due to insufficient quality data and the complexity of the 
1
H NMR spectra but 









Figure 5.11: Comparison of 
1





within 175·4BArF. Four-fold splitting (blue) and two-fold splitting (red) are shown due to 
desymmetrisation from a D4h to a Cs point group. G
31
 was found to be present as a minor 










5.5.2 Alternative binding groups 
As demonstrated above, quinones possess the ideal geometry and polarity to fit within the 
cavity of 175·4X, however, other functional groups can also bind within the cavity due to 
similar hydrogen bond acceptor functional groups. Aldehydes, ketones, amides and nitro 
groups have all been shown to bind within the cage cavity (Figure 5.12 and Table 5.5).  
 
Figure 5.12: The structures of compounds containing different hydrogen bond acceptor 





were found to have very similar binding constants for 175·4BArF in CD2Cl2. 
This suggests that the binding contribution of aldehydes within the hydrogen bond donor site 
is similar to that observed for nitro groups, an observation supported by the similar βs 
reported in literature (5.8 and 5.3 for acetone and nitromethane respectively).
30
 The binding 
constant for glycine anhydride in 175·4BArF in CD2Cl2 could not be determined due to the 
binding lying within the transition from fast to slow exchange on the 
1
H NMR timescale. A 




 was determined in CD3CN, a value higher than that 
recorded for naphthoquinone under the same conditions and therefore, based on the results 
obtained previously, much higher than the predicted binding constant of benzoquinone in 
CD3CN. This highlights the propensity of amide groups to function as strong hydrogen bond 
acceptors as also shown by Hunter et al. with a covalent macrocyclic system.
31,32
 The 
macrocyclic system was also shown to bind G
37
 in a similar manner to G
29
 but in comparison, 
G
29







Table 5.5: Measured binding constants within 175·4BArF for a range of compounds 
containing different hydrogen bond acceptor groups. 
Guest Name Host Ka (M
-1
) ΔG (kJmol-1) 
G
34





















a) determined in CD3CN due to pseudo fast/slow exchange in CD2Cl2 b) association constant 
too weak to measure. 
This dramatic reduction in binding compared with benzoquinone can be explained by the 
change in compound geometry. While benzoquinone, as well as all of the other ditopic 
guests discussed, maintain a planar geometry, 1,4-cyclohexadione exhibits a chair 
conformation due to the saturated carbon ring. Firstly, this shortens the oxygen to oxygen 
distance from 5.32 Å to 5.21 Å which increases the C-H···O hydrogen bond distance and 
reduces the strength of the interaction. Additionally, in order to align within the cavity such 
that both carbonyl groups can interact fully with the hydrogen bond donor sites, the angle 
must be either offset or alternatively, the interactions may only occur between two of the 
four hydrogen bond donors in each binding pocket. Either of these outcomes will 
significantly reduce the hydrogen bonding strength and give rise to the weak host:guest 
interaction observed. While the covalent macrocycle described by Hunter et al. may maintain 
a degree of flexibility that can accommodate small changes in the guest geometry,
31,32
 the 
rigid framework provided by the metal-ligand coordination of 175·4BArF, required for 
rational design and rapid synthesis, is highly sensitive to the exact position of binding groups. 








5.6 Summary & Conclusions 
The strength of host:guest interactions plays an integral role in governing the various 
potential applications of metallosupramolecular assemblies. Although many systems have 
been shown to bind both charged and neutral guests, many of these rely on the hydrophobic 
effect. Guest binding in apolar solvents has been comparatively less common as the strong 
coulombic attraction between the metallosupramolecular assembly and the associated 
counter ions results in strong competition for the internal cavity.  
Quinones were found to bind strongly within the interior of 175·4OTf in organic solvents, 
driven by the multiple hydrogen bonding pockets created by complexation of palladium to 
the pyridyl ligands. Further studies with a variety of counter anions (OTf⁻, BF4⁻, PF6⁻, SbF6⁻ 
and BArF⁻) and solvents showed that the binding strength could be increased by a factor 25 
by simple alteration of the conditions towards large non-coordinating anions and apolar 
solvents. In addition, combining the optimised conditions (175·4BArF in CH2Cl2) with a 
strong binding guest, pentacenedione (G
32





, one of the highest reported for metallosupramolecular systems. 
Although quinones possess an ideal geometry for binding within 175·4X, a range of other 
functional groups were also found to interact with the cage cavity including ketones, 
aldehydes, amides and nitro groups. The strong hydrogen bonding pockets present within 
175·4X could potentially be utilised to alter the reactivity of bound guests and potential 
catalytic processes are discussed later in Chapter 6.  
It is hoped that this approach to enhancing guest binding can be applied to a large range of 
other metallosupramolecular systems and charged hosts and potentially aid progress in a 
number of research areas. This simple method for altering guest binding also allows the 
straight forward tuning of reaction conditions when both very weak and/or very strong 







5.7.1 General Information 
Unless stated otherwise, all reagents and solvents were purchased from Alfa Aesar, VWR or 
Sigma Aldrich and used without further purification. Column chromatography was carried 
out using Geduran Si60 (40-63 µm) as the stationary phase and TLC was performed on 
precoated Kieselgel 60 plates (0.20 mm thick, 60F254. Merck, Germany) and observed under 

















prepared according to literature procedures. 1-Nitrohexane was a kind gift from Patrick 
Fuchs (Zeitler Group, Universität Leipzig).   
Molecular modelling of the counter anions was carried out using Spartan ’10 V1.1.0 using an 
LACVP split basis set. A 6-31G* basis set was used for atoms H-Ar and a LANL2DZ 
effective core basis set was used for heavier atoms. Molecular modelling of the guests was 
carried out using a standard 6-31G* basis set. 
For details regarding the NMR, MS, Ultraviolet-visible light spectroscopy and emission 






5.7.2 Synthetic Procedures 
 
Figure 13: Structure of 175.4X showing NMR assignments. 
175.4OTf and 175.4BF4 were prepared using a modified literature procedure.
26
  
Synthesis of 175·4X 
A solution of Pd(CH3CN)4·2X (0.179 mmol) in CH3CN (0.5 mL) was charged slowly to a 
solution of 1,3-bis(3-ethynylpyridyl)benzene (0.179 mmol) in CH3CN (5 mL) whilst stirring. 
The solution was stirred overnight at room temperature. A solid was isolated by 
concentration of the solution under vacuum followed by precipitation with Et2O. The solid 
was filtered, washed with Et2O and dried under vacuum to yield the product as a white or off 
white powder. 
175·4OTf  Yield = 58.2 mg, 84% 
175·4BF4  Yield = 65.6 mg, 87% 
Anion-metathesis 
For most counter anions, the reduced solubility of the resultant cage in polar solvents 
allowed removal of any residual OTf by washing with MeOH (Method A) but an aqueous 









A solution of KPF6 or NaSbF6 (100 eq) in CH3CN (1 mL) was charged to a solution of 
175.4OTf in CH3CN (1 mL). After thoroughly mixing, the solution was concentrated and the 
product precipitated with MeOH (5 mL). The solid was filtered, washed with MeOH and 
dried under vacuum. 
175.4PF6  Yield = 4.1 mg, 38% 
175.4SbF6  Yield = 11.8 mg, 77% 
Method B: 
175.4OTf (52.0 mg, 0.027 mmol) and NaBArF (95.5 mg, 4 eq.) were dissolved in CH3CN (5 
mL) and MeOH (5 mL). After thoroughly mixing, the solution was diluted with water (3 
mL). The resultant solid was filtered, washed with water and dried under vacuum. The solid 
was re-dissolved in DCM (10 mL) and NaBArF (95.5 mg, 4 eq.) and water were charged. 
The organic phase extracted and the solvent was removed under vacuum. The residue was 
re-dissolved in CH3CN (1 mL) and MeOH (1 mL). The product was precipitated with water, 
filtered, washed with 1:1 MeOH/water and dried under vacuum to yield a white or off-white 
solid. 




H NMR (500 MHz, CD3CN) δ 9.47 – 9.42 (m, 8H, Ha), 9.12 – 9.05 (m, 8H, Hb), 8.12 – 8.06 
(m, 8H, Hd), 7.96 (t, J = 1.7 Hz, 4H, He), 7.70 – 7.65 (m, 8H, Hc), 7.65 – 7.59 (m, 8H, Hf), 
7.51 (t, J = 7.7 Hz, 4H, Hg). 
13
C NMR (126 MHz, CD3CN) δ 153.98, 151.05, 143.86, 135.09, 
134.25, 130.72, 128.33, 124.70, 123.17, 94.94, 85.30. *
13
C OTf peak not observed due to 
strong coupling and low concentration. 
19
F NMR (471 MHz, CD3CN) δ -78.47. 
1
H DOSY 









H NMR (500 MHz, CD3CN) δ 9.40 – 9.38 (m, 8H, Ha), 9.08 – 9.04 (m, 8H, Hb), 8.12 – 8.07 
(m, 8H, Hd), 7.93 (td, J = 1.7, 0.6 Hz, 4H, He), 7.70 – 7.66 (m, 8H, Hc), 7.66 – 7.60 (m, 8H, 
Hf), 7.51 (td, J = 8.1, 0.7 Hz, 4H, Hg). 
13
C NMR (126 MHz, CD3CN) δ 153.96, 150.99, 
143.87, 135.13, 134.21, 130.76, 128.36, 124.68, 123.16, 94.93, 85.39. 
19
F NMR (471 MHz, 






H DOSY NMR (500 MHz, CD3CN) –logD = 9.14 
hydrodynamic radius = 8.1 Å. 
175·4PF6 
1
H NMR (500 MHz, CD3CN) δ 9.29 – 9.23 (m, 8H, Ha), 9.05 – 8.99 (m, 8H, Hb), 8.14 – 8.08 
(m, 8H, Hd), 7.92 (t, J = 1.7 Hz, 4H, He), 7.70 – 7.67 (m, 8H, Hc), 7.67 – 7.62 (m, 8H, Hf), 
7.52 (t, J = 7.8 Hz, 4H, Hg). 
13
C NMR (126 MHz, CD3CN) δ 153.83, 151.01, 144.00, 135.15, 
134.21, 130.82, 128.51, 124.71, 123.12, 94.99, 85.28. 
19
F NMR (471 MHz, CD3CN) δ -72.79 
(d, J = 706.6 Hz). 
1




H NMR (400 MHz, CD3CN) δ 9.25 – 9.21 (m, 8H, Ha), 9.04 – 8.99 (m, 8H, Hb), 8.14 – 8.08 
(m, 8H, Hd), 7.94 (t, J = 1.3 Hz, 8H, He), 7.70 – 7.66 (m, 8H, Hc), 7.66 – 7.62 (m, 8H, Hf), 
7.52 (t, J = 7.7 Hz, 4H, Hg). 
13
C NMR (126 MHz, CD3CN) δ 153.80, 150.98, 144.03, 135.36, 
134.14, 130.80, 128.54, 124.77, 123.11, 95.06, 85.23. 
1
H DOSY NMR (500 MHz, CD3CN) –
logD = 9.15 hydrodynamic radius = 8.3 Å. 
175·4BArF 
1
H NMR (400 MHz, CD3CN) δ 9.26 – 9.21 (m, 8H, Ha), 9.04 – 8.99 (m, 8H, Hb), 8.12 – 8.07 
(m, 8H, Hd), 7.91 (t, J = 1.3 Hz, 4H, He), 7.72 – 7.65 (m, 56H, Hc, HBArF), 7.65 – 7.61 (m, 8H, 
Hf), 7.55 – 7.46 (m, 4H, Hg). 
13
C NMR (126 MHz, CD3CN) δ 163.23 – 161.77 (m), 153.86, 
151.00, 144.02, 135.89 – 135.38 (m), 135.23, 134.14, 130.83, 129.89 (q, J = 32.0 Hz), 
128.52, 125.43 (q, J = 271.1 Hz), 124.70, 123.09, 118.74 – 118.57 (m), 95.01, 85.22. 
19
F 
NMR (376 MHz, CD3CN) δ -63.26. 
1
H DOSY NMR (500 MHz, CD3CN) –logD = 9.18 









H NMR (500 MHz, CD3CN, 300 K) of 175
4+




C NMR (126 MHz, CD3CN, 300 K) of 175
4+









F NMR (471 MHz, CD3CN, 300 K) of 175
4+











Figure 5.17: ESI-MS of 175·4OTf. The peaks found by experiment (black) are shown in 

























Figure 5.18: ESI-MS of 175·4BF4. The peaks found by experiment (black) are shown in 

























Figure 5.19: ESI-MS of 175·4PF6. The peaks found by experiment (black) are shown in 























Figure 5.20: ESI-MS of 175·4SbF6. The peaks found by experiment (black) are shown in 
























Figure 5.21: ESI-MS of 175·4BArF. The peaks found by experiment (black) are shown in 


















5.7.5 Stability of 175·4Ph4B 
 
Figure 5.22: Degradation of 175·4X (green), where X = Ph4B (purple) monitored by 
1
H 
NMR (500 MHz, CD3CN, 300 K). The disassembly of the cage structure is observed to give 
the free ligand (blue) and the cross-coupled biphenyl byproduct (red). 
 
Figure 5.23: Comparison of NaBArF (left) and NaPh4B (right) upon the addition of Pd
2+
. 






5.7.6 1H NMR Titrations 
For each titration, a solution of 175·4X with a guest compound was titrated into a solution of 
175·4X, maintaining a constant concentration of 175·4X throughout. For each observable 
peak shift of 175·4X in the 
1
H NMR spectra, the peak position was plotted against the 
concentration of guest. A global non-linear curve fitting function was then applied to the 
combined plots using the 1:1 binding model given by:
13
  
𝑦 = 𝑦0 + ∆𝑦
(
 






𝑦 = 𝑦0 + ∆𝑦 ∗ 𝑧 
𝑦0 = 𝑝𝑒𝑎𝑘 𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛 𝑤𝑖𝑡ℎ 𝑛𝑜 𝑔𝑢𝑒𝑠𝑡 
∆𝑦 = 𝑝𝑒𝑎𝑘 𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛 𝑤𝑖𝑡ℎ 100% 𝑏𝑜𝑢𝑛𝑑 
𝑥 = 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑔𝑢𝑒𝑠𝑡 
 
𝑧 =
−𝑏 ± √(𝑏)2 − 4𝑎𝑐
2𝑎
 
𝑤ℎ𝑒𝑟𝑒 𝑎 =  𝐾𝑎 ∗ 𝑃, 𝑏 = 1 + 𝐾𝑎(𝑃 + 𝑥) 𝑎𝑛𝑑 𝑐 = 𝐾𝑎 










Figure 5.24: Modelled fitting functions for a range of binding constants with a host 
concentration of 1 mM. Note that at Ka > 10
6
, the error in the calculated value becomes too 









Figure 5.25: An example of the fitting function applied to peak shifts for 175·4SbF6 upon 
titration of naphthoquinone in CD3NO2.The guest peaks are highlighted in orange and 
uncoloured peaks were not reported due to either no visible change or difficulties in 






5.7.7 Competition Experiments 
For each titration, a solution of 175·4X with a guest compound and a competitor was titrated 
into a solution of 175·4X and the competitor, maintaining a constant concentration of 
175·4X and competitor whilst varying the concentration of the guest. The concentration of 
the host:guest complex, measured by peak integration, was plotted against the concentration 
of guest. A global non-linear curve fitting function was then applied to the combined plots 





(𝐵(𝑥 + 𝑃) + (𝑅 − 𝑃)) − √(𝐵(𝑥 + 𝑃) + (𝑅 − 𝑃))
2
− 4(𝐵 − 1)𝐵𝑥𝑃
2(𝐵 − 1)
 
𝑦 = 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 ℎ𝑜𝑠𝑡/𝑔𝑢𝑒𝑠𝑡 𝑐𝑜𝑚𝑝𝑙𝑒𝑥  
𝑥 = 𝑡𝑜𝑡𝑎𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑔𝑢𝑒𝑠𝑡 
𝑃 = 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 ℎ𝑜𝑠𝑡 
𝑅 = 𝑡𝑜𝑡𝑎𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑐𝑜𝑚𝑝𝑒𝑡𝑖𝑡𝑜𝑟 













Figure 5.26: Modelled Fitting curves for competition experiments with host and competitor 
concentrations set at 1 mM. For B > 1000, more reliable results may be obtained by using a 
stronger competitor or increasing the concentration of the competitor. Note due to the peak 










5.7.8 Error Determination 
A single example from each of the standard titrations and the competition titrations was 
repeated three times to assess the reliability and accuracy of the calculated binding constants. 
As only three data points were collected due to practical considerations, complex data 
analysis is not possible but the total range across the three titres was used to estimate the 
percentage experimental error associated with each technique. 
Table 5.6: Calculated binding constants for naphthoquinone in 175·4SbF6 over three 
separate titrations.  
Titration Ka (M
-1
) Standard Error Range % Experimental Error 
1 22178 ± 1713 - - 
2 38463 ± 6664 - - 
3 35487 ± 5530 - - 
Average 32043 ± 4340 16285 ± 25 % 
 
Table 5.7: Calculated binding constants for anthraquinone in 175·4BArF over three 
separate competition experiments using benzoquinone as a competitor.  
Titration Ka (M
-1
) Standard Error Range % Experimental Error 
1 3.99 x 10
7 
± 0.27 x 10
7 
- - 
2 4.93 x 10
7
 ± 0.36 x 10
7
 - - 
3 5.75 x 10
7
 ± 0.51 x 10
7
 - - 
Average 4.89 x 10
7
 ± 0.38 x 10
7
 1.76 x 10
7 
± 18 % 
 
Although the errors associated with this experimental technique are large, the results are 
used to compare values on a logarithmic scale. In this case, ± 25 % error remains relatively 
small but never the less, the associated error should be taken into account when comparing 







Figure 5.27: A graphical representation of the binding constants calculated for 







5.7.9 Mass Spectrometry of Host:Guest Complexes 
 
 
Figure 5.28: ESI-MS of 175·4BArF in CH3CN with 2 equivalents of G
31
. The host:guest 
peaks found by experiment (black) are shown in comparison with their modelled isotopic 


















Figure 5.29: ESI-MS of 175·4BArF in CH3CN with 2 equivalents of G
32
. The host:guest 

















Figure 30: Normalised stack plot of MSMS of [G
32⊂175·BArF]3+ isolated from ESI-MS of 
175·4BArF in CH3CN with 2 equivalents of G
32
. Increasing collisional energy (E) results in 
the gradual dissociation of G
32
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The emergent hydrogen bond donor properties of a Pd2L4 system were investigated for 
catalytic activity in a range of organic transformations. The optical and electrochemical 
properties of a range of guest compounds were found to be highly dependent on 
encapsulation within the cage cavity. Initial reaction screening did not result in any 
observable rate enhancements, and Diels-Alder reactions were drastically inhibited due to 
the steric restraints within the enclosed cavity. However, using an alternative method, the 
oxidation potential of the mild oxidant, p-chloranil, was significantly increased upon binding 
within 175·4X such that the oxidation of cinnamyl alcohol occurred through completely 














Molecular encapsulation within a cage species, self-assembled or not, can drastically alter 
the properties of the bound guest. In order to achieve catalysis, these properties must be 
carefully controlled to allow the stabilisation of transition states or reactive intermediates 
whilst showing a lower affinity for the resultant products. Within the field of 
metallosupramolecular catalysis, reaction rate enhancement is often achieved through 
preorganisation of the substrates and a subsequent increase in the effective molarity.
1–6
 
However, this method, particularly when applied to bi-molecular reactions, often leads to 
efficient product inhibition since the final geometry is, by definition, a more appropriate 
guest for the cage cavity. Alternatively, Raymond and co-workers showed how a similar 
preorganisation of a unimolecular reaction, termed “constrictive binding”, can lead to 
efficient catalysis. In this case, the cationic intermediate is highly stabilised by the anionic 
cage cavity and subsequent formation of a neutral product reduces product inhibition and 
allows efficient catalytic turn-over.
7–15
 
In terms of more conventional organocatalysis, hydrogen bond donors have shown great 
promise as non-covalent activating agents for previously unreactive functional groups.
16–19
 
Catalysis is achieved by stabilisation of reactive intermediates and/or increasing the 
susceptibility to nucleophilic attack as a result of electronic manipulation of the target 
substrate. Since activation is achieved through non-covalent interactions at a specific binding 





Scheme 6.1: An example of an enantioselective conjugate addition catalysed by a chiral 








Similar to many hydrogen bond donor organocatalysts, the Pd2L4 cage system developed by 
Hooley and co-workers and discussed extensively in Chapter 5, shows a strong affinity for 
1,4-quinone type guests in organic solvents (Figure 6.1). Other functional groups including 
aldehydes, ketones, amides and nitro groups also showed preferential binding within the 
cage cavity through hydrogen bonding to the ortho-pyridyl positions. Due to the similarities 
with known organocatalysts, 175·4X was investigated as potentially novel hydrogen bond 




Figure 6.1: The structure of the Pd2L4 metallosupramolecular cage chosen utilised as a 







6.3 Modulation of Guest Properties 
The modulation of guest properties can be viewed as a potential forerunner to achieving 
supramolecular catalysis. A range of neutral organic guests were previously explored and 
discussed in detail in Chapter 5. Extended quinone compounds showed slow binding on an 




. Quinones  and their 
derivatives are well know to have interesting redox and photophysical properties. Substituted 
anthraquinones are often brightly coloured and fluoresce strongly under UV light (Figure 
6.2)
21,22
 while halogenated quinones are used as common oxidising, dehydrogenation and 





Figure 6.2: Guest compounds that show modulation of optical properties when encapsulated 
within 175·4X. 
6.3.1 Optical Properties 
Strong binding of 2-aminoanthraquinone within 175·4BArF leads to the desymmetrisation of 
the cage from a D4h to a Cs point group and splitting of the 
1
H NMR signals (see Chapter 5). 
Like many substituted anthraquinone compounds, 2-aminoanthraquinone is both highly 
coloured and emissive (emission λmax = 540 nm) (Figure 6.3). Hydrogen bonding within the 
cavity results in a strong red shift in both the visible absorption band and the emission 
wavelength. 
The significant red-shift observed for both the absorption and emission, 70 and 34 nm 
respectively, is potentially due to stabilisation of the LUMO by hydrogen bond formation 
within the cage cavity. Both computer modelling and literature suggest that the LUMO of 2-
aminoanthraquinone is heavily situated on the oxygen atoms whilst the HOMO is located 
preferentially on the amino functionalised aromatic ring (Figure 6.4).
28
 Stabilisation of the 






oxygen atoms within the cage cavity will therefore lead to a smaller HOMO-LUMO gap and 
consequently lower energy absorption and emission. 
 
 
Figure 6.3: Comparison of absorption and emission maxima for 2-aminoanthraquinone both 
in solution (CH3CN) and after the addition of 1 eq. of 175·4BArF. 
 
Figure 6.4: Computer modelling (DFT, B3LYP, 6-31G*) of the HOMO and LUMO of 2-
aminoanthraquinone. 
Pentacenedione shows strong emission in the solid state or thin film but only very weak 
emission in the solution phase. Encapsulation within 175·4X results in strong emission 







and 6.6). The emission of encapsulated G
32
 also adopts well-structured bands and a small 
stokes-shift consistent with π-π transitions common to many polyaromatic systems. This 
drastic alteration in the photophysical properties of G
32
 is likely due to the cage preventing 
the formation of weakly emissive excimers. Although the solution behaviour of G
32
 has not 
been extensively reported,
29
 strong emission is observed in the solid state (i.e. high 
concentrations) compared with the relatively weak emission from dilute solutions.
30
 For 
comparison, the excimer formation of pyrene is a well-studied and documented phenomenon 
routinely used for studying short or long range interactions in both supramolecular and 
biological chemistry.
31–33
    
 




and iii) 175·4BArF under ambient lighting (left) and irradiation with 365 nm UV-light. 
 








The unusual “turn-on” fluorescence of pentacenedione can also be utilised to probe the 
formation of 175·4X. Since only the combined complex G
32⊂175·4X emits light at 450-500 
nm, the presence of intact cage can be deduced by the addition of G
32
 and monitoring the 
emission under UV-light. The very high binding affinity of G
32
 for 175·4X also aids in the 
nearly quantitative formation of G
32⊂175·4X at equimolar concentrations. 
Vitamin K1 (Figure 6.7), a common biomolecule used in the blood clotting pathway, is also 
based on a quinone backbone and was found to bind within the cage cavity of 175·4BArF 
with a Ka = 2.66 x 10
3
 in CD2Cl2. However, the lack of strong visible-light absorption 
outwith the spectral region of 175·4BArF prevented any applications as a vitamin K1 sensor. 
 
Figure 6.7: The structure of Vitamin K1. 
6.3.2 Electrochemistry 
While the optical properties of luminescent guests are highly sensitive to the cage 
environment, the hydrogen bonding environment within 175·4X may also alter the redox 
potentials of encapsulated molecules. The redox chemistry of quinones has been widely 
studied for over a century and many simple quinones display fully reversible one and two 
electron reduction processes to form the semiquinone and dianion respectively. In aqueous 
media, the dianion is readily protonated to form the corresponding hydroquinone. The 
electrochemical reversibility of quinones makes them ideal candidates for a range of 
different redox processes and derivatives, such as ubiquinone, are widely used in biological 











Figure 6.8: The structure of ubiquinone, 180, used in biological systems as an electron 
transporter. 
Previous literature has shown how the reduction potentials of quinones change in the 
presence of hydrogen bond donors and Brønsted acids. In general, a shift towards more 
positive potentials is observed upon addition of hydrogen bond donors due to stabilisation of 
the reduced semiquinone and dianion. A gradual change is observed due to the rapid 
association/dissociation of the interacting species. In contrast, protonation or deprotonation 
of the reduced compounds is often much slower and is therefore often responsible for 
irreversible processes at standard scan rates. 
 
Figure 6.9: A range of 1,4-quinone guests explored for changes in redox potentials. 






 but no 
protonation should occur due to the aprotic solvent and dry conditions. As expected, addition 






 resulted in a general trend towards more positive reduction 
potentials indicating the propensity of 175·4X to activate quinones towards reductive 
reaction pathways (Figure 6.10). Significant changes were also observed in the redox 
potentials of pentacenedione (G
32
) upon the addition of 175·4X but the low solubility made 
quantification difficult. Due to the complexity of the cyclic voltammetry measurements, the 







Figure 6.10: Cyclic voltammetry (0.5 mM in CH3CN, 0.1 M TBA·PF6, 200 mV/s) of quinone 
guests with and without a stoichiometric loading of 175·4OTf.  
 
Figure 6.11: Differential pulse voltammetry (0.5 mM in CH3CN, 0.1 M TBA·PF6) of quinone 












 in solution and encapsulated in 175·4X. 
Compound E1/2 E1/2 (with 1 eq. 175·4X) 
G
29
 -0.998, -0.318 -0.306, -0.133 
G
28
 -1.113, -0.495 -0.475, -0.318, -0.133 
G
31
 -1.282, -0.739 -0.739, -0.627, -0.335 
All measurements made in CD3CN at room temperature. 
In agreement with literature measurements with strong hydrogen bond donors, the second 




 with 1 equivalent of 175·4OTf and the first 
reduction peak became irreversible. However, the original reduction peaks for G
31
 remained 
similar with 1 equivalent of 175·4OTf but new peaks were observed at more positive 
potentials. As such, G
28
 shows the most dramatic change upon addition of 175·4OTf despite 
having the lowest association constant. 
This can be attributed to the host:guest dynamics and the rate of association/dissociation of 
the encapsulated quinones. For G
28
, the kinetic barrier is low and rapid guest exchange 
means that at slow scan rates, the signals are affected by the strong association of the 
reduced compounds with the cage internal cavity. When the scan rate is increased, additional 
reversible peaks become visible (Figure 6.12). In contrast, the stronger binder, G
31
, displays 
a consistent peak pattern upon increasing the scan rate, consistent with the higher kinetic 
barrier confirmed by slow binding on a 
1
H NMR timescale (Figure 6.13).  
It should be noted that although the quinone compounds display very strong binding 
constants in previous 
1
H NMR experiments, which would suggest almost complete 
encapsulation with 1 equivalent of 175·4OTf, the high concentration of PF6‾ anions present 
during the electrochemical measurements would drastically reduce the percentage of quinone 
bound as a result of competitive binding. 
Although the electrochemistry of the host:guest complexes is clearly very complicated, the 
overall effect of binding to 175·4OTf is to shift the reduction potentials to a more positive 
position. Thus, the addition of 175·4OTf will make reduction of quinone compounds much 







Figure 6.12: Cyclic voltammetry (0.5 mM in CH3CN, 0.1 M TBA·PF6) of a 1:1 mixture of G
28
 
and 175·4OTf with variable scan rates. 
 
Figure 6.13: Cyclic voltammetry (0.5 mM in CH3CN, 0.1 M TBA·PF6) of a 1:1 mixture of G
5
 






6.4 Stabilisation of Reactive Species 
6.4.1 Diels-Alder 
Fujita and co-workers pioneered the use of metallosupramolecular container compounds as 
molecular flasks for a range of 2+2 and 2+4 cycloadditions. The stoichiometric rate 
enhancement observed for a range of Diels-Alder reactions is ascribed to the dramatic 
increase in effective concentration brought about by co-encapsulation of two compatible 
substrates within a single cavity. However, strong product inhibition prevented any catalytic 
turn over. 
Solution phase Diels-Alder reactions have been studied extensively due to their widely 
applicable use in organic synthesis and the production of important medicinal and industrial 
compounds. Lewis acid catalysis has been developed as an efficient method for improving 
both the reaction rate and selectivity of Diels-Alder reactions.
37–44
 In a similar manner, 
hydrogen bond donor catalysts have also shown great utility in promoting and controlling the 
outcome of Diels-Alder reactions.
45–49
 Thus, the hydrogen bonding environment of 175·4OTf 
was considered as a catalyst for promoting the Diels-Alder reaction between naphthoquinone 
and selected dienes. 
Reaction of naphthoquinone with cyclopentadiene readily forms the Diels-Alder adduct at 
room temperature in CD3CN (Scheme 6.3). However, repeating the reaction in the presence 
of 175·4OTf led to a reduction in the reaction rate rather than the intended increase. 
Interestingly, the initial reaction rate was only slightly affected but as the reaction proceeded, 
the effect became more pronounced until approximately one equivalent of naphthoquinone 
remained, at which point the reaction had all but ceased (Figure 6.14). Initially, with only a 
catalytic quantity of cage present, the reaction proceeded as normal for the 95% of 
naphthoquinone free in solution. As naphthoquinone was used up, the proportion of 
encapsulated naphthoquinone increased until the reaction rate slowed to the point at which 
the dimerisation of cyclopentadiene occurred at a competitive rate and prevented the reaction 
from going to completion. 
This behaviour was attributed to efficient protection of naphthoquinone from the bulk media 
by 175·4OTf, presumably by steric confinement, despite the potential activation of the 
substrate through hydrogen bonding. In order for a Diels-Alder process to proceed, there 






cavity prevent the formation of this intermediate, any reaction will be prevented. A similar 





Scheme 6.3: The investigated Diels-Alder reaction between naphthoquinone (G
29
) and 
cyclopentadiene (181).  
 






6.5 Supramolecular Catalysis 
175·4X was screened for catalytic activity in a number of different chemical reactions, all 
based around activation of quinone substrates through hydrogen bonding within the internal 
cavity. 
6.5.1 Nucleophilic Substitution 
Nucleophilic substitution of naphthoquinone and related halogenated analogues is well 
known process for the synthesis of highly coloured dye compounds. Hydrogen bond 
donation to the carbonyl groups was predicted to enhance the electron withdrawing effect 
and make the alkene more susceptible to nucleophilic attack. The resultant enolate type 
intermediate would also be stabilised by the positive hydrogen bonding pockets (Scheme 
6.4). The reaction of naphthoquinone or 2,3-dichloronaphthoquinone with a range of primary 
amines proceeded readily in CH2Cl2 to produce highly coloured products. However, GC 
analysis of the reaction mixtures showed no noticeable difference in the reaction rate upon 
the addition of 175·4BArF. As with the Diels-Alder reaction described above, the absence of 
any acceleration in the reaction rate could be explained by sterics. 
 
Scheme 6.4: Nucleophilic substitution of naphthoquinone analogues with amines. 
6.5.2 Nitroaldol 
In a similar manner to the nucleophilic substitution, encapsulation within the hydrogen 






compounds in a range of nitroaldol reactions. Reactions were attempted with both 
naphthoquinone and G
38
 in nitromethane (Scheme 6.5). G
38
 was intended to extend the 
reaction site further out of the cage interior to help reduce any steric constraints preventing 
reactions taking place. In all cases, no obvious signs of the intended reaction were observed, 
even when nitromethane was used as the solvent, and the addition of non-nucleophilic bases 
led to either partial or complete degradation of 175·4BArF (Table 6.2). 
 
Scheme 6.5: Nitroaldol reaction between known guests and nitromethane. 
Table 6.2: Nitroaldol reactions with nitromethane. 
Compoud Base Solvent Observation 
G
29
 none neat No reaction 
G
29
 2,6-lutidine neat Yellow to dark brown, partial cage dissociation 
G
29
 DBU neat Yellow to dark brown, complete cage dissociation 
G
38
 none neat No reaction 
G
38
 2,6-lutidine neat Yellow to dark brown, partial cage dissociation 
G
38
 DBU neat Yellow to dark brown, complete cage dissociation 
 
Current literature utilises hydrogen bond donors (HBD) as catalysts for activation of 
nitroalkenes.
20,51–53
 Hydrogen bonds formed between the catalyst and the nitro group further 
increase the electron withdrawing effect of the nitro group and make the alkene more 
susceptible to nucleophilic attack. Standard reagents such as nitrostyrene were thought to be 
too sterically encumbered to undergo reaction within the cage cavity; however, the flexible 
alkyl chain of nitrohexene was thought to allow encapsulation. Small 
1
H NMR shifts 
consistent with weak guest encapsulation were observed upon the addition of 1-nitrohexene 






Nitroethane was chosen as a potential nucleophile due to the small size and unreactivity 
towards the cage (Scheme 6.6). The use of Et3N as a base gave the largest change in both the 
crude 
1
H NMR and GC traces. However, the crude reaction mixture was incredibly complex 
suggesting a large range of reaction and degradation pathways and no single species could be 
isolated or identified (Table 6.3).  
 
Scheme 6.6: Nitroaldol reaction between 1-nitrohexene and nitroethane. 
Table 6.3: Conditions used for nitroaldol reactions between 1-nitrohexene and nitroethane. 
Compound Base Observation 
G
40 none No reaction 
G
40
 DBU Small peaks in NMR, complete cage dissociation 
G
40
 Na2CO3 No reaction 
G
40
 Et3N New peaks in NMR, partial cage dissociation 
 
6.5.3 2-Hydroxynaphthoquinone (Lawsone) 
Lawsone was examined as a potential substrate for a number of reactions; however, the 
addition of a base, such as DBU, Et3N or Na2CO3, to Lawsone in the presence of 175·4BArF 
resulted in complete degradation of the assembled structure. Slight shifts were also observed 
for the 
1
H NMR spectrum of Lawsone. A possible explanation for the NMR shifts and rapid 
cage degradation is the deprotonation of Lawsone to form a bidentate ligand which rapidly 
displaces the pyridine ligands of the cage to form complex 188 (Scheme 6.7). 
 







6.5.4 Baeyer-Villiger Oxidation 
The Baeyer-Villiger oxidation was deemed an appropriate reaction for 175·4BArF catalysis 
as the hydrogen bonding environment could increase the susceptibility of the carbonyl to 
nucleophilic attack from the peroxy acid whilst the resultant rearrangement would produce a 
more weakly bound ester, preventing strong product inhibition. Sodium perborate was 
chosen as a mild peroxide source to avoid the need for strong oxidants that could degrade 
175·4BArF. Benzoic, acetic and trifluoroacetic acid were used as additives to generate the 
required peroxy acid in situ (Scheme 6.8). However, no reaction was observed by TLC for 
any of the reaction conditions tested.  
 
Scheme 6.8: The proposed Baeyer-Villiger oxidation reaction of naphthoquinone. 
6.5.5 Imine Formation 
Hydrogen bond donation could also potentially stabilise the initial intermediate formed from 
nucleophilic attack of a primary amine on an aldehyde in a method analogous to the more 
general acid catalysed formation of imines. Initial NMR studies showed a weak interaction 
between benzaldehyde and the cage internal cavity indicating the propensity of the system to 
hydrogen bond to substrates containing only a single aldehyde group. 
Upon addition of n-butyl amine, no reaction was observed by TLC, with or without the 
presence of 175·4OTf (Scheme 6.9). The addition of molecular sieves or Mg2SO4 to aid the 
removal of water did not improve the result. It should be noted that previous studies with 
palladium based cages have shown they are absorbed irreversibly onto the surface of the 
molecular sieves.   
 






In all of the attempted reactions described above, encapsulation of substrates within the cage 
cavity either directly hinders the reaction rate or produces no detectable rate enhancement 
despite the likely hydrogen bond activation. As such, steric confinement within the cavity 
appears to prevent any reactivity. In order avoid this, encapsulation of the catalyst, rather 














6.6 Catalyst Activation 
6.6.1 Enhanced Oxidation with p-Chloranil 
Hydrogen bond donors have been shown to decrease the reduction potential of quinones 
through stabilisation of the hydroquinone form.
54–5657
 As shown previously, electrochemical 
analysis of benzoquinone in the presence of 175·4OTf altered the first reduction potential 
from -0.318 V to -0.133 V (vs Ag/AgCl). Another quinone, p-chloranil, is commonly used as 
an oxidant in organic synthesis but many processes are slow due to the relatively mild 
reduction potential (0.010 V vs SCE).
58
 Switching to the to more highly oxidising derivative 
DDQ, is also unfavourable due to the high cost and potential release of highly toxic cyanide. 
Encapsulation of p-chloranil within the hydrogen bonding cavity of 175·4BArF could 
therefore increase the reduction potential and thus increase the rate of oxidation. 
 
Figure 6.15: Differential Pulse Voltammetry of p-chloranil with increasing concentrations of 
175·4OTf. 







Addition of 175·4OTf to a solution of p-chloranil resulted in the appearance of new peaks at 
more positive potentials (Figure 6.15). With excess 175·4OTf, and therefore near complete 






situated at significantly more oxidising potentials, 0.315 V and -0.176 V vs Ag
+
/AgCl 
respectively.  This increase in the reduction potential of p-chloranil by 120 mV suggests that 
encapsulation within 175·4X could significantly increase the compound’s oxidising ability 
and synthetic utility. 
6.6.2 Oligomerisation of Cinnamyl Alcohol 
In order to assess the benefits of encapsulating p-chloranil within 175·4X, the oxidation of 
cinnamyl alcohol to cinnamyl aldehyde was chosen as a model reaction (Scheme 6.10). 
Initial experiments, monitored by GC, showed a small rate enhancement (1.5x) in the rate of 
consumption of 192 upon addition 175·4OTf in CH3CN at reflux. Using a combination of 
175·4BArF in CH2Cl2 at room temperature to maximise binding gave a rate of enhancement 
of approximately 10 fold (Figure 6.16). Control experiments with pentacenedione as 
competitive binder proceeded at the background rate indicating that the internal cavity of the 
cage was essential for the rate enhancement rather than just the presence of the cage, free 
ligand or palladium ions.  
 








Figure 6.16: Percentage conversion of cinnamyl alcohol as measured by GC peak 
integration.  
However, the initial rate studies described above were carried out using GC to directly 
compare the product and reactant peak integrals. In order to confirm these observations, the 
same reactions were then repeated with a standard to quantify the conversion correctly and 
check that no by-products were produced. 
Using pentadecane as an internal standard, the control reactions were shown to very slowly 
oxidise the cinnamyl alcohol as expected. However, the cage-catalysed reaction was shown 
to produce another product not visible by GC and the apparent increase in oxidation rate 
measured previously was due solely to a reduction in the reactant peak. The unobserved 
product was presumably removed by the silica plug required prior to running a GC sample.  
1
H NMR studies of the reaction process showed the rapid consumption of cinnamyl alcohol 
resulting in the loss of the alkene signals and formation of a broadened series of aromatic 








Figure 6.17: Partial 
1
H NMR (500 MHz, CH2Cl2, 300 K) of cinnamyl alcohol 
oligomerisation in the presence of p-chloranil/175·4BArF showing the rapid disappearance 
of the alkene peaks (blue) and corresponding broadening of the aromatic peaks (red). 
Phenolic derivatives of cinnamyl alcohol are well known to undergo dehydrogenative 
polymerisation to form lignins.
59–61
 This complex biological process normally involves the 
use of peroxidase enzymes and/or hydrogen peroxide. Despite the lack of a phenolic moiety 
in the cinnamyl alcohol studied, a similar mechanism for the polymerisation of cinnamyl 
alcohol in the presence of chloranil/175·BArF was proposed based on the formation of an 
oxidised radical cation intermediate. As with lignins, the linkages are always formed 
between the β position and a variety of nucleophilic sites. Due to the lack of a phenolic site, 
the reaction is assumed to progress via coupling to the alcohol or alkene groups. However, 
further studies are required to elucidate the exact nature of this process and confirm the 
identity of the products formed but given the complexity of lignin type polymers and the 
extensive research to date, this may require an in-depth and time intensive investigation. 
Interestingly, the same process can be replicated with alternative quinone oxidants (Figure 
6.18). Reaction monitoring by GC showed that the trend in reagent conversion matched the 






dichlorobenzoquinone and 2,5-dichlorobenzoquinone are identical in solution, 2,5-
dichlorobenzoquinone gave a greater product yield. This was explained by the difference in 
the reduction potentials in the presence of 175·4OTf, presumably due to a difference in the 
relative association constants arising from a different molecular shape. However, it should be 
noted that the electrochemical conditions could not be matched to exact conditions used for 
the reaction due to the need to use BArF counter anions to enable maximum guest occupancy. 
 
Figure 6.18: Alternative quinones used as oxidants for the polymerisation of cinnamyl 
alcohol. 
Table 6.4: Redox potentials of G
29




 both in solution and encapsulated 
within 175·4X. 
Compound Name E1/2 (V)
a
 











 benzoquinone -0.318 -0.133 6.2 
G
43
 2-chlorobenzoquinone -0.142 0.039 11.7 
G
44
 2,6-dichlorobenzoquinone -0.001 0.180 20.3 
G
45
 2,5-dichlorobenzoquinone -0.001 0.190 26.7 
G
46
 p-chloranil 0.195 0.315 99.7 
a) all measurements made in TBA·PF6 0.1 M in CH3CN versus Ag
+
/AgCl b) total conversion 
after 24 h by GC using pentadecane as an internal standard 
6.6.3 Friedel-Crafts Type Reactions 
Initial attempts to quantify the oxidative polymerisation of cinnamyl alcohol were made 
using mesitylene as the GC standard but this resulted in the complete alteration of the 
reaction pathway. Control experiments still showed that both the p-chloranil and the cage 
cavity were required for the reaction to occur but in this case, mesitylene was consumed 
during the reaction process and multiple new peaks were identified by GC. The two main 
products were isolated by column chromatography and analysed by 
1
H NMR spectroscopy. 






mesitylene (Scheme 6.11). Both the mono- (major product) and di- (minor product) coupled 
species were identified. The isolated products indicated a Friedel-Crafts type coupling 
between mesitylene and cinnamyl alcohol with the alcohol functioning as a leaving group. 
The up-field position of the methylene bridge indicated that the oxygen is not present in the 
structure and the characteristic alkene coupling is still observed. 
 
Scheme 6.11: Proposed reaction between cinnamyl alcohol and mesitylene in the presence of 
both chloranil and the cage catalyst. 
No reaction was observed when cinnamyl alcohol was replaced with a range of different 
alcohols, including the saturated derivative 3-phenylpropan-1-ol (197c) (Scheme 6.12). This 
confirmed that the reaction did not take place via nucleophilic attack of the directly oxidised 
mesitylene. Therefore, both the previously described oligomerisation and this Friedel-Crafts 
process proceed through the initial oxidation of cinnamyl alcohol. As such, the electron-rich 
mesitylene acts as a trapping agent and prevents the cinnamyl alcohol reacting with itself. 
 
Scheme 6.12: Reactivity of mesitylene towards alternative O-nucleophiles. 
Based on this hypothesis, the reaction was repeated with both electron-poor and electron-rich 
aromatics. As expected, replacing mesitylene with benzene did not give any observable 






previously described when mesitylene was absent. Presumably, the cinnamyl alcohol 
functions as a better reaction partner than the electron poor benzene. 
Surprisingly though, when the process was repeated with the electron rich anisole, the cage 
catalyst was completely degraded and again, no Friedel-Crafts products were observed. This 
result can be explained by direct oxidation of the electron rich anisole by the activated p-
chloranil. This prevents oxidation of the cinnamyl alcohol and results in additional, as of yet, 







6.7 Summary & Conclusions 
Encapsulation within the multiple hydrogen bond donor cavity of 175·4X was shown to 
modulate the properties of a number of guest compounds. The absorption and emission of 
coloured quinone derivatives were significantly red-shifted upon binding. Furthermore, 
pentacenedione exhibited a 16 fold enhancement in emission intensity and a significant blue 
shift in the presence of 175·4X, attributed to isolation of individual pentacendione molecules 
from the bulk phase and removal of the excimer formation pathway.  
The reduction potentials of quinones were all shown to be highly dependent on the presence 
of 175·4X and significant shifts to more positive potentials were observed. As a result of 
these observations, 1·4X was screened as a potential hydrogen bond donor catalyst in a range 
of organic transformations but with no obvious rate increase detected. Indeed, 175·4X was 
found to efficiently protect naphthoquinone from undergoing a Diels-Alder reaction with 
cyclopentadiene despite the hydrogen bond activation, presumably due to steric constraints 
preventing the necessary molecular overlap. In an alternative method, the oxidation power of 
p-chloranil was increased upon encapsulation in 175·4X, such that the oxidation of cinnamyl 
alcohol proceeded via a completely different reaction pathway resulting in oligomerisation. 
This pathway could be further altered by the addition of mesitylene to give the Friedel-Crafts 
adduct. As such, a self-assembled system, with emergent properties not present in the 
constituent parts, was able to drastically alter reaction pathways through hydrogen bond 








6.8.1 General Information 
Unless stated otherwise, all reagents and solvents were purchased from Alfa Aesar, VWR or 
Sigma Aldrich and used without further purification. Column chromatography was carried 
out using Geduran Si60 (40-63 µm) as the stationary phase and TLC was performed on 
precoated Kieselgel 60 plates (0.20 mm thick, 60F254. Merck, Germany) and observed under 

















prepared according to literature procedures. 1-Nitrohexane was a kind gift from Patrick 
Fuchs (Zeitler Group, Universität Leipzig).   
For details regarding the NMR, MS, Ultraviolet-visible light spectroscopy and emission 






6.8.2 Absorption of 2-aminoanthraquinone 
 
Figure 6.19: Absorption of 2-aminoanthraquinone (CH2Cl2, 100 µM, 300 K) with and 
without the presence of 175·4BArF. 
6.8.3 Emission of 2-aminoanthraquinone 
 
Figure 6.20: Normalised emission (CH2Cl2, 100 µM, 300 K) of 2 -aminoanthraquinone with 






6.8.4 Absorption & Emission of Pentacenedione Host:Guest 
Complex 
 
Figure 6.21: Normalised absorption and emission (CH2Cl2, 100 µM, 300 K) of a 1:1 mixture 
of pentacenedione and 175·4BArF. 
 
Figure 6.22: Emission spectra (CH2Cl2, 100 µM, 300 K) of pentacenedione with and without 






Table 6.5: Comparison of pentacendione emission free and encapsulated within 175·4BArF. 
Compound Excitation λmax Area Relative Quantum Yield 
G
32









6.8.5 Vitamin K1 Sensing 
 
Figure 6.23: Ultraviolet-visible light spectroscopy (CH2Cl2, 100 µM, 300 K) of vitamin K1 






6.8.6 Electrochemistry of 1,4-quinones 
 
Figure 6.24: Differential Pulse Voltammetry of G
29
 before (black) and after the addition of 
175·4OTf (blue). 
 
Figure 6.25: Differential Pulse Voltammetry of G
28








Figure 6.26: Differential Pulse Voltammetry of G
31
 before (black) and after the addition of 
175·4OTf (blue). 
6.8.7 Naphthoquinone Diels-Alder 
Naphthoquinone (1.58 mg, 0.010 mmol) and freshly distilled cyclopentadiene (0.66 mg, 
0.010 mmol) were dissolved in a solution of 175·4OTf in CD3CN (0.5 mL, 1 mM). The 
solution was left at room temperature and the reaction was monitored by timed 
1
H NMR 
experiments (500 MHz, CD3CN, 300 K). A control reaction was repeated without 175·4OTf 











H NMR of 175.4OTf (green) before (bottom) and after (top) the addition of 1-




H NMR of 175.4OTf (green) before (bottom) and after (top) the addition of 






6.8.9 Oligomerisation of Cinnamyl Alcohol 
Cinnamyl alcohol (0.81 mg, 6.0 µmol) was charged to a mixture of p-chloranil (1.48 mg, 6.0 
µmol) and 175·4BArF (2.87 mg, 10 mol%) in CD2Cl2 (0.6 mL). The reaction was kept at 
room temperature and monitored by 
1
H NMR.  
6.8.10 Friedel-Crafts Type Reactions 
The following general method was used for all Friedel-Crafts reactions. An aromatic 
compound (6.0 µmol) was charged to a mixture of an alcohol (6.0 µmol), p-chloranil (1.48 
mg, 6.0 µmol) and 175·4BArF (2.87 mg, 10 mol%) in CD2Cl2 (0.6 mL). The reaction was 
kept at room temperature and monitored by 
1
H NMR.  
 
Scheme 6.13: A Friedel-Crafts type reaction between cinnamyl alcohol and mesitylene using 







Figure 6.29: Partial 
1
H NMR (500 MHz, CD2Cl2, 300 K) of cinnamyl alcohol/mesitylene 
reaction. The mesitylene aromatic singlet (red) functions as a useful indicator for the 
















H NMR (500 MHz, CDCl3) δ 7.36 – 7.32 (m, 2H, Hc), 7.32 – 7.27 (m, 2H, Hb), 7.23 – 7.18 
(m, 1H, Ha), 6.92 (s, 2H, Hh), 6.36 – 6.24 (m, 2H, Hd, He), 3.56 (d, J = 4.3 Hz, 2H, Hf), 2.35 
(s, 6H, Hg), 2.32 (s, 3H, Hi). 
13
C NMR (126 MHz, CDCl3) δ 137.81, 136.75, 135.66, 133.25, 
130.03, 129.03, 128.55, 127.87, 127.01, 126.14, 32.71, 21.00, 20.03.  m/z (EI) = 236 (M
+
,  
98%), 221 (100), 162 (38), 143 (43), 132 (75), 115 (68), 91 (48), 77 (47). m/z (HR-EI): 
236.15530 (predicted [M] = 23615595). 
 
1
H NMR (500 MHz, CDCl3) δ 7.34 – 7.29 (m, 4H, Hc), 7.29 – 7.24 (m, 4H, Hb), 7.21 – 7.15 
(m, 2H, Ha), 6.94 (s, 1H, Hh), 6.36 – 6.22 (m, 4H, Hd, He), 3.59 (dd, J = 5.3, 1.2 Hz, 4H, Hf), 
2.33 (s, 6H, Hg), 2.32 (s, 3H, Hi). 
13
C NMR (126 MHz, CDCl3) δ 137.83, 135.69, 134.72, 
134.31, 130.13, 130.11, 128.56, 128.12, 127.02, 126.16, 33.44, 20.20, 15.83.  m/z (EI) = 352 
(M
+
, 100%), 337 (20), 248 (38), 235 (85), 157 (59), 115 (27), 91 (31). m/z (HR-EI): 








1 S. Horiuchi, T. Murase and M. Fujita, Chem. – An Asian J., 2011, 6, 1839–1847. 
2 S. Horiuchi, Y. Nishioka, T. Murase and M. Fujita, Chem. Commun., 2010, 46, 3460–
3462. 
3 T. Murase, S. Horiuchi and M. Fujita, J. Am. Chem. Soc., 2010, 132, 2866–2867. 
4 Y. Nishioka, T. Yamaguchi, M. Yoshizawa and M. Fujita, J. Am. Chem. Soc., 2007, 
129, 7000–7001. 
5 M. Yoshizawa, Y. Takeyama, T. Okano and M. Fujita, J. Am. Chem. Soc., 2003, 125, 
3243–3247. 
6 M. Yoshizawa, M. Tamura and M. Fujita, Science, 2006, 312, 251–254. 
7 D. Fiedler, R. G. Bergman and K. N. Raymond, Angew. Chemie Int. Ed., 2004, 43, 
6748–6751. 
8 D. Fiedler, H. van Halbeek, R. G. Bergman and K. N. Raymond, J. Am. Chem. Soc., 
2006, 128, 10240–10252. 
9 W. M. Hart-Cooper, K. N. Clary, F. D. Toste, R. G. Bergman and K. N. Raymond, J. 
Am. Chem. Soc., 2012, 134, 17873–17876. 
10 W. M. Hart-Cooper, C. Zhao, R. M. Triano, P. Yaghoubi, H. L. Ozores, K. N. 
Burford, F. D. Toste, R. G. Bergman and K. N. Raymond, Chem. Sci., 2015, 6, 1383–
1393. 
11 C. J. Hastings, M. P. Backlund, R. G. Bergman and K. N. Raymond, Angew. Chemie 
Int. Ed., 2011, 50, 10570–10573. 
12 C. J. Hastings, M. D. Pluth, R. G. Bergman and K. N. Raymond, J. Am. Chem. Soc., 
2010, 132, 6938–6940. 
13 M. D. Pluth, R. G. Bergman and K. N. Raymond, J. Am. Chem. Soc., 2008, 130, 
11423–11429. 
14 M. D. Pluth, R. G. Bergman and K. N. Raymond, Acc. Chem. Res., 2009, 42, 1650–
1659. 
15 M. D. Pluth, R. G. Bergman and K. N. Raymond, Science, 2007, 316, 85–88. 
16 A. G. Doyle and E. N. Jacobsen, Chem. Rev., 2007, 107, 5713–5743. 
17 Y. Takemoto, Org. Biomol. Chem., 2005, 3, 4299–4306. 
18 M. S. Taylor and E. N. Jacobsen, Angew. Chemie Int. Ed., 2006, 45, 1520–1543. 
19 X. Yu and W. Wang, Chem. - An Asian J., 2008, 3, 516–532. 







21 P. F. Gordon and P. Gregory, in Organic Chemistry in Colour, 1987. 
22 H.-S. Bien, J. Stawitz and K. Wunderlich, in Ullmann’s Encyclopedia of Industrial 
Chemistry, 2000. 
23 T. D. Lash, Chem. – A Eur. J., 1996, 2, 1197-1200. 
24 R. P. Linstead, J. Chem. Soc., 1954, 3569-3574. 
25 R. P. Linstead, J. Chem. Soc., 1960, 3123–3132. 
26 H. Naeimi and Z. Babaei, J. Chinese Chem. Soc., 2015, 62, 41–46. 
27 C. B. Nielsen and F. C. Krebs, Tetrahedron Lett., 2005, 46, 5935–5939. 
28 M. Mercha, J. Chem. Phys., 1999, 110, 9536-9546. 
29 S. Kaur, A. Gupta, V. Bhalla and M. Kumar, J. Mater. Chem. C, 2014, 2, 7356–7363. 
30 P. De Marco, F. Bisti, F. Fioriti, M. Passacantando, C. Bittencourt, S. Lettieri,  a. 
Ambrosio, P. Maddalena, S. Prezioso, S. Santucci and L. Ottaviano, J. Appl. Phys., 
2012, 112, 1–5. 
31 N. Li, L. Qi, J. Qiao and Y. Chen, Anal. Chem., 2016, 88, 1821–1826. 
32 S. Karuppannan and J. C. Chambron, Chem. - An Asian J., 2011, 6, 964–984. 
33 J. Duhamel, Langmuir, 2012, 28, 6527–6538. 
34 D. M. Ziegler, Am. J. Clin. Nutr., 1961, 9, 43–49. 
35 A. Kroger and V. Dadak, Eur. J. Biochem, 1969, 11, 328–340. 
36 H. Nohl, W. Jordan and R. J. Youngman, Adv. Free Radic. Biol. Med., 1986, 2, 211–
279. 
37 F. Fringuelli, O. Piermatti, F. Pizzo and L. Vaccaro, European J. Org. Chem., 2001, 
2001, 439–455. 
38 U. Pindur, G. Lutz and C. Otto, Chem. Rev., 1993, 93, 741–761. 
39 Y. Huang, T. Iwama and V. H. Rawal, J. Am. Chem. Soc., 2002, 124, 5950–5951. 
40 S. Otto, F. Bertoncin and J. B. F. N. Engberts, J. Am. Chem. Soc., 1996, 118, 7702–
7707. 
41 E. J. Corey, Angew. Chemie - Int. Ed., 2002, 41, 1650–1667. 
42 L. C. Dias, J. Braz. Chem. Soc., 1997, 8, 289–332. 
43 H. B. Kagan, O. Riant and M. March, Chem. Rev., 1992, 92, 1007–1019. 
44 G. Silvero, M. J. Arévalo, J. L. Bravo, M. Ávalos, J. L. Jiménez and I. López, 
Tetrahedron, 2005, 61, 7105–7111. 






46 S. Otto, W. Blokzijl and J. B. F. N. Engberts, J. Org. Chem., 1994, 59, 5372–5376. 
47 P. M. Pihko, Angew. Chemie Int. Ed., 2004, 43, 2062–2064. 
48 A. N. Thadani, A. R. Stankovic and V. H. Rawal, Proc. Natl. Acad. Sci. U. S. A., 
2004, 101, 5846. 
49 K. H. Jensen and M. S. Sigman, Angew. Chemie - Int. Ed., 2007, 46, 4748–4750. 
50 P. Mal, B. Breiner, K. Rissanen and J. R. Nitschke, Science, 2009, 324, 1697–1699. 
51 J. M. Roberts, B. M. Fini, A. A. Sarjeant, O. K. Farha, J. T. Hupp and K. A. Scheidt, 
J. Am. Chem. Soc., 2012, 134, 3334–3337. 
52 G. Talavera, E. Reyes, J. L. Vicario and L. Carrillo, Angew. Chemie - Int. Ed., 2012, 
51, 4104–4107. 
53 M. J. Narcis, D. J. Sprague, B. Captain and N. Takenaka, Org. Biomol. Chem., 2012, 
10, 9134–6. 
54 N. Gupta and H. Linschitz, J. Am. Chem. Soc., 1997, 119, 6384–6391. 
55 P. S. Guin, S. Das and P. C. Mandal, Int. J. Electrochem., 2011, 2011, 1–22. 
56 A. K. Turek, D. J. Hardee, A. M. Ullman, D. G. Nocera and E. N. Jacobsen, Angew. 
Chemie - Int. Ed., 2015, 539–544. 
57 B. Nepal and S. Scheiner, J. Org. Chem., 2016, 81, 4316-4324. 
58 H. Matsubara, T. Maegawa, Y. Kita, T. Yokoji and A. Nomoto, Org. Biomol. Chem., 
2014, 12, 5442–7. 
59 R. Whetten and R. Sederoff, Plant Cell, 1995, 7, 1001–1013. 
60 J. Ralph, K. Lundquist, G. Brunow, F. Lu, H. Kim, P. F. Schatz, J. M. Marita, R. D. 
Hatfield, S. A. Ralph, J. H. Christensen and W. Boerjan, Phytochem. Rev., 2004, 3, 
29–60. 
61 T. Ito, R. Hayase, S. Kawai, H. Ohashi and T. Higuchi, J. Wood Sci., 2002, 48, 216–
221. 
62 P. Liao, B. W. Langloss, A. M. Johnson, E. R. Knudsen, F. S. Tham, R. R. Julian and 
R. J. Hooley, Chem. Commun., 2010, 46, 4932. 
63 V. U. Pandit, S. S. Arbuj, U. P. Mulik and B. B. Kale, Environ. Sci. Technol., 2014, 
48, 4178–83. 
64 J. J. Mason and J. Bergman, Org. Biomol. Chem., 2007, 5, 2486–2490. 
65 J. Barluenga, H. Fanlo, S. López and J. Flórez, Angew. Chem. Int. Ed., 2007, 46, 
4136–40. 







This work represents a significant advance in the areas of metallosupramolecular and 
photoredox catalysis. However, the overall aim of combining both fields with a single self-
assembled system remains unaccomplished. In order to achieve those aims, future work will 
hopefully capitalise on the discoveries described herein, to design and synthesise modular 
systems that can incorporate photoactive building blocks into container compounds that also 
contain binding sites capable of activating substrates towards a range of potential reactions.    
It is also hoped that the counter ion dependent guest binding discussed within will have 
wider reaching implications for a number of topical areas and potential supramolecular 
applications in years to come. 
   
